Doctor of Philosophy by Zhou, Jie
EFFORTS TOWARDS THE TOTAL SYNTHESIS OF BREVENAL AND 
DEVELOPMENT OF OLEFINIC AMIDE AND OLEFINIC LACTAM 









A dissertation submitted to the faculty of  
The University of Utah 
















Department of Chemistry 













Copyright © Jie Zhou 2010 
All Rights Reserved 
 
 








The dissertation of Jie Zhou 
has been approved by the following supervisory committee members: 
 
Jon D. Rainier , Chair 08/26/2010 
Date Approved 
Gary E. Keck , Member 08/26/2010 
 
Date Approved 
Cynthia J. Burrow , Member 08/26/2010 
 
Date Approved 
Haitao(Mark) Ji , Member 08/26/2010 
 
Date Approved 




and by Henry S. White , Chair of  
the Department of Chemistry 
 





Brevenal and its dimethyl acetal were isolated from laboratory cultures of the 
dinoflagellate Karenia brevis by Barden and co-workers in 2005. Brevenal has the 
potential to serve as therapeutic agents for the treatment of brevetoxins poisoning 
because of their low toxicity and ability to block the effect of brevetoxins in vivo. 
This dissertation describes our efforts towards the total synthesis of brevenal. A C-
glycoside/metathesis approach is used in our synthesis. Of note is the generation of α-
C-glycosides in one pot by using a DMDO oxidation and zinc mediated C-C bond 
formation sequence. Lewis acid TBSOTf is very important in these reactions. 
Nucleophiles prefer to add from the axial position regardless of the epoxides. 
Cyclic enamides are valuable in their own and interesting precursors to a variety 
of natural products containing nitrogen. Although the olefinic-amide cyclizations 
would be synthetically useful, there are few reports of related cyclization that employ 
amides. Described here is the use of a reduced Titanium alkylidene reagent to effect 
one-step olefinic-amide and olefinic-lactam cyclizations. 
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Marine polycyclic ether natural products have been interesting synthetic targets 
for years because of their unique and highly complex structures in addition to their 
diverse and potent biological activities.1-3 Since the discovery of brevetoxin B in 1981,4 a 
number of bioactive polyether compounds have been isolated from the marine 
dinoflagellate Karenia brevis, the organism responsible for the toxic red tides along 
Florida’s Gulf Coast.5 The most well-known of these are the brevetoxins, which consist 
of three different structural backbones: brevetoxin B (Figure 1.1), brevetoxin A (Figure 



























PbTx-2 (1.1), R = CH2C(=CH2)CHO
PbTx-3 (1.2), R = CH2C(=CH2)CH2OH
PbTx-5 (1.3), K-Ring acetate
PbTx-6 (1.4), H-Ring epoxide
PbTx-8 (1.5), R = CH2COCH2Cl
PbTx-9 (1.6), R = CH2CH(CH3)CH2OH
A B C D




































PbTx-1   (1.7), R = CH2C(=CH2)CHO
PbTx-7   (1.8), R = CH2C(=CH2)CH2OH
PbTx-10 (1.9), R = CH2CH(CH3)CH2OH
 















     Figure 1.3. Structure of hemibrevetoxin B  
 








            Brevetoxins A and B bind with high affinity to site 5 of voltage gated sodium 
channels (VGSC) in neurons. Orientation of the brevetoxins is believed to be in a head-
down with the A-ring lactone facing the cell interior and the tail end of the molecule 
facing outward.6  
Voltage gated sodium channels are ion channels. Ion channels are integral 
membrane proteins that permit the passage of ions based solely on their charge and size. 
The archetypal channel pore is just one or two atoms wide at its narrowest point and is 
selective for specific species of ions, such as sodium or potassium. Ions move through the 
channel pore single file nearly as quickly as the ions move through free fluid. Passage 
through the pore is governed by a gate which may be opened or closed by chemical or 
electrical signals, temperature, or mechanical force, depending on the type of channel.     
Ion Channels are classified according to the trigger that opens the channel for 
such ions in eukaryotes. Sodium channels are responsible for the passage of sodium ions 
through a cell's plasma membrane and consist of a large α subunit that associates with 
other proteins, such as β subunits. An α subunit forms the core of the channel and is 
functional on its own. It has four repeat domains, labeled I through IV, each containing 
six membrane-spanning regions, labeled S1 through S6. Binding of brevetoxins A and B 
to tissues containing VGSC results in membrane depolarization, repetitive firing, and 
increased sodium currents.7-10 Further experiments indicate that brevetoxins A and B 
activate VGSC by prolonging their mean open time, inhibiting channel inactivation, and 
shifting the channel activation potential to  more negative values. Humans are most 
commonly affected by brevetoxins that have been aerosolized in sea spray or that have 
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bioaccumulated in shellfish. Inhaled brevetoxins cause respiratory irritation and breathing 
difficulties in sensitive populations.11-13  
Gambierdiscus toxicus is another important dinoflagellate. It produces a number 
of ladder like polycyclic ethers such as ciguatoxin 1.11 (Figure 1.4), maitotoxin 1.12 
(Figure 1.5), gambierol 1.13 (Figure 1.6), gambieric acids 1.14-1.17 (Figure 1.6) and 
yessotoxin 1.18 (Figure 1.6).  
Ciguatera, the most widespread seafood poisoning event, is caused by the 
ingestion of coral reef fish that have become toxic through their diet.14 The main 
responsible toxins are thought to be the ciguatoxins and maitotoxin. The clinical 
symptoms are diverse.15 Neurologic disturbances are prominent. Reversal of thermal 
sensation is one of the most characteristic symptoms of ciguatera. Other illnesses 
included prostration, cyanosis, erethism and joint pain. 


































































































































































































































GAA (1.14), R1 = H, R2 = H
GAB (1.15), R1 = Me, R2 = H
GAC (1.16), R1 = H, R2 =
O Me O
OH1' 3'







































yessotoxin (1.18)  
Figure 1.6. Structures of gambierol, gambieric acids and yessotoxin 
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Ciguatoxin was first isolated by Scheuer’s group at University of Hawaii16 and the 
structure was elucidated by Yasumoto’s group in 1989.17 Ciguatoxin was found in both 
the dinoflagellate Gambierdiscus toxicus and in toxic fish. Ciguatoxins target the VGSCs 
in a similar fashion to the brevetoxins, but their binding affinities are 25- to 400- fold 
stronger.18  
            Maitotoxin, the largest nonpolymeric natural product, has a molecular weight of 
3422 Daltons (as the disodium salt, C164H256O68S2Na2). It contains 32 rings, 98 
stereogenic centers and one trisubstituted double bond. Maitotoxin was first isolated from 
the gut of the surgeon fish Ctenochaetur striatus19 and later from the dinoflagellate 
Gambierdiscus toxicus.20 Maitotoxin has extremely potent bioactivity. The lethality 
against mice (LD50 is 50 ng/kg) suggests that it is the most potent nonproteineceous 
toxin.21 Maitotoxin was found to increase Ca2+ influx which could be blocked by 
verapamil, suggesting that maitotoxin acts on a voltage-sensitive Ca2+ channel.22 The 
Ca2+ flux induced by maitotoxin leads to secondary effects such as muscle contractions, 
stimulation of hormones/neurotransmitter release, activation of phospholipases C and A2 
and activation of protein kinases.23 
Gambierol is another polyether isolated from the dinoflagellate Gambierdiscus 
toxicus by Yasumoto and co-workers in 1993.24 It shows toxicity against mice with a 
LD50 of 0.6 µg/Kg. The symptoms that result from gambierol resemble those shown by 
ciguatoxins, inferring the possibility that it is also implicated in ciguatera.25 Synthetic 
gambierol from our laboratory has helped in the understanding of the interactions 
between gambierol and VGSC. In collaboration with Tom Murray and co-workers, 
gambierol was found to inhibit the binding of PbTx-2 to site 5 of VGSC and act as a 
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competitive antagonist of PbTx-2.26(a) In collaboration with Jan Tytgat and Dirk 
Synders, we found that gambierol is a low nM antagonist of voltage gated potassium 
channels and that it does not bind to VGSCs.26(b) In collaboration with Murray, we 
have also demonstrated that gambierol does not elicit a neurotoxic response.26(a)  
            Other important compounds from Gambierdiscus toxicus include the gambieric 
acids. The gambieric acids have displayed strong antifungal activity with inhibitory 
activity against Aspergillus niger that was 2000 times greater than that of amphotericin 
B.27 A further study by Yasumoto and Hirama showed that gambieric acid A 
competitively inhibits the binding of isotope-labeled dihydro-brevetoxin ([3H]PbTx-3) 
from the VGSC of rat brain synaptosomes.25 
            Diarrhetic shellfish poisoning (DSP) is widely distributed over the world, 
particularly in Japan and the northwestern part of Europe.28 It is associated with eating 
bivalves such as mussels, scallops or clams which have accumulated dinoflagellate toxins. 
Yessotoxin was isolated from the scallop Patinopecten yessoensis in Japan.29 It was 
found to induce apoptosis through a mitochondrial signal transduction pathway.30 Both 
yessotoxin and its disulfated counterpart bind to the transmembrane domain of 
glycophorin A and cause the dissociation of oligomers of the protein.30 
 
Isolation and bioactivities of brevenal 
            In 2005, a new polyether natural product named brevenal (Figure 1.7) was 
isolated from laboratory cultures of Karenia brevis together with its dimethyl acetal 
derivative by Baden and co-workers.31 More recently, these compounds have also been 



















brevenal (1.19): R = CHO
brevenal dimethyl acetal (1. 20): R = CH(OMe)2  
Figure 1.7. Initial structure of brevenal and brevenal dimethyl acetal 
 
The presence of brevenal has been found to vary with the phase and toxicity of the 
bloom.32 Brevenal and its dimethyl acetal derivative contain five fused cyclic ether rings 
and a structural backbone that is different from both the brevetoxins and hemibrevetoxin 
B. The arrangement of the 6, 7, 6, 7, 7 ether rings in brevenal is unique among 
dinoflagellate metabolites. 
The interactions between brevenal and VGSC were evaluated by using a rat brain 
synaptosome receptor-binding assay. Brevenal and its dimethyl acetal were found to 
inhibit [3H]-PbTx-3 binding in a concentration-dependent manner.31 Similar antagonistic 
activity against brevetoxins’ binding to VGSC has also been observed for synthetic 
gambierol26 and gambieric acid A.25 
The antagonistic effects of brevenal and brevenal acetal on brevetoxin toxicity 
were tested using a fish bioassay. Brevenal shows no toxicity at micromolar 
concentrations while brevetoxins are lethal in nanomolar concentrations. In addition, Fish 
exposed to a combination of brevenal and PbTx-2 survived longer than those exposed to 
PbTx-2 alone. This result suggests that brevenal can delay brevetoxin-induced mortality 
in fish.31 When brevenal dimethyl acetal was used instead of brevenal, the delay of 
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mortality did not achieve statistical significance. The “anti-toxin” properties of brevenal 
were further explored by Abraham and co-workers in sheep models. Their study shows 
brevenal can block bronchoconstriction caused by the inhalation of the brevetoxins. They 
also found that brevenal increases mucociliary clearance at a 10-6 lower concentration 
when compared to amiloride.33 Amiloride is currently used to treat cystic fibrosis which 
is caused by a mutation in the gene for the protein cystic fibrosis transmembrane 
conductance regulator.33  
Thus, brevenal and its derivative have the potential to serve as therapeutic agents 
for the treatment of brevetoxin poisoning because of their low toxicity and ability to 
block the effects of the brevetoxins in vivo. Because of this and an interest in better 
understanding the ion channel binding properties of the ladder toxins, we initiated a 
program targeting the synthesis of brevenal and derivatives. Thus, following a brief 
discussion of other work targeting brevenal is a detailed discussion of our work. 
 
Sasaki’s total synthesis of brevenal 
Brevenal has received a significant amount of attention since its discovery due to 
its unique structure and its novle biological activity. Before discussing our efforts toward 
brevenal, a brief summary of the work from other groups is outlined here. 
            In 2006, Sasaki reported the first total synthesis of the initially proposed structure 
of brevenal.34 They found that the 1H NMR and 13C NMR spectra for the synthetic 
material were not identical to those reported for the natural product. Later that year, they 
reported a revised synthesis where a detailed spectroscopic comparison suggested that the 
natural product was the C26 epimer of the originally proposed structure (Figure 1.8).35 
11 
 



















Figure 1.8. Revised structure of brevenal 1.21 
 
The key features of their synthesis included a convergent assembly of the 
pentacyclic polyether skeleton by a Suzuki-Miyaura coupling and a stereoselective 
construction of the left-hand (E,E)-diene system by a CuTC-promoted modified Stille 
coupling (Scheme 1.1).  
The synthesis of AB ring fragment commenced with an Evans aldol reaction 
between aldehyde 1.25 and oxazolidinone 1.26, which provided the syn aldol adduct 
(Scheme 1.2). The chiral auxiliary was reductively removed with NaBH4 to provide 1,3-
diol 1.27 as a single isomer. After 10 steps, epoxide 1.28 was formed. Deprotection of the 
PMB group followed by 6-endo cyclization afforded the A ring 1.29 after TES ether 
formation. Another four steps gave 1.30. Hydrogenation of 1.30 with concomitant 
hydrogenolysis of the benzyl ester, followed by Yamaguchi lactonization generated a 
seven-membered lactone which was  converted to AB ring enol phosphate 1.23 in 85%  
yield for three steps.  
For the synthesis of DE ring fragment 1.24, the known ether 1.3136 was chosen as 
a starting material (Scheme 1.3). Ether 1.31 was converted to primary triflate 1.32 in five 
steps. Then triflate 1.32 was subjected to nucleophilic displacement with allylmagnesium 

































































1. 23 1. 24  





























1) n-Bu2BOTf, Et3N, 
    CH2Cl2, -78 oC to 0 oC
2) NaBH4, THF/H2O, rt













1) DDQ, CH2Cl2/H2O(20:1), rt
2) TESOTf, 2, 6-lutidine, CH2Cl2



















1) H2, 20% Pd(OH)2/C, THF/MeOH (2:1)
2) 2,4,6-Cl3C6H2COCl, Et3N, THF, rt;
    then DMAP, toluene, 110 oC
3) KHMDS, (PhO)2P(O)Cl, HMPA, 
THF, -78 oC
(85% for 3 steps)
 








terminal olefin followed by deprotection and incorporation of a β-alkoxyacrylate 
provided 1.34 in 88% yield for three steps. Reductive cyclization of 1.34 with SmI2 
generated a mixture of 1.35 and 1.36 with the desired stereochemistry at C26. Each of 
these compounds was reduced to yield diol 1.37. The subsequent seven steps included 
protecting group manipulation and one carbon elongation to generate 1.38. Iodination and 
subsequent elimination afforded DE ring fragment 1.24 in 98% yield. 
With the coupling fragments in hand, they assembled the pentacyclic polyether as 
shown in Scheme 1.4. Suzuki-Miyaura coupling between 1.23 and the alkylborane from 
1.24 afforded 1.39. Ketone 1.40 was formed in 8 steps involving hydroboration, 
oxidation, protection and Rubottom oxidation. In order to form the C ring, ketone 1.40 
was treated with EtSH in the presence of Zn(OTf)2 to generate thioacetal 1.41 after 
protection. Then thioacetal 1.41 was oxidized by mCPBA followed by addition of AlMe3 
to afford pentacyclic polyether 1.42 in good yield. The side chains were installed in 18 
steps to finish (-)-brevenal. The longest linear sequence of Sasaki’s synthesis was 68 
steps. Sasaki’s powerful coupling strategy led not only to the first total synthesis of 
brevenal but also to a revision of the proposed structure. 
 
Yamamoto’s total synthesis of brevenal 
In 2009, Kadota and Yamamoto published their total synthesis of brevenal.37 
They used a Horner-Wadsworth-Emmons reaction to install the left-hand side chain and a 
Wittig reaction to install the right-hand side chain. The pentacyclic ether core was 
constructed by an intramolecular allylation of an α-acetoxy ether and a subsequent ring-

































1) Cu(OAc)2, PdCl2, O2, DMA/H2O, rt
2) TBAF, THF, rt
3) methyl propiolate, NMM, CH2Cl2











1. 31 1. 32















































1) I2, PPh3, benzene, 
    imidazole
2) t-BuOK, THF, 0 oC
(98% for 2 steps)
 
Scheme 1.3. Sasaki’s synthesis of DE ring exocyclic enol ether 1.24 
      
 


























1. 23 1. 24
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1) EtSH, Zn(OTf)2, 

















     CH2Cl2 (86%)
mCPBA, CH2Cl2, -78 oC























Scheme 1.4. Sasaki’s synthesis of the pentacyclic polyether core 




























































1. 44 1. 45  






The synthesis of the ABC ring fragment 1.44 is outlined in Scheme 1.6. The 
known compound 1.4638 was converted to key intermediate 1.47 in 10 steps. Yamaguchi 
lactonization set the 6,7 fused ring system. Enol phosphate 1.49 was formed under the 
usual conditions. Then a Suzuki-Miyaura coupling of 1.49 and the alkyl borate from 1.50 
afforded enol ether 1.51. After 4 steps, 1.51 was converted to ketone 1.52. Cyclization 
took place using EtSH/Zn(OTf)2 to generate the thioacetal which was subjected to Me2Zn, 
Zn(OTf)2 to install the angular methyl group in 89% yield. The intermediate 1.53 was 
converted to the coupling partner 1.44 in additional 7 steps.  
Scheme 1.7 describes the synthesis of the pentacyclic polyether core. A 
Yamaguchi esterification between the two key segments generated ester 1.54 after TES 
deprotection using camphorsulfonic acid. After additional 4 steps, stannane 1.55 was 
formed. Modified Rychnovsky acetylation of ester 1.55 provided the α-chloroacetoxy 
ether which underwent intramolecular allylation by MgBr2.OEt2 to give 1.56. Ring-
closing metathesis of diene 1.56 led to pentacyclic ether 1.57 in 69% yield. After another 
11 steps, brevenal was formed. The longest linear sequence in Yamamoto’s synthesis was 
57 steps with a 0.84% overall yield. 
 
Crimmins’ approach towards brevenal 
In 2010, Crimmins reported their progress towards brevenal.39 A Horner-
Wadsworth-Emmons olefination was planned to couple the AB-ring and E-ring (Scheme 
1.8). Construction of the AB-ring and E-ring fragments would be achieved through an 




































































t-BuLi, B-MeO-9-BBN, Et2O, -78 oC; then 
PdCl2(dppf), aq K2CO3, DMF, rt





























1) EtSH, Zn(OTf)2, 
    THF, rt
1. 53
2) Me2Zn, Zn(OTf)2


















Scheme 1.6. Yamamoto’s synthesis of ABC ring acid 1.44 



























































2) CSA, MeOH/CH2Cl2, 0 oC










































1) i-Bu2AlH, CH2Cl2, -78 oC; then
   (ClCH2CO)2O, pyridine, DMAP
2) MgBr2.OEt2, 5A MS, CH2Cl2, 
-78 oC to 0 oC











The synthesis of the AB-ring subunit started with a Horner-Wadsworth-Emmons 
olefination between 1.61 and 1.62 (Scheme 1.9). After further transformations, 1.64 was 
cyclized under acidic condition to give enol ether 1.65. The angular methyl group was 
installed in three steps: 1) thioacetal 1.66 formation via an epoxide intermediate, 2) 
protection of the hydroxyl group as a TES ether and 3) methyl group installation by 
mCPBA /AlMe3. After six steps, 1.67 was converted into oxazolidinone 1.68. Treatment 
of the sodium enolate of 1.68 with bromoacetonitrile resulted in a highly 
diastereoselective glycolate alkylation to furnish the nitrile 1.69. In another three steps, 
1.69 was converted to diene 1.70. Ring-closing metathesis by Grubbs’ second generation 
catalyst afforded 1.71. Then 1.71 was converted to β-ketophosphonate 1.59 in five steps. 
The synthesis of the E-ring began with an asymmetric aldol addition between 
oxazolidinone 1.72 and aldehyde 1.73 (Scheme 1.10). The product 1.74 was converted to 
aldehyde 1.75 in four steps. A Wittig reaction followed by deprotection gave homoallylic 
alcohol 1.76. Alkylation of 1.76 with bromoacetic acid followed by coupling with valine-
derived oxazolidinone 1.77 generated 1.78. Then, diastereoselective alkylation of 1.78 
with bromoacetonitrile gave 1.79 which was converted to diene 1.80 as a diastereomeric 
mixture in three steps. Treatment of diene 1.80 with Grubbs’ second generation catalyst 
led to the formation of 1.81 in 91% yield. After four steps, aldehyde 1.60 was formed.      
With both coupling partners in hand, they pushed one step further. The Horner-
Wadsworth-Emmons reaction between β-ketophosphonate 1.59 and aldehyde 1.60 
afforded enone 1.82 in 90% yield (Scheme 1.11). So far, they proved the coupling 






































































1. 59 1. 60  































1. 61 1. 62
+ Ba(OH)2, THF 2 steps










1. 64 1. 65
1) DMDO, CH2Cl2, -78 oC
2) EtSH, Zn(OTf)2, CH2Cl2







1) TESCl, KHMDS, 
-78 oC (98%)
2) mCPBA, CH2Cl2;
   then AlMe3, -78 oC























































































































1) H2C=PPh3, THF (90%)





1) NaH, BrCH2COOH (87%)




















































Results and Discussion 
First generation of brevenal 
The intriguing structure and unique biological activities of the marine ladder 
toxins have also attracted our attention. In addition to the interest in ion channel binding 
properties, our successful experiences with hemibrevetoxin B,40 gambierol41 and 
gambieric acid   A42 encouraged us to pursue the synthesis of brevenal.    
The retrosynthetic plan is outlined in Scheme 1.12. At that time, Sasaki and co-
workers had not published their total synthesis of brevenal. So we began our work 
targeting the initially proposed brevenal. The side chains would be incorporated at the 
end of the synthesis. The B-ring would come from a hydroxy-ketone cyclization and 





































































































































































































Scheme 1.12. Retrosynthetic analysis of brevenal 3.19 
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metathesis) reaction sequence. The fully functionalized C-E ring system 1.85 would be 
synthesized by a Mukaiyama aldol reaction. The E-ring would be in turn come from an 
acid mediated cyclization and the D-ring would be constructed using a Takai/ring closing 
metathesis sequence. The fully functionalized C-ring 1.88 would come from tri-O-acetyl-
L-glucal. Our work began with the lower cost D-glucal derivative that would lead to the 
enantiomer of the natural product.  
Hydrolysis of tri-O-acetyl-D-glucal 1.90 afforded D-glucal 1.91 in 98% yield. The 
hydroxyl groups at the C-4 and C-6 positions were simultaneously protected as the silyl 
ethers. The C-3 hydroxyl group was protected as a TBDPS ether to afford 1.93. Then 
cyclic enol ether 1.93 was methylated at the α-C to give compound 1.94 in 98% yield. 
Oxidation of 1.94 with DMDO and addition of allylmagnesium chloride to the 
intermediate epoxide gave secondary alcohol 1.95 as a single diastereomer in 92% yield. 
The stereochemical outcome of this reaction could be explained by coordination of the 
Mg counterion to the axial lone pair of the pyranyl oxygen and ligand transfer via six 
membered transition structure 1.9843 (Figure 1.9). Selective removal of the TBDPS group 
by NaH afforded diol 1.96 in 86% yield. After selective protection, we arrived at TMS 
ether 1.97 (Scheme 1.13).  
5,5-dimethoxypentanoic acid which would react with alcohol 1.97 was prepared 
according to the procedure44 shown in Scheme 1.14. Methanolysis of δ-valerolactone 
gave hydroxy-ester 1.100 after refluxing for 3 days. Oxidation of the free alcohol 
afforded aldehyde 1.101 which was protected as the corresponding dimethyl acetal to 
give 1.102 in 50% yield for the three steps. Hydrolysis of ester 1.102 afforded acid 1.103 








1. 98  





































t-BuLi, THF,  0 oC; then 









1) DMDO, CH2Cl2, -78 oC
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Steglich esterification between 1.97 and 1.103 generated ester 1.104 in 82% yield 
(Scheme 1.15). Removal of the TMS group gave 1.105 in 95% yield. Barton 
deoxygenation afforded compound 1.106 in 80% yield over two steps. One-carbon 
homologation of allyl derivative 1.106 began with a hydroboration/oxidation reaction to 
give primary alcohol 1.107. Oxidation to the aldehyde using TPAP/NMO and Wittig 
methylenation gave homoallyl derivative 1.108. At this stage, olefinic-ester 1.108 was 
converted into the corresponding acyclic enol ether which was then cyclized using 
Schrock’s molybdenum catalyst to afford seven-membered enol ether 1.109 in 55% yield 
over the two steps. However, Grubbs 2nd generation catalyst afforded only a 30% yield of 
1.109. 
The tricycle 1.109 was oxidized with DMDO to give an epoxide that was reduced 
by iBu2AlH to give secondary alcohol 1.112 in 78% yield as a single diastereomer 
(Scheme 1.16). This result was consistent with the DFT calculation on the DMDO 
epoxidation of a related substrate.45 We believe that torsional interactions between the 
pseudo-axial allylic proton and DMDO in the transition state result in epoxidation from 
the lower face as indicated in Figure 1.10. After 1.110 was formed, reduction by iBu2AlH 
afforded product 1.112 presumable via an intramolecular hydride transfer as indicated in 
1.111. 
The E-ring in 1.113 was generated using a hydroxy-acetal cyclization and 
elimination using PPTS and pyridine.  Enol ether 1.113 was oxidized by DMDO to afford 
a mixture of the corresponding epoxides which were allowed to react with 
allylmagnesium chloride to give secondary alcohols 1.114 and 1.115 as a 2:1 mixture 
(78% yield) favoring the desired product 1.114 (Scheme 1.17).  
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 BH3.DMS, THF,  0 oC;
NaHCO3, H2O2, 0 oC
(78%, regioselectivity: 4:1 )
1) TPAP, NMO, 4A MS, CH2Cl2
2) Ph3PCH3Br, t-BuOK, THF, rt
1) TiCl4, TMEDA, THF, Zn, PbCl2,












































1) CS2, NaH; MeI, -25 oC to -5 oC
2) Bu3SnH, AIBN, Benzene, 80 oC












(80%  over 2 steps)
o
2) Schrock's catalyst, Hexanes
 60 oC























































                                         Scheme 1.15.  Formation of the D-ring 
      





























































Scheme 1.16.   Oxidation of the D-ring 













































































MgCl, CH2Cl2, -78 oC
+
 














The mixture of 1.114 and 1.115 was acylated and the olefins were subjected to a 
hydroboration/oxidation to give 1.117 after PMB ether formation. The acetate was 
removed using potassium carbonate. Oxidation of the alcohol 1.118 using TPAP/NMO 
gave a mixture of ketones in 85% yield. At this stage, the two isomers 1.119 and 1.120 
were separated and the minor isomer 1.120 was equilibrated using imidazole to provide 
the desired product 1.119 in 85% yield (Scheme 1.18). 
The completion of our first generation synthesis of the C-E ring system is given in 
Scheme 1.19. During our initial studies, the stereochemistry for the tertiary alcohol had 
not been revised by Sasaki. Thus, we performed a three-step sequence to install the axial 
alcohol. Ketone 1.119 was subjected to a Wittig reaction to form 1,1-disubstituted olefin 
1.121 in 83% yield. Olefin 1.121 was epoxidized by mCPBA and then reduced by 
LiEt3BH to provide desired tertiary alcohol 1.122 that corresponded to the proposed 
structure of brevenal in 56% yield over two steps. The relative stereochemistry of 1.122 
was confirmed by nOe experiments.  1.122 was protected as a TBS ether to give 1.123 in 
90% yield. The silylene in 1.123 was selectively removed with HF.pyridine to give the 
corresponding diol that was diprotected as the corresponding TES ethers. The primary 
alcohol was released using AcOH to afford 1.124 in 50% yield over the three steps.  
As we were completing our work to the C-E ring system, Sasaki and co-workers 
published their brevenal total synthesis. It became clear to that our synthesis of the C-E 
ring subunit was too long to enable us to efficiently complete the synthesis and to 


































1) BH3. DMS, THF, 0 oC,
    then NaHCO3, H2O2
2) PMB acetimidate, TfOH, ether, 0 oC































































imidazole, toluene, reflux, 9h
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1) mCPBA, NaHCO3, toluene






















































3) AcOH, THF, H2O
  (50%  for 3 steps)
PMBO
(83%)
Ph3PCH3Br,  THF, 
t-BuOK, 0 oC to rt
 
Scheme 1.19. Completion of the fully functionalized C-E ring 
 
Second generation of brevenal 
Our second generation retrosynthetic plan is outlined in Scheme 1.20. As in our 
initial approach, the side chains would be incorporated at the end of the synthesis. The C-
ring would come from a hydroxy-ketone cyclization and reduction sequence. The D-ring 
would come from olefinic-ester cyclization. Intermediate 1.126 would come from an 
esterification between the AB-ring moiety 1.127 and the E-ring 1.128. In addition to 
enabling us to more efficiently generate brevenal and analogs, this approach would result 
in the synthesis of the correct enantiomer of brevenal. 
The synthesis of the E-ring subunit began with (L)-glyceraldehyde acetonide 
1.129.46 Addition of homoallylmagnesium bromide (prepared from 4-bromo-1-butene) to 


































































































Scheme 1.20. Retrosynthetic analysis of brevenal  
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Acetonide 1.130 was deprotected using PPTS, MeOH to give triol 1.131 in 90% yield. 
Triol 1.131 was selectively protected as the corresponding benzylidene to give 1.132 in 
87% yield (Scheme 1.21). It is worthwhile to mention that refluxing conditions decreased 
the amount of five-membered ring (benzylidene acetal of 1,2-diols) formation from 30% 
to less than 10%. Steglich esterification between 1.132 and 4-(4-methoxybenzyloxy) 
butanoic acid (prepared according to a known procedure47 as shown in Scheme 1.22) 
provided olefinic-ester 1.133 in 82% yield.  
With olefinic-ester 1.133 in hand, we were prepared to test the cyclization 
chemistry (Scheme 1.23). A general method of making cyclic enol ethers is a two-step 
protocol: 1) ester to acyclic enol ether formation (Takai reaction) 2) ring closing 
metathesis. By using a titanium methylidene reagent, the Takai reaction provided the 
acylic enol exclusively. Ring closing metathesis using the Grubbs’ second generation 
catalyst gave a 35%-40% yield of cyclic enol ether 1.138 together with a significant 
amount of byproducts coming from isomerization of the olefin. In contrast, the use of the 
titanium ethylidene reagent on ester 1.134 gave cyclic enol ether 1.138 in 68% yield 
together with 22% of acyclic enol ether 1.139 which could be converted into 1.138 in 
20% yield using the Grubbs’ second generation catalyst under an atmosphere of ethylene.  
Cyclic enol ether 1.138 was oxidized by DMDO to give the corresponding 
epoxide. Reduction with iBu2AlH afforded secondary alcohol 1.140 as the major product. 
(Less than 5% of the diastereomer was observed). Oxidation using NMO and TPAP gave 
ketone 1.141 in 80% yield (Scheme 1.24). The relative stereochemistry was confirmed 
using nOe experiments. Next, the addition of methylmagnesium bromide to ketone 1.141 
























ZnCl2, THF,  -90 oC








DCC, DMAP, CH2Cl2, rt
























Scheme 1.22. Synthesis of 4-(4-methoxybenzyloxy)butanoic acid 
       










    TiCl4, CH2Cl2, THF,
    TMEDA, Zn, PbCl2,












(35% to 40% for 2 steps)
    TiCl4, CH2Cl2, THF,
    TMEDA, Zn, PbCl2,
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Grubbs' 2nd generation catalyst
 
Scheme 1.23. Formation of the E-ring 
 








  DMDO, CH2Cl2, -78 oC;
i-Bu2AlH, CH2Cl2, 
   -78 oC to 0 oC
NMO, TPAP, 4 A MS





















































Scheme 1.24. Generation of the tertiary alcohol at C-26 
 
The relative stereochemistry at the C26 stereocenter of 1.143 was established by nOe 
correlations between the 26-Me and 27-H. The corresponding nOe correlations were not 
observed for 1.142. 
Tertiary alcohol 1.142 was protected as the corresponding TBS ether to give 
1.144 in 90% yield. The acetal in 1.144 was deprotected using PPTS in methanol to give 
diol 1.145 in 90% yield. The generation of the primary triflate and the secondary TES 
ether was realized in one-pot to give 1.146. Displacement of the triflate with allyl cuprate 
generated in situ afforded homoallyl derivative 1.147 in 75% yield over the two steps. 












TESOTf, 2,6-lutidine  CuI, THF, -40 
























































Scheme 1.25. Synthesis of the E-ring alcohol 
       
The AB-ring acid was synthesized as shown in Scheme 1.26. Starting from 
TBDPS protected aldehyde 1.149, crotylation generated the desired alcohol 1.150. 
Steglich esterification between 1.150 and known acid 1.10344 afforded olefinic-ester 
1.151. One-carbon homologation of the vinyl derivative 1.151 generated allyl derivative 
1.152.  The olefinic-ester 1.152 was then subjected to the titanium ethylidene cyclization 
to obtain cyclic enol ether 1.153 in 75 % yield. Cyclic enol ether 1.153 was treated with 
DMDO followed by AlMe3 to obtain secondary alcohol 1.154 in 65% yield. Using PPTS 
and pyridine, the B-ring was formed in two steps from 1.154. Treatment of 1.155 with 
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DMDO followed by allylmagnesium chloride resulted in the allylated product 1.156 in 
80% yield. In order to test our coupling strategy, we simplified the acid partner. The free 
alcohol in 1.156 was protected as the corresponding TES ether which was converted to 
acid 1.158 in two steps. 
After getting the appropriate coupling partners 1.148 and 1.158, Yamaguchi 
esterification brought the two pieces together (Scheme 1.27). With the ester in hand, 
olefinic-ester cyclization was attempted to give the brevenal D-ring. Unfortunately, the 
titanium ethylidene reagent gave acyclic enol ether 1.160 in 50% yield. Subjecting 
acyclic enol ether 1.160 to Grubbs’ 2nd generation catalyst led to the decomposition of 
1.160.  Methylenation and ring closing metathesis was also unsuccessful. Treatment of 
1.159 with titanium methylidene reagent led to its decomposition (Scheme 1.28).  
 
Third generation of brevenal 
In order to circumvent the cycliztion problem, a modified coupling strategy was 
proposed (Scheme 1.29). Here, we plan to use an olefinic-ester cyclization to construct 
the C-ring. Disconnection of ester 1.164 leads to the AB-alcohol 1.165 and E-acid 1.166. 
In collaboration with Mr. John Rohanna, the AB-ring alcohol was synthesized 
from intermediate 1.156. Oxidation using TPAP and NMO gave ketone 1.167 in 91% 
yield (Scheme 1.30). Rubottom oxidation of 1.167 installed the α-hydroxyl group as a 
TES protected ether. Deprotection of the TES group in 1.168 gave hydroxy-ketone 1.169. 
Reduction of 1.169 with iBu2AlH gave syn diol 1.170 which was selectively protected as 
the corresponding C(14) benzyl ether 1.171 in 82% yield. The coupling partner E-ring 
44 
 
acid 1.172 was formed in three steps from the intermediate 1.147, involving 


















MeO OMe DMDO, CH2Cl2, -78 oC;





OH 1) PPTS, PhCl, 60 
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    6 h (85%)
2) PPTS, PhCl, pyr
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1) BH3.DMS, THF,  0 oC; 
    NaHCO3, H2O2,  0 oC














2) TPAP, NMO, 4A MS, CH2Cl2 
3) Ph3PCH3Br, t-BuOK, THF, rt
o

















1) O3, CH2Cl2; PPh3
2) NaClO2, NaH2PO4,
    2-methyl-2-butene
































































































Scheme 1.27. Model studies of coupling strategy 























































































































































 NMO, TPAP, 4A MS





















































Scheme 1.30. Synthesis of the AB-ring alcohol 
      
With both coupling partners in hand, we began to test our new coupling strategy 
(Scheme 1.32). Yamaguchi esterification between E-acid 1.172 and AB-alcohol 1.171 
provided ester 1.173 in 76% yield. A Takai reaction constructed the C-ring smoothly to 
give 1.174 in 70% yield. The next step was the installation of the angular methyl group. 
However, the use of a DMDO epoxidation/AlMe3 addition afforded a mixture of 




1) OsO4, NMO, t-BuOH
2) Pb(OAc)4, benzene
3) NaClO2, NaH2PO4,
    2-methyl-2-butene



















Scheme 1.31. Synthesis of  E-ring acid 
 
As a consequence of the mechanism for this transformation, the presence of a 
mixture resulted from a nonselective DMDO oxidation (Scheme 1.33). Since this was the 
late stage synthesis of brevenal, we felt this result was unacceptable and began to explore 
new conditions to take full use of the mixture of epoxides. In order to avoid the 
intramolecular transfer of the methyl group as proposed with intermediates 1.179 and 
1.180, we felt that the oxygen anion needed to be blocked.  
In 2005, Scott Roberts reported the addition of ketene acetal 1.182 to epoxide 
1.181 in the presence of TBSOTf to afford β-C-ketoside 1.183 in 77% as a single 
diastereomer (Scheme 1.34).43 DFT calculations predicted that the low-energy conformer 
for the oxocarbenium 1.184 was a boat.  The stereochemical outcome of the reaction 
could be explained by the approach of the nucleophile to the face of the oxocarbenium 
that was opposite the pseudoaxial TBS ether. Considering our strategy for the total 
synthesis of brevenal, we began considering the use of TBSOTf as Lewis acid in this 
transformation. 
Alexander Wei’s group carried out syn additions to 4α-epoxypyranosides using 
organozinc reagents (Table 1.1).48(a)  The addition of RZnX species to 4α-






















































 DMDO, CH2Cl2, -78 oC; then













































Scheme 1.32. Coupling between AB-alcohol and E-ring acid 







































































































































Scheme 1.34. Mukaiyama-type addition reaction with ketene acetal 
 
and sp-carbon nucleophiles, producing the corresponding L-idopyranoside derivatives in 
good to high yields. The most reliable syn additions were produced by generating RZnX 
species via the transmetallation of organolithium or Grignard reagents. The use of excess 
ZnBr2 was important in this chemistry. Systematic examination of reaction conditions 
revealed that the presence of excess ZnBr2 significantly improved the efficiency of 
addition.  
Song Xue reported the zinc-mediated synthesis of α-C-glycosides from 1,2-
anhydroglycosides.48(b) They demonstrated a new method for the synthesis of α-C-
glycosides by using CF3CO2ZnR which was generated in situ from the reaction of ZnR2 
with CF3CO2H in CH2Cl2. Importantly, the reactions of functionalized zinc reagents with 
anhydroglycosides proceeded smoothly and were amenable to the presence of  halides 
and esters as shown in Table 1.2. 
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Entry RZnX Product Yield (%) 
1 
O ZnBr  
1.186 84 
2 





4 ZnBr  1.189 69 













Based on the previous work from our group49 and the work outlined above48, we 
proposed to use organozinc reagents as nucleophiles. Before attempting the chemistry on 
the real system, we began with two model systems as outlined below.  
Beginning with tri-O-benzyl-D-glucal 1.198 as the initial model, epoxidation of 1.198 
followed by the addition of dimethylzinc in the presence of TBSOTf generated α-C-
glycoside 1.199 as a single diastereomer in 89% yield (Table 1.3, entry 1). In order to 
determine the stereochemistry of product 1.199, the TBS group in 1.199 was removed 
with TBAF to give the known free alcohol 1.200 whose spectrum matched that published 
previously.49(a)  However, the addition of dimethylzinc in the absence of TBSOTf only 
 













Entry ZnR2 Product   Yield (%) 
1 ZnMe2 1.192 81 
2 ZnEt2 1.193 65 
3 ZnPh2 1.194 64 
4 Zn(CH2CH2CH2CH2Cl)2 1.195 58 
5 Zn(CH2CH2CH2CH2OAc)2 1.196 53 
6 
















DMDO, CH2Cl2, 0 oC; then
ZnR2, TBSOTf, CH2Cl2, 0 oC
1.198  
Entry R Products Yield (%) 
1 Me 1.199 89 
2 Et 1.201 86 
 
 
gave 30% of 1.200. Diethylzinc gave a similar result, affording the corresponding 
addition products 1.201 in 86% (Table 1.3, entry 2). The stereochemistry of 1.201 was 
determined after conversion of 1.201 into the corresponding acetate 1.202 whose 
spectrum matched that reported previously.48(b) The stereochemical outcome for the 
generation of 1.199 and 1.201 was rationalized as illustrated in Scheme 1.35. Epoxide 
1.191 reacts with TBSOTf to give oxocarbenium intermediate 1.203. The nucleophile 
then attacks from the axial direction to give syn products 1.199 and 1.201. 
When (i-Pr)2Zn was used in this reaction, α-isomer 1.204 was isolated in 80% 
yield (Scheme 1.36). The stereochemistry of 1.204 was determined by the J 1,3 values for 
H(1), H(2) and H(2), H(3) (ie. JH(1),H(2) = 4.4 Hz, JH(2),H(3) = 7.3 Hz). Interestingly, acetate 
1.205 corresponding to 1.204 showed a different conformation as evidenced by its H(2) 
splitting pattern and coupling constant. The small J 1.3 values for H(1), H(2) and H(2), 






















1.191 1. 203 1.199 (R = Me)1. 201 (R = Et)  











DMDO, CH2Cl2,  0 oC;
 i-Pr2Zn, TBSOTf,  0 oC
















Scheme 1.36. Diisopropylzinc as a nucleophile 
 
In addition to the sp3-carbon nucleophiles, the zinc chemistry was also applicable 
to the coupling of sp2-carbon nucleophiles with 1.198 (Table 1.4). Divinylzinc which 
came from the metathesis reaction between vinyl magnesium chloride and zinc chloride, 
reacted with the epoxide from 1.198 to give 1.206 as a single diastereomer in 75% yield. 
Interestingly, in contrast to the sp3 nucleophiles, no TBSOTf was necessary in this 
reaction. We believe that this is due to the presence of excess magnesium salts that serve 
to active the epoxide. Diphenylzinc, which came from the reaction between phenyl 
magnesium chloride and zinc chloride, provided a similar result. Phenyl adduct 1.207 
was generated as a single diastereomer in 72% yield. When commercial diphenylzinc was 
used in this reaction, no phenyl adduct 1.207 was observed regardless of the presence of 
TBSOTf. The only product from this reaction was the diol which came from hydrolysis  
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DMDO, CH2Cl2, 0 oC; then
ZnR2, CH2Cl2, 0 oC
 
Entry R Products Yield (%) 
1 vinyl 1.206 75 
2 phenyl 1.207 72 
 
 
of 1.191 during workup. The low solubility of commercial diphenylzinc in solvents such 
as THF, CH2Cl2, ether and toluene might be the reason for the observed discrepancy. 
In addition to zinc reagents, ketene acetal 1.182 was used as a nucleophile as 
shown in Scheme 1.37. The addition of 1.182 to epoxide 1.191 in the presence of 







 DMDO, CH2Cl2, 0 oC; then









1.198 1. 2081.182  




Encouraged by the preliminary results using tri-O-benzyl-D-glucal, we sought a 
more complex model system and chose 1.209, whose epoxidation chemistry would more 
closely match that of our brevenal substrate in that it would not be diastereoselective. 
Enol ether 1.209 was prepared in two steps from known compound 1.210 (Scheme 1.38). 
Esterification between 1.210 and propanoic acid afforded ester 1.211 in 92% yield. 
Olefinic-ester cyclization using the titanium ethylidene reagent generated cyclic enol 
ether 1.209 in 80% yield.  
Epoxidation of 1.209 followed by the addition of ZnMe2 in the presence of 
TBSOTf afforded 1.212 as a 1.2:1 mixture of silyl ethers in 82% yield. Deprotection of 
1.212 followed by oxidation generated ketone 1.214 as a single diastereomer in 76% 
yield for the two steps (Scheme 1.39). The stereochemistry of 1.214 was established 
using nOe experiments. These data support our hypothesis regarding axial addition of the 
organozinc reagents regardless of the stereochemistry of the epoxide. In a similar fashion, 

































1. 209  



















 DMDO, CH2Cl2, -78 oC; then
 ZnMe2, TBSOTf, THF, -78 oC
(82%)
HF.Pyridine
  NMO, 4A MS,
    TPAP, CH2Cl2



















































 DMDO, CH2Cl2, -78 oC; then
 ZnEt2, TBSOTf, THF, -78 oC
1)HF.Pyridine
2) NMO, 4A MS,
   TPAP, CH2Cl2
o
1. 215 1. 216
1. 217





Scheme 1.40. Addition of ZnEt2 to bicyclic enol ether 1.215 
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We next examined the reactions with sp2-hybridized carbon nucleophiles. The 
addition of divinylzinc to the epoxides from 1.215 afforded 1.219 as a single 
diastereomer after oxidation (Table 1.5, entry 1). The stereochemistry for 1.219 was 
established by nOe experiments. In a similar fashion, the addition of diphenylzinc also 
gave ketone 1.221 as a single diastereomer after oxidation (Table 1.5, entry 2). In order to 
determine the stereochemistry of 1.221, the benzyl groups were removed and the triol 
was converted to its corresponding acetate 1.222.  
Ketene acetal 1.182 was added to the mixture of epoxides from 1.215 to give 
ketone 1.224 as a single diastereomer after deprotection and oxidation (Scheme 1.41).  
 


















 DMDO,  -78 oC; NMO, 4A MS
o
then ZnR2, THF, 









Entry R Alcohol Yield (%) 
(DMDO/ZnR2)
Products Yield (%) 
(Oxidation)
1 vinyl 1.218 75 1.219 90 













 DMDO, CH2Cl2, -78 oC; then


















1. 215 1. 223
1.182 1)HF.Pyridine
2) NMO, 4A MS
   TPAP, CH2Cl2
o
(65% for 2 steps)
1. 224  
Scheme 1.41. Ketene acetal addition to epoxides from 1.215 
 
Encouraged by the results from ketene acetal 1.182, we studied the reaction using 
glycine-derived silyl enolate 1.22550 as a nucleophile (Scheme 1.42). The reaction 
between 1.198 and 1.225 led to products 1.226 which came from the hydrolysis of 1.225 
and diol which came from the opening of epoxide 1.191 during workup. Longer reaction 
time or high temperature gave the same result. Serine-derived organozinc compound 
1.22751 has been widely employed in palladium catalyzed cross-coupling reaction.52 
When 1.227 was used as a nucleophile in our coupling chemistry, 1.228 which came 
from the protonation during workup was isolated together with diol from 1.198. In 
addition, when Pd(OAc)2 was employed instead of TBSOTf, 1.229 which came from the 







DMDO, CH2Cl2,  0 oC; then





























DMDO, CH2Cl2,  0 oC; then
TBSOTf,  0 oC, CH2Cl2
DMDO, CH2Cl2,  0 oC; then
Pb(OAc)2,  0 oC, CH2Cl2
 
Scheme 1.42. Glycine-derived and serine-derived nucleophiles 
 
One of the limitations of this zinc chemistry is the source of the organozinc 
reagents. There are few commercially available organozinc reagents. So a general 
preparation of functionalized dialkylzinc is necessary. For simple organozinc reagents 
such as divinylzinc and diphenylzinc which were used in Table 1.4 and 1.5, the 
transmetalation of lithium or magnesium organometallics with zinc salts has been used 
frequently. Functionalized dialkylzinc substrates can be prepared from boron-zinc 
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exchange, which was developed by Paul Knochel and co- workers.53 We started with a 
simple known substrate 1.230.53 Hydroboration of 1-octene with Et2BH afforded 1.231. 
Then 1.231 underwent a boron-zinc exchange with Et2Zn to give a mixture of 1.230, Et3B 
and ZnEt2. The excess ZnEt2 and newly formed Et3B could be pumped off under high 
vacuum (Scheme 1.43). However, it is hard to remove ZnEt2 completely. 1.232 was 
isolated in 40% yield together with 30% of 1.201. In order to remove ZnEt2 completely, 
we tried higher temperature and longer time under high vacuum which led to the 
decomposition of the zinc reagents.  
In summary, the use of DMDO/ZnMe2 and TBSOTf would generate the axial 
addition product enabling us to overcome the lack of selectivity in the epoxidation 
reaction (Scheme 1.44). After deprotection and oxidation, products 1.233 would give 
ketone 1.234. Cyclization of 1.234 would then give the brevenal pentacyclic core 1.235. 
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DMDO, CH2Cl2,  0 oC;
then TBSOTf,  1.230,
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The synthesis of the requisite acid commenced with intermediate 1.132. 
Esterification with alcohol 1.132 afforded olefinic-ester 1.237 in 82% yield.  Treatment 
of 1.237 with the titanium ethylidene reagent afforded oxepene 1.238 in 65% yield. 
Oxepene 1.238 was subjected to DMDO followed by iBu2AlH to generate ketone 1.239 
after TPAP and NMO oxidation. Methylmagnesium bromide addition gave tertiary 
alcohol 1.240 as an 8:1 mixture favoring the desired diastereomer. After protecting group 
manipulation and allyl cuprate displacement of the primary triflate from 1.242, 1.240 was 
converted into 1.243. The TES group was removed and the alcohol was protected as the 
corresponding PMB ether 1.244. The completion of the synthesis of the coupling partner 
1.245 involved oxidative cleavage of the alkene and Pinnick oxidation (Scheme 1.45).  
With 1.245 in hand, the coupling strategy was tested as described in Schemes 1.46 
and 1.47. Yamaguchi esterification between 1.171 and 1.245 afforded ester 1.246 in 77% 
yield. Olefinic-ester cyclization gave C-ring enol ether 1.247 in 70% yield. The next step 
involved the installation of angular methyl group on the C-ring. Treatment of 1.247 with 
DMDO/ZnMe2 and TESOTf generated the desired product 1.248 together with between 
20% and 50% of 1.249 and 1.250 (Scheme 1.47). We believe that 1.249 is the result of 
methoxy group addition to the epoxide from 1.247 instead of the methyl group and that it 
results from the presence of Zn(OMe)R. The non reproducible results with ZnMe2 forced 
us to explore other conditions. These experiments are being carried out currently by Yuan 
Zhang (Scheme 1.48). Enol ether 1.247 was converted to thioacetal 1.251 via epoxide 
intermediates. The resulting hydroxyl groups were protected as TES ethers and the thiol 
groups were converted to a methyl group using Zn(OTf)2 and ZnMe2. Deprotection 
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Scheme 1.46. Coupling between AB-alcohol and E-ring acid 
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Illustrated in Scheme 1.49 is our proposed completion of brevenal. Upon 
completion of the pentacyclic core 1.254, the side chains would be installed following 
Yamamoto’s protocol.37 Protecting group manipulation and oxidation of the primary TES 
ether by Swern oxidation would afford aldehyde 1.255. Wittig reaction followed by 
oxidation would install the right-hand side chain to give 1.256. After protecting group 
manipulations, 1.256 would be converted to primary alcohol 1.257. The left-hand side 
chain would be constructed by the Horner-Wadsworth-Emmons reaction of aldehyde 
from 1.257. With 1.258 in hand, oxidation state manipulations on the allylic ester and 
global deprotection would give brevenal. 
In summary, this chapter described our efforts towards the total synthesis of 
brevenal. In the first generation, a C-glycoside and enol ether ring closing metathesis 
centered strategy was used to construct the enantiomer of the C-E ring system of brevenal. 
In the second generation, disconnection of brevenal at the CD ring junction led to a more 
convergent strategy. The key transformations of the synthesis of the AB ring and the E 
ring include a one-step olefinic-ester cyclization and DMDO/nucleophile addition to form 
C-glycosides. Compared to Sasaki and Yamamoto’s work, our linear steps would be 
shorter. In addition, our strategy is more convergent, flexible and amenable to analog 
synthesis. Compared to Crimmins’ approach which is relied on aldol reactions of chiral 
oxazolidinones to introduce chiral centers, our synthesis used few chiral reagents. Most 
of the stereocenters were generated from the selectivity of the molecular itself. Overall, 
we believe this approach would lead to an efficient synthesis of brevenal and its analogs 
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NMR spectra were recorded on either a Varian Inova-500 MHz or a Varian VXR-
500 MHz spectrometer. Chemical shifts were reported in δ, parts per million (ppm), 
relative to benzene (7.15) or chloroform (7.25) as internal standard. Coupling constants, J, 
were reported in Hertz (Hz) and refer to apparent peak multiplicities and not true 
coupling constants. Optical rotations were obtained on a Perkin Elmer Model 343 
polarimeter (Na D line) using a microcell with a 1 decimeter path length. Specific 
rotations ([α]D, Unit: °cm2/g) are based on the equation [α]D = (100α)/(l·c) and are 
reported as unitless numbers where the concentration c is in g/100 ml and the path length 
l is in decimeters. Specific rotations are reported as an average of 10 recordings with an 
integration time of 5 seconds for each recording. Mass spectra were recorded at the Mass 
Spectrometry Facility at the Department of Chemistry of the University of Utah at Salt 
Lake City on a Finnigan MAT 95 mass. IR spectra were recorded on a Bruker Tensor 27 
FT-IR spectrometer. Solvents were purified according to the guidelines in Purification of 
Common Laboratory Chemicals (Perrin, Armarego, and Perrin: Oxford, 1966). THF, 
ether, benzene and toluene were distilled from sodium/benzophenone. CH2Cl2, DMSO, 
NEt3, (i-Pr)2NEt, TMEDA, MeOH, and CH3CN were distilled from CaH2. Zn dust (<10 
μm, Aldrich) was activated by sequentially washing with HCl, H2O, ether, and acetone 
and then drying under vacuum overnight. All other reagents were used without 
purification. Unless otherwise stated, all reactions were run under an atmosphere of dried 
nitrogen in flame-dried glassware. Concentration refers to removal of solvent under 
reduced pressure (house vacuum at ca. 20 mmHg). Compounds were named using 











1. 94  
(4aR,8R,8aR)-2,2-di-tert-butyl-8-(tert-butyldiphenylsilyloxy)-6-methyl-4,4a,8, 
8a-tetrahydropyrano[3,2-d][1,3,2]dioxasiline (1.94). To a solution of MeOH (100 mL) 
and tri-O-acetyl-D-glucal 1.90 (19.0 g, 69.9 mmol) at rt was added K2CO3 (3.66 g, 20.5 
mmol). The reaction mixture was stirred at rt for 3 d. Concentration and chromatography 
(CH2Cl2:MeOH, 6:1) provide 1.91 (10.0 g, 98%) as a colorless oil.  
To a solution of D-glucal 1.91 (6.76 g, 46.3 mmol) in DMF (185 mL) at –40 oC 
was added tBu2Si(OTf)2 (17.0 mL, 52.5 mmol) dropwise over 15 min. The solution was 
stirred for an additional 0.5 h. Pyridine (4.46 mL, 55.0 mmol) was added and the solution 
was stirred for 5 min. The solution was diluted with ether (500 mL). The phases were 
separated. The organic phase was washed with sat. NaHCO3 (aq., 150 mL), H2O (2 x 150 
mL), and dried with Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 
15:1) gave 1.92 (12.2 g, 92%) as a white solid. 
To a solution of 1.92 (8.80 g, 27.3 mmol), imidazole (4.19 g, 54.6 mmol) and 
DMF (150 mL) at rt was added TBDPSCl (9.76 g, 35.5 mmol) over 0.5 h. After stirring 
for 12 h, the reaction was quenched with water (100 mL). The phases were separated and 
the aqueous phase was extracted with ether (3 x 200 mL). The organic extracts were 
washed with brine (100 mL) and then concentration. Chromatography (hexanes:ethyl 
acetate, 50:1) provided 1.93 (15.3 g, 95%)as a colorless oil.  
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To slurry of 1.93 (13.5 g, 25.8 mmol) in THF (3.40 mL) at 0 oC was added tBuLi 
(0.121 L of a 1.70 M solution in pentane, 0.206 mol). After stirring for 0.5 h the reaction 
was cooled to –70 oC and diluted with THF (62 mL); CH3I (32.1 mL, 0.515 mmol) was 
added over 0.5 h. After warming to rt the reaction was quenched with sat. NH4Cl (aq.,1 
L). The aqueous phase was extracted with ether (3 x 1 L). The extracts were dried with 
Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 50:1) provided 1.94 
(13.6 g, 98%) as a white solid. Rf  0.67 (hexanes:ethyl acetate, 10:1); [α]D20 = -17.9 (c = 
0.50, THF); 1H NMR (500 MHz, C6D6) δ 7.96 (dd, J = 7.8, 1.5 Hz, 2 H), 7.91-7.89 (m, 2 
H), 7.28-7.15 (m, 6 H), 4.56 (m, 1 H), 4.42 (brs, 1 H), 4.31 (dd, J = 10.7, 7.3 Hz, 1 H), 
4.12 (dd, J = 10.3, 5.4 Hz, 1 H), 3.97 (t, J = 10.3 Hz, 1H), 3.65 (ddd, J = 10.3, 10.3, 5.7 
Hz, 1 H), 1.46 (s, 3 H),  1.27 (s, 9 H), 1.10 (s, 9 H), 1.02 (s, 9 H); 13C NMR (125 MHz, 
C6D6) δ 151.0, 136.6, 136.3, 135.2, 129.9, 129.9, 128.6, 100.8, 77.9, 72.9, 72.8, 66.4, 











1. 95  
(4aR,6S,7R,8R,8aR)-6-allyl-2,2-di-tert-butyl-8-(tert-butyldiphenylsilyloxy)-6-
methyl-hexahydropyrano[3,2-d][1,3,2]dioxasilin-7-ol (1.95). To a solution of 1.94 
(2.74 g, 5.09 mmol) and CH2Cl2 (83.0 mL) at –78 oC was added a solution of dimethyl 
dioxirane (31.9 mL of a 0.18 M solution in CH2Cl2, 5.74 mmol) dropwise. The reaction 
was warmed to 0 oC. After stirring at 0 oC for 0.5 h, the reaction was cooled to -78 oC and 
a solution of allyl magnesium chloride (25 mL of a 2.0 M solution in THF, 50 mmol) was 
added. After stirring for an additional 0.2 h at -78 oC, the reaction mixture was quenched 
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with sat. NH4Cl (aq., 200 mL) and allowed to warm to rt. The aqueous phase was 
extracted with CH2Cl2 (5 x 100 mL) and dried with Na2SO4. Concentration and 
chromatography (hexanes:ethyl acetate, 50:1 to 20:1) provided 1.95 (2.79 g, 92%) as a 
colorless oil. Rf  0.55 (hexanes:ethyl acetate, 10:1); [α]D20 =  -4.68 (c = 0.39, THF); 1H 
NMR (500 MHz, C6D6) δ 7.95 (dd, J = 8.3, 1.8 2 H), 7.84-7.80 (m, 2 H), 7.25-7.15 (m, 6 
H), 6.01-5.93 (dddd, J = 17.6, 10.3, 7.3, 7.3 Hz 1 H), 5.05-4.98 (m, 2 H), 4.17-4.14 (dd, J 
= 10.3, 4.9 Hz 1 H),  4.01-3.95 (m, 2 H), 3.91 (t,  J = 9.8 Hz, 1 H)  3.60-3.53 (m, 2 H), 
2.36-2.26 (m, 2 H), 1.25 (s, 9 H), 1.15 (s, 9 H), 1.06 (s, 9 H), 1.00 (s, 3 H); 13C NMR 
(125 MHz, C6D6) δ 137.3, 136.9, 135.7, 134.0, 130.2, 130.0, 128.3, 117.9, 79.3, 78.2, 
77.8, 76.4, 69.1, 67.8, 45.1, 27.8, 27.4, 27.3, 22.9, 20.1, 20.0, 16.5; IR (neat) 3577, 2934, 











1. 96  
(4aR,6S,7R,8R,8aS)-6-allyl-2,2-di-tert-butyl-6-methyl-hexahydropyrano[3,2-
d][1,3,2]dioxasiline-7,8-diol (1.96). To a solution of 1.95 (2.40 g, 4.03 mmol) and 
HMPA (60 mL) was added NaH (0.435 g, 18.1mmol) at 0 oC. After stirring at 0 oC for 3 h, 
the reaction was quenched with sat. NH4Cl (aq., 300 mL) and then the aqueous phase was 
extracted with ether (5 x 100 mL). The extracts were washed with brine (200 mL) and 
dried with Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 10:1 to 
5:1) provided diol 1.96 (1.24 g, 86%) as a colorless oil. Rf  0.68 (hexanes:ethyl acetate, 
1:1); [α]D20 = -4.47 (c = 0.29, THF); 1H NMR (500 MHz, C6D6) δ 6.10-6.01 (dddd, J = 
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17.6, 10.3, 7.3, 7.3 Hz, 1 H), 5.13-5.09 (m, 2 H), 4.18-4.15 (dd, J =  10.3, 4.9 Hz, 1 H), 
3.88 (t, J = 10.3 Hz, 1 H) 3.72-3.62 (m, 3 H), 3.53 (d, J =  9.3 Hz, 1 H), 3.13 (brs, 2 H) 
2.52-2.41 (m, 2 H), 1.23 (s, 3 H), 1.08 (s, 18 H); 13C NMR (125 MHz, C6D6) δ 135.3, 
118.0, 78.8, 77.9, 75.6, 75.2, 68.7, 67.7, 45.1, 27.7, 27.3, 26.8, 22.8, 20.1, 16.9; IR (neat) 

















pyrano[3,2-d][1,3,2]dioxasilin-7-yl 5,5-dimethoxypentanoate (1.105). To a solution of 
1.96 (0.925 g, 2.58 mmol), i-Pr2NEt (1.16 ml, 6.60 mmol) and CH2Cl2 (116 mL) at -78 oC 
was added TMSOTf (0.470 ml, 2.58 mmol). After stirring at -78 oC for 1 h, the reaction 
was quenched with sat. NaHCO3 (aq., 100 mL) and then the reaction mixture was 
extracted with CH2Cl2 (5 x 60 mL). The organic extracts were washed with brine (100 
mL) and dried with Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 
25:1) provided 1.97 (0.90 g, 81%) as a colorless oil. 
To a solution of 1.97 (1.40 g, 3.26 mmol) in CH2Cl2 (23 mL) at rt was added acid 
1.103 (0.814 g, 5.02 mmol, prepared according to the procedure given below), followed 
by 1,3-dicyclohexylcarbodiimide (2.08 g, 10.1 mmol) and DMAP (0.821 g, 6.71 mmol). 
After stirring at rt for 12 h, the reaction mixture was filtered. The filtrate was washed 
with sat. NaHCO3 (aq., 25 mL), extracted with CH2Cl2 (5 x 25 mL), and dried with 
Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 50:1 to 25:1) 
provided 1.104 (1.54 g, 82%) as a colorless oil.  
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To a solution of 1.104 (1.50 g, 2.61 mmol) and MeOH (75mL) at rt was added 
H2O (7.5 mL) and AcOH (4.48 mL, 78.3 mmol). After stirring at rt for 1 h, the reaction 
was quenched with sat. NaHCO3 (aq., 60mL), extracted with CH2Cl2 (5 x 40 mL), and 
dried with Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 10:1 to 
5:1) provided 1.105 (1.24, 95%) as a colorless oil. Rf  0.35(hexanes:ethyl acetate, 5:1); 
[α]D20 = -8.0 (c = 0.51, THF); 1H NMR (500 MHz, C6D6) δ 5.99-5.91 (m, 1H), 5.19 (d, J 
= 9.3 Hz, 1 H), 5.11-5.08 (m, 2 H), 4.25 (t, J = 5.4 Hz, 1 H), 4.11 (dd, J = 9.8, 4.9 Hz, 
1H), 3.82 (t, J = 9.8 Hz, 1 H), 3.76 (t, J = 9.3 Hz, 1 H), 3.69 (t, J = 9.3 Hz, 1 H), 3.61-
3.57 (m, 1 H), 3.11 (s, 6 H), 2.79 (s, 1 H), 2.33-2.17 (m, 4 H), 1.74-1.68 (m, 2 H), 1.66-
1.61 (m, 2 H),  1.15 (s, 3 H), 1.05 (s, 9 H), 1.04 (s, 9 H); 13C NMR (125 MHz, C6D6) 
δ172.2, 132.8, 118.7, 104.3, 79.0, 77.1, 75.2, 73.7, 68.7, 67.5, 52.4, 52.3, 45.1, 34.2, 31.9, 
27.7, 27.3,22.8, 20.5, 20.1, 17.5; IR (neat) 3360, 2939, 1749, 1098 cm-1; LRMS (CI) 






1. 103  
5,5-dimethoxypentanoic acid (1.103). A solution of δ-valerolactone (5.0 g, 
50mmol) and concentrated H2SO4 (ca. 0.025 mL) in dry methanol (50 ml) was heated 
under reflux for 3 d. The mixture was cooled in an ice bath and NaHCO3 (0.5 g) was 
added. After stirring for 10 min, the solid was separated by filtration. Concentration 
afforded a mixture of 1.100 (90%) and δ-valerolactone (10%).  
The crude product from above was dissolved in dry CH2Cl2 (50 ml) and then the 
solution was added to a solution of PCC (12g, 0.056 mmol) in CH2Cl2 (20 ml). After 
stirring at rt for 2 h, the mixture was diluted with pentane (100 ml). The solid was filtered. 
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Concentration afforded aldehyde 1.101 which was converted into the corresponding 
acetal without further purification.  
To the solution of 1.101 in CH2Cl2 (15 ml) at 0 oC was added a solution of 25ml 
methanol and 0.25 mL concentrated H2SO4. Trimethyl orthoformate (5.15 ml, 47.1 mmol) 
was added. After stirring at 0 oC for 2 h, the reaction was quenched with sat. NaHCO3 
(aq., 20 mL), extracted with CH2Cl2 (5 x 100 mL), and dried with Na2SO4. Concentration 
and chromatography (hexanes:ethyl acetate, 10:1 to 5:1) afforded acetal 1.102 (4.43 g, 
50.4% from δ-valerolactone).  
The acetal 1.102 (4.0 g, 27mmol) was dissolved in a solution of 1 N NaOH (30 
mL, 30 mmol) and methanol (30 mL). After stirring for 2 h, the reaction was washed with 
ether (3 x 50 mL) and the aqueous was neutralized to pH = 3 by addition of 1 N HCl. The 
mixture was extracted with CH2Cl2 (5 x 100 mL) and then dried with Na2SO4. 
Concentration afforded the acid 1.103 (3.39 g, 92%) as a colorless oil whose spectrum 

















[1,3,2] dioxasilin-7-yl 5,5-dimethoxypentanoate (1.106). To 1.105 (0.913 g, 1.82 mmol) 
in CS2 (30.0 mL, 499 mmol) at -25 oC was added NaH (0.248 g, 10.3 mmol).After the 
reaction mixture was allowed to warm to -5  oC over 1 h,  MeI (5.66 mL, 90.9 mmol) was 
added dropwise, and the reaction was warmed to 15 oC over 2 h. The reaction mixture 
was quenched with sat. NH4Cl (aq., 60 mL), extracted with CH2Cl2 (5 x 40 mL), and 
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dried with Na2SO4. The solution was concentrated and the crude xanthate was taken on to 
the subsequent deoxygenation reaction without further purification.  
To a solution of the xanthate ester (1.07 g, 1.82 mmol) from above and benzene 
(15 mL) at rt was added tributyltin hydride (7.40 mL, 27.4 mmol). The reaction mixture 
was heated to reflux and then AIBN (ca. 10 mg) was added. After 1 h, the reaction 
mixture was cooled to rt. Concentration and chromatography (hexanes:ethyl acetate, 10:1) 
provided 1.106 (0.708 g, 80% over two steps) as a colorless oil. Rf 0.55 (hexanes:ethyl 
acetate, 3:1); [α]D20 = -11.3 (c = 0.61, THF); 1H NMR (500 MHz, C6D6) δ 5.94 (dddd, J 
= 18.0, 10.5, 7.5 Hz, 1 H), 5.04 (m, 2 H), 4.99 (dd, J = 12.0, 4.5 Hz, 1 H), 4.21 (t, J = 5.8 
Hz, 1 H), 4.12 (dd, J = 9.8, 4.8 Hz, 1 H), 3.82 (t, J = 10.0 Hz, 1 H), 3.78 (ddd, J = 11.8, 
9.8, 4.8 Hz, 1 H), 3.57 (ddd, J = 9.8, 5.0 Hz, 1 H), 3.10 (s, 3 H), 3.09 (s, 3 H), 2.29-2.20 
(m, 2 H), 2.07 (t, J = 7.0 Hz, 2 H), 1.71-1.61 (m, 3 H), 1.58-1.53 (m, 3 H), 1.17 (s, 3 H), 
1.07 (s, 9 H), 1.03 (s, 9 H); 13C NMR (125 MHz, C6D6) δ 172.0, 133.8, 118.6, 104.6, 76.3, 
73.6, 72.0, 71.2, 68.3, 52.7, 52.7, 45.3, 35.1, 34.4, 32.4, 28.0, 27.7, 23.1, 20.8, 20.5, 16.8; 

















[3,2-d][1,3,2]dioxasilin-7-yl 5,5-dimethoxypentanoate (1.108). To 1.106 (0.625 g, 1.29 
mmol) in THF (40 mL) at 0 oC was added BH3.DMS (0.80ml of a 10.0 M solution in 
DMS, 8.0 mmol) dropwise. After stirring at 0 oC for 2 h, the reaction was quenched with 
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the addition of sat. NaHCO3 (aq., 38 mL) dropwise, followed by the addition of aq. H2O2 
(5.16 mL of a 30% solution) dropwise. After stirring at 0 oC for 0.5 h, sat. Na2S2O3 ( aq., 
100 mL) was added and the reaction mixture was extracted with CH2Cl2 (5 x 50 mL) then 
dried with Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 10:1 to 
3:1) provided the primary alcohol 1.107 (0.507 g, 78%) as a colorless oil. 
To the solution of 1.107 (0.31 g, 0.62 mmol) in CH2Cl2 (10 ml) at rt was added 
4Å MS (0.40 g), NMO (0.155 g, 1.54 mmol), and TPAP (ca. 5 mg). After stirring at rt for 
1h, the reaction mixture was filtered through neutralized silica. The solution was 
concentrated and the crude aldehyde was taken on to the subsequent Wittig reaction 
without further purification.  
To the crude aldehyde (0.35 g) from above was added THF (72 mL) at rt. Then 
Wittig reagent (6.2 mL of a 0.15 M solution, 0.93 mmol, prepared according to the 
procedure below) was added dropwise. After stirring at rt for 0.3 h, the reaction was 
quenched with sat. NH4Cl (aq., 30 mL), extracted with CH2Cl2 (5 x 20 mL) and dried 
with Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 50:1) provided 
1.108 (0.25 g, 80% over two steps) as a colorless oil.  
The methylene Wittig reagent was prepared as follows: To methyltriphenyl 
phosphonium bromide (0.175 g, 0.490 mmol) in THF (2.5 mL) was added a solution of 
potassium tert-butoxide (0.45 mL of a 1.0 M solution in THF, 0.45 mmol) dropwise at rt. 
The resulting yellow solution was used after stirring for 0.3 h.  
Data for 1.108: Rf  0.60 (hexanes:ethyl acetate, 3:1); [α]D20 = -17.3 (c = 0.35, 
THF); 1H NMR (500 MHz, C6D6) δ 5.78 (dddd, J = 16.8, 10.3, 6.8 Hz, 1 H), 5.07-5.01 
(m, 2 H), 4.94 (dd, J = 10.5, 2.0 Hz, 1 H), 4.21 (t, J = 5.5 Hz, 1 H), 4.13 (dd, J = 10.0, 5.0 
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Hz, 1 H), 3.83 (t, J = 10.0 Hz, 1 H), 3.80 (partially overlapping ddd, J = 11.3, 9.3, 4.3 Hz, 
1 H), 3.59 (ddd, J = 9.8, 4.8 Hz, 1 H), 3.10 (s, 3 H), 3.09 (s, 3 H), 2.46 (dt, J = 8.5, 4.0 Hz, 
1 H), 2.36-2.30 (m, 1 H),  2.20-2.12 (m, 1 H), 2.05 (t, J = 7.5 Hz, 2 H), 1.74 (m, 1 H), 
1.69-1.61 (m, 3 H), 1.60-1.53 (m, 3 H), 1.16 (s, 3 H), 1.11 (s, 9 H), 1.07 (s, 9 H); 13C 
NMR (125 MHz, C6D6) δ 172.2, 139.4, 115.0, 104.6, 76.0, 73.7, 72.2, 71.2, 68.3, 52.7, 
52.6, 40.0, 35.1, 34.4, 32.4, 28.0, 27.7, 23.1, 20.8, 20.5, 16.8; IR (neat) 2939, 2862, 1741, 











Seven-membered cyclic enol ether ring (1.109). To a solution of TiCl4 (0.65 mL, 
5.9 mmol) in CH2Cl2 (54 mL) at 0 oC was added THF (2.87mL, 35.8 mmol) dropwise. 
The solution was stirred at 0 oC for 0.2 h and then TMEDA (5.32 mL, 35.7 mmol) was 
added dropwise to the resulting light-yellow solution. The ice bath was removed and after 
0.3 h Zn dust (0.868 g, 13.4 mmol) was added followed by PbCl2 (0.196 g, 0.705 mmol). 
Over 0.3 h, the reaction slurry turned from green to blue to blue-green at which time a 
solution of 1.108 (0.10 g, 0.20 mmol), CH2Br2 (0.416 ml, 5.93 mmol), and CH2Cl2 (12 
mL) was added via a cannula. The resulting mixture was stirred rapidly and heated at 
reflux for 1.6 h. Then the reaction mixture was cooled to 0 oC and stirred with sat. K2CO3 
(aq., 1.33 mL) for 0.5 h. The mixture was filtered through a plug of neutral silica and 
concentrated. Flash chromatography (hexanes:ethyl acetate, 100:1 w/ 2% Et3N) provided 




To the crude acyclic enol ether (100 mg) in hexane (15 ml) in a glove box at rt 
was added Schrock’s molybdenum catalyst (30.4 mg, 0.040 mmol). The reaction was 
sealed, removed from the glove box and then heated at 60 oC for 16 h. Concentration and 
chromatography (hexanes:ethyl acetate, 100:1 w/ 2% Et3N) provided the cyclic enol ether 
1.109 (51.7 mg, 55% over two steps) as a colorless oil. Rf  0.70 (hexanes:ethyl acetate, 
3:1); [α]D20 = +17.4 (c = 0.25, THF); 1H NMR (500 MHz, C6D6) δ 4.60 (dd, J = 3.3 Hz, 1 
H), 4.32 (t, J = 5.3 Hz, 1 H), 4.20 (dd, J = 10.0, 5.0 Hz, 1 H), 3.88 (t, J = 9.8 Hz, 1 H), 
3.78 (ddd, J = 11.3, 9.5, 5.0 Hz, 1 H), 3.68 (ddd, J = 9.5, 4.8 Hz, 1 H), 3.41 (dd, J = 12.3, 
4.3 Hz, 1 H), 3.15 (s, 3 H), 3.14 (s, 3 H), 2.44 (dt, J = 12.0, 4.8 Hz, 1 H), 2.10-2.03 (m, 1 
H), 2.00-1.89 (m, 2 H), 1.88-1.80 (m, 1 H), 1.76 (dt, J = 14.5, 4.0, 1 H), 1.69-1.58 (m, 3 
H), 1.50 (ddd, J = 12.8, 3.8 Hz, 1 H), 1.22 (s, 3 H), 1.10 (s, 9 H), 1.09 (s, 9 H); 13C NMR 
(125 MHz, C6D6) δ 160.0, 128.9, 105.7, 104.9, 82.0, 78.4, 74.4, 70.9, 68.5, 52.7, 52.5, 
41.1, 36.8, 36.5, 32.7, 28.1, 27.7, 23.2, 23.0, 21.6, 20.5, 14.6; IR (neat) 2952, 2889, 1464, 
















Preparation of alcohol 1.112. To 1.109 (70.0 mg, 0.149 mmol) in CH2Cl2 (26.0 
mL) at      –78 oC was added dimethyl dioxirane (2.8 mL of a 0.10 M solution in CH2Cl2, 
0.28 mmol) dropwise. The reaction was warmed to 0 oC and concentrated. The colorless 
oil was taken up in CH2Cl2 (38 mL), cooled to -78 oC and iBu2AlH (0.28 mL of a 1.0 M 
solution in hexanes, 0.28 mmol) was added at once. After stirring at -78 oC for 0.3 h, the 
reaction was quenched with sat. NH4Cl (aq., 25 mL), extracted with CH2Cl2 (5 x 20 mL) 
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and dried with Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 20:1 
to 5:1) provided 1.112 (51.0 mg, 78% over two steps) as a colorless oil. [α]D20 = +27.6 (c 
= 0.13, THF); 1H NMR (500 MHz, C6D6) δ 4.33 (t, J = 5.5 Hz, 1 H), 4.25 (dd, J = 10.3, 
4.8 Hz, 1 H), 3.92 (t, J = 10.0 Hz, 1 H), 3.77 (ddd, J = 11.0, 9.3, 4.5 Hz, 1 H), 3.69 (ddd, 
J = 10.0, 5.0 Hz, 1 H), 3.62 (dd, J = 12.0, 4.5 Hz, 1 H), 3.41 (ddd,  J = 11.5, 5.0, 2.0 Hz, 
1 H), 3.37-3.32 (m, 1 H), 3.16 (s, 3 H), 3.15 (s, 3 H), 2.23 (dt,  J = 12.0, 4.5 Hz, 1 H), 
2.11 (ddd, J = 12.5, 3.0 Hz, 1 H), 1.78 (q, J = 23.3, 11.8 Hz, 1 H), 1.72-1.55 (m, 3 H), 
1.54-1.44 (m, 3 H), 1.43-1.29 (m, 3 H), 1.25 (s, 3 H), 1.11 (s, 9 H), 1.09 (s, 9 H); 13C 
NMR (125 MHz, C6D6) δ 105.0, 85.7, 77.8, 77.7, 75.2, 74.6, 70.9, 68.7, 52.7, 52.6, 37.1, 
35.5, 35.2, 33.1, 28.1, 27.8, 27.2, 21.8, 20.5, 16.4; IR (neat) 3351, 2361, 1469, 1090 cm-1; 





















Summary of COSY spectrum for 1.112: 
Proton at 4.25 ppm (H-1) shows crosspeaks with protons at 3.92 ppm (H-1) and 3.69 ppm 
(H-2) 
Proton at 3.92 ppm (H-1) shows crosspeaks with protons at 4.25 ppm (H-1) and 3.69 ppm 
(H-2) 
Proton at 3.69 ppm (H-2) shows crosspeaks with protons at 3.77 ppm (H-3), 4.25 ppm 
(H-1) and 3.92 ppm (H-1) 
Proton at 3.77 ppm (H-3) shows crosspeaks with protons at 3.69 ppm (H-2), 2.23 ppm 
(H-4) and 1.78 ppm (H-4) 
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Proton at 3.62 ppm (H-5) shows crosspeaks with protons at 2.23 ppm (H-4) and 1.78 ppm 
(H-4) 
Summary of 1D nOe difference experiments for 1.112: 
Irradiation at 1.25 ppm (CH3-7) resulted in enhancement at 3.69 ppm (H-2) and 3.35 ppm 
(H-10) 
Irradiation at 3.62 ppm (H-5) resulted in enhancement at 3.77 ppm (H-3) and 3.40 ppm 
(H-11) 













Preparation of cyclic enol ether 1.113. To 1.112 (51.0 mg, 0.104 mmol) in 
chlorobenzene (9.60 mL) at rt was added pyridine (0.05 mL, 0.625 mmol), followed by 
PPTS (0.381 mg, 1.52 mmol). The reaction mixture was heated to 140 oC for 3 h. At this 
time, the mixture was cooled to rt and quenched with sat. NaHCO3 (aq., 20 mL), 
extracted with CH2Cl2 (5 x 20 mL), and dried with Na2SO4. Concentration and 
chromatography (hexanes:ethyl acetate, 50:1 to 10:1) provided 1.113 (44.3 mg, 80%) as a 
colorless oil. Rf  0.49 (hexanes:ethyl acetate, 10:1); [α]D20 = +7.6 (c = 0.11, THF); 1H 
NMR (500 MHz, C6D6) δ 6.33 (d, J = 6.5 Hz, 1 H), 4.54 (ddd, J = 6.5, 3.8 Hz, 1 H), 4.18 
(dd, J = 10.0, 4.5 Hz, 1 H), 4.00 (q, J = 16.0, 7.5 Hz, 1 H), 3.88 (t, J = 10.0 Hz, 1 H), 3.76 
(ddd, J = 11.0, 9.3, 4.5 Hz, 1 H), 3.62 (ddd, J = 9.5, 4.3 Hz, 1 H), 3.47 (ddd, J = 9.0, 4.5 
Hz, 1 H), 2.99 (dd, J = 12.0, 4.5 Hz, 1 H), 2.45-2.36 (m, 1 H), 2.23-2.11 (m, 2 H),  2.00-
1.92 (m, 1 H), 1.85-1.70 (m, 4 H), 1.68-1.60 (m, 1 H), 1.13 (s, 9 H), 1.09 (s, 9 H), 1.08 (s, 
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3 H); 13C NMR (125 MHz, C6D6) δ 148.4, 113.7, 84.6, 83.7, 83.5, 77.7, 77.6, 74.9, 70.9, 
69.0, 37.6, 36.8, 34.6, 29.2, 28.1, 27.7, 23.2, 21.4, 20.5, 16.0; IR (neat) 2931, 2859, 1091 
















Preparation of ketone 1.119. To 1.113 (30.0 mg, 0.0706 mmol) in CH2Cl2 (9.0 
mL) at -78 oC was added dimethyl dioxirane (1.4 mL of a 0.10 M solution in CH2Cl2, 
0.14 mmol) dropwise. The reaction mixture was warmed to 0 oC and concentrated. The 
colorless oil was taken up in CH2Cl2 (11.4 mL), cooled to -78 oC, and allyl magnesium 
chloride (0.18 mL of a 2.0 M solution in THF, 0.35 mmol) was added at once. After 
stirring at -78 oC for an additional 0.2 h, the reaction mixture was warmed to rt and 
quenched with sat. NH4Cl (aq., 20 mL). The phases were separated. The aqueous phase 
was extracted with CH2Cl2 (5 x 20 mL) and dried with Na2SO4.Concentration and 
chromatography (hexanes:ethyl acetate, 20:1 to 5:1) provided alcohol 1.114 and 1.115 as 
a 2:1 mixture (26.5 mg, 78%). 
To the mixture above (26.5 mg, 0.0550 mmol) in CH2Cl2 (1.6 mL) at rt was added 
i-Pr2NEt (0.166 ml, 0.956 mmol), Ac2O (0.083 mL, 0.88 mmol) and then DMAP (ca. 
5mg). After stirring at rt for 1 h, the reaction was diluted with CH2Cl2(10 mL) and 
quenched with sat. NaHCO3 (aq., 4 mL). The phases were separated. The aqueous phase 
was extracted with CH2Cl2 (5 x 10 mL) and dried with Na2SO4. Concentration and 
chromatography (hexanes:ethyl acetate, 20:1) provided the acetates corresponding to 
1.114  and 1.115 as colorless oils (27.4 mg, 95%).  
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To the acetates (27.4 mg, 0.0520 mmol) in THF (1.6 mL) at 0 oC was added 
BH3.DMS (0.040mL of a 1.0 M solution in DMS, 0.40 mmol) dropwise. After stirring at 
0 oC for 2 h, the reaction was quenched with the addition of sat. NaHCO3 (aq., 3 mL) 
dropwise, followed by addition of aq. H2O2 (0.3 mL of a 30% solution) dropwise. After 
stirring at 0 oC for 0.5 h, sat. Na2S2O3 (aq., 9 mL) was added and the reaction mixture 
was extracted with CH2Cl2 (5 x 10 mL).The extracts were dried with Na2SO4, 
concentrated and taken on to the protection without further purification.  
To the crude alcohol from above in Et2O (1.0 mL) at 0 oC was added 4-
methoxybenzyl acetimidate (0.033 mL, 0.13 mmol) followed by TfOH (ca. 0.125 ml of a 
2 x10 –3 M solution). The reaction mixture was warmed to rt over 1 h then quenched with 
sat. NaHCO3 (aq., 3 mL), extracted with CH2Cl2 (5 x 10 mL) and dried with Na2SO4. 
Concentration and chromatography (hexanes:ethyl acetate, 50:1 to 20:1) provided the 
corresponding PMB ethers as colorless oil (18.9 mg, 55% over two steps).  
The PMB ethers (18.9 mg, 0.0285 mmol) were taken up in MeOH (3.0 mL) and 
potassium carbonate (30.0 mg, 0.217 mmol) was added at once. After stirring at rt for 1 h, 
the reaction was diluted with H2O (3.0 mL), extracted with CH2Cl2 (5 x 10 mL) and dried 
with Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 20:1 to 5:1) 
provided the corresponding secondary alcohols as colorless oils (16.8 mg, 95%). 
To the alcohols (16.8 mg, 0.0272 mmol) from above in CH2Cl2 (3.0 mL) at rt was 
added 4Å MS (50.0 mg), NMO (15.0 mg, 0.148 mmol), then TPAP (ca. 2 mg). After 
stirring at rt for 1 h, the reaction mixture was filtered through neutralized silica plug. 
Concentration and chromatography (hexanes:ethyl acetate, 50:1 to 10:1) provided ketone 
1.119 (10 mg, 57%) and 1.120 (5 mg, 28%) as colorless oils. 
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To the minor isomer 1.120 (5.0 mg, 0.0081 mmol) in toluene (2.0 mL) was added 
imidazole (18.0 mg, 0.264 mmol). After refluxing overnight, the reaction was cooled to rt 
and concentrated. Chromatography (hexanes:ethyl acetate, 50:1 to 10:1) provided 1.119 
(4.3 mg, 85%) as a colorless oil. Rf  0.56 (hexanes:ethyl acetate, 3:1); [α]D20 = +13.4 (c = 
0.11, THF); 1H NMR (500 MHz, C6D6) δ 7.21 (d, J = 8.5 Hz, 2 H), 6.79 (d, J = 8.5 Hz, 2 
H), 4.30 (d, J = 3.5 Hz, 2 H), 4.21 (dd, J = 10.3, 4.9 Hz, 1 H), 3.90 (t, J = 10.3 Hz, 1 H), 
3.81(ddd, J = 11.0, 9.0, 4.4 Hz, 1 H), 3.67 (ddd, J = 9.8, 4.9 Hz, 1 H), 3.61 (dd, J = 8.8, 
4.3 Hz, 1 H), 3.33-3.29 (m, 1 H), 3.29 (overlapping s, 3 H), 3.20 (dd, J = 12.2, 4.0 Hz, 1 
H), 3.08 (ddd, J = 10.8, 3.9 Hz, 1 H), 2.66 (ddd, J = 9.0, 4.5, 1 H), 2.57-2.50 (m, 1 H), 
2.21 (dt,  J = 12.0, 4.3 Hz, 1 H), 2.14-2.10 (m, 1 H), 1.93-1.63 (m, 8 H), 1.51 (ddd, J = 
14.3, 10.3, 3.5 Hz, 1 H), 1.35 (m, 1 H), 1.14 (s, 9 H), 1.14(s, 3 H), 1.10 (s, 9 H); 13C 
NMR (125 MHz, C6D6) δ 214.7, 131.6, 129.8, 114.4, 87.2, 86.9, 85.0, 80.0, 77.7,  74.9, 
73.2, 71.3, 70.0, 68.7, 55.1, 38.5, 37.2, 36.6, 31.9, 31.2, 30.2, 28.1, 27.7, 26.6, 23.2, 20.5, 
18.4; IR (neat)  2937, 2862, 1715, 1084 cm-1; LRMS (CI) calcd for C34H55O8Si 619.4 


















Preparation of alcohol 1.122. To the solution of 1.119 (12.0 mg, 0.019 mmol) in 
THF (1.6 mL) at rt was added the methylene Wittig reagent (0.50 mL of a 0.30 M 
solution, 0.15 mmol, prepared according to the procedure described in the experimental 
section for 1.108). After stirring at rt for 1 h, the reaction was quenched with sat. NH4Cl 
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(aq., 5 mL). The phases were separated and the aqueous phase was extracted with CH2Cl2 
(5 x 20 mL). The extracts were dried with Na2SO4. Concentration and chromatography 
(hexanes:ethyl acetate, 50:1 to 10:1) provided terminal olefin 1.121 (10.0 mg, 83%) as a 
colorless oil.  
To a solution of 1.121 (10.0 mg, 0.0160 mmol) in toluene (2.0 mL) at 0 oC was 
added NaHCO3 (66.0 mg, 0.785 mmol) followed by mCPBA (100 mg, 0.580 mmol). 
After stirring at 0 oC for 2 h, the reaction was quenched with Na2S2O3 (aq., 10 mL).The 
phases were separated and the aqueous phase was extracted with CH2Cl2 (5 x 20 mL). 
The extracts were dried with Na2SO4. Concentration and chromatography (hexanes:ethyl 
acetate, 50:1 to 5:1) provided the epoxide as a colorless oil. 
To a solution of the epoxide (7.0 mg, 0.011 mmol) from above in THF (3.0 mL) 
at 0 oC was added LiEt3BH (0.050 mL of a 1.0 M solution in THF, 0.050 mmol). After 
stirring at 0 oC for 3 h, the reaction was quenched with H2O (2 mL). The phases were 
separated and the aqueous phase was extracted with CH2Cl2 (5 x 10 mL). The extracts 
were dried with Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 10:1 
to 1:1) provided desired alcohol 1.122 (4.8 mg, 48% for three steps) and undesired 
alcohol epi-1.122 (0.8 mg 8% for three steps) as colorless oils. Rf  0.60 (hexanes:ethyl 
acetate, 1:1); [α]D20 = +51.2 (c = 0.073, THF); 1H NMR (500 MHz, C6D6) δ 7.26 (d, J = 
8.5 Hz, 2 H), 6.81 (d, J = 8.5 Hz, 2 H), 4.36 (d, J = 7.0 Hz, 1 H), 4.21 (dd, J = 10.0, 5.0 
Hz, 1 H), 3.90 (t, J = 10.0 Hz, 1 H), 3.80 (ddd, J = 11.3, 9.3, 4.8 Hz, 1 H), 3.64 (ddd, J = 
10.0, 5.0 Hz, 1 H), 3.46-3.30 (m, 3 H),  3.31 (s, 3 H), 3.20-3.18 (m, 1 H), 3.15 (ddd, J = 
8.8, 5.0  Hz, 1 H), 3.02 (dd, J = 12.0, 4.0 Hz, 1 H), 2.27 (dt, J = 12.5, 4.0 Hz, 1 H), 2.11-
2.04 (m, 1 H),  1.99-1.88 (m, 2 H), 1.86-1.63 (m, 7 H), 1.58 (m, 2 H), 1.18 (s, 3 H), 1.14 
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(s, 3 H), 1.10 (s, 9 H), 1.00 (s, 3 H); 13C NMR (125 MHz, C6D6) δ 129.8, 114.4, 88.7, 
86.6, 85.5, 82.5, 77.9,  74.9, 74.5, 73.2, 71.0, 70.8, 68.7, 55.1, 38.9, 38.1, 36.9, 30.2, 29.8, 
28.2, 28.1, 27.7, 24.0, 23.2, 20.5, 16.7; IR (neat) 3444, 2937, 2862, 1086 cm-1; LRMS (CI) 

























Summary of COSY spectrum for 1.122: 
Proton at 3.90 ppm (H-1) shows crosspeaks with protons at 4.21 ppm (H-1) and 3.64 ppm 
(H-2) 
Proton at 4.21 ppm (H-1) shows crosspeaks with protons at 3.90 ppm (H-1) and 3.64 ppm 
(H-2) 
Proton at 3.64 ppm (H-2) shows crosspeaks with protons at 3.80 ppm (H-3), 3.90 ppm 
(H-1) and 4.21 ppm (H-1) 
Proton at 3.80 ppm (H-3) shows crosspeaks with protons at 3.64 ppm (H-2), 2.27 ppm 
(H-4) and 1.80 ppm (H-4) 
Proton at 3.02 ppm (H-5) shows crosspeaks with protons at 2.27 ppm (H-4) and 1.80 ppm 
(H-4) 
Summary of 1D nOe difference experiments for 1.122: 




Irradiation at 3.64 ppm (H-2) resulted in enhancement at 1.18 ppm (CH3-7) and 4.21 ppm 
(H-1) 
Irradiation at 3.80 ppm (H-3) resulted in enhancement at 3.02 ppm (H-5) and 2.27 ppm 
(H-4) 
Irradiation at 3.02 ppm (H-5) resulted in enhancement at 3.80 ppm (H-3) and 3.15 ppm 
(H-11) 
Irradiation at 3.15 ppm (H-11) resulted in enhancement at 3.02 ppm (H-5) 

















Preparation of alcohol 1.124. To the solution of 1.122 (4.0 mg, 6.3μmol) in 
CH2Cl2 (3.0 mL) at 0 oC was added NEt3 (0.136 mL, 1.05 mmol) followed by TBSOTf 
(0.136 mL, 0.592 mmol) dropwise, and DMAP (ca. 0.5mg). The reaction was warmed to 
rt over 1 h at which time it was quenched with sat. NaHCO3 (aq., 3 mL), extracted with 
CH2Cl2 (5 x 10 mL) and then dried with Na2SO4. Concentration and chromatography 
(hexanes:ethyl acetate, 50:1 to 10:1) provided protected alcohol 1.123 (4.3 mg, 90%) as a 
colorless oil.  
To the solution of 1.123 (4.3 mg, 5.7μmol) in THF (2.0 ml) at rt was added 
HF.pyridine (0.04 mL of a 1.0 M solution in THF, 0.04 mmol). After stirring at rt for1 h, 
the reaction was quenched with sat. NaHCO3 (aq., 3 mL), extracted with CH2Cl2 (5 x 10 
mL) and then dried with Na2SO4. Concentration and chromatography (hexanes:ethyl 
acetate, 50:1 to 10:1) provided the diol as a colorless oil.  
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To the diol from above in CH2Cl2 (2.0 mL) at rt was added NEt3 (0.16 mL, 1.2 
mmol) followed by TESCl (0.080 mL, 0.47 mmol) and DMAP (ca. 0.5 mg). After stirring 
at rt for 1 h, the reaction was quenched with sat. NaHCO3 (aq., 2.0 mL), extracted with 
CH2Cl2 (5 x 10 mL) and then dried with Na2SO4. The solution was concentrated and 
taken on to the next step without further purification.  
To the crude diprotected alcohol in THF (1.2 mL) at 0 oC was added H2O (0.6 mL) 
at once followed by AcOH (3.2 mL) dropwise. After stirring at 0 oC for 1 h, the reaction 
was quenched with sat. NaHCO3 (aq., 3 mL), extracted with CH2Cl2 (5 x 10 mL) and 
dried with Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 10:1 to 
3:1) provided alcohol 1.124 (2.0 mg, 50 % from 1.123) as a colorless oil. Rf 0.47 
(hexanes:ethyl acetate, 3:1); [α]D20 = +1.67 (c = 0.36, THF); 1H NMR (500 MHz, C6D6) 
δ 7.27 (d, J = 9.5 Hz, 2 H), 6.83 (d, J = 8.5 Hz, 1 H), 4.37 (s, 2 H), 3.86-3.81 (m, 2 H), 
3.80-3.62 (m, 2 H), 3.53-3.38 (m, 5 H), 3.31 (s, 3 H), 3.28-3.23 (m, 1 H), 3.03 (dd, J = 
11.5, 4.0  Hz, 1 H), 2.26-2.18 (m, 1 H), 2.18-2.02 (m, 2 H), 2.0-1.93 (m, 1 H), 1.90-1.62 
(m, 8 H), 1.56-1.46 (m, 2 H), 1.42-1.28 (m, 2 H), 1.13 (s, 3 H), 1.06 (s, 3 H), 0.98 (t, J = 
7.8 Hz, 9 H), 0.95 (s, 9 H), 0.60 (q, J = 8.0 Hz, 6 H), 0.07 (3 H), 0.06 (3 H); 13C NMR 
(125 MHz, C6D6) δ 160.0, 129.7, 114.4, 89.3, 86.6, 84.9, 82.7, 78.0, 77.0, 75.2, 73.2, 
71.0, 67.9, 63.1, 55.1, 38.3, 38.0, 37.5, 30.6, 30.0, 29.8, 28.2, 28.1, 26.7, 26.4, 24.3, 18.7, 
16.1, 7.4, 5.7, -1.6, -1.7; IR (neat) 2950, 2931, 1461, 1086 cm-1; LRMS (CI) calcd for 







(R)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)pent-4-en-1-ol (1.130). A solution of 
L-gulono-1,4-lactone (4.44 g, 24.8 mmol) in DMF (40 mL) was cooled to 10 oC and p-
toluenesulfonic acid (36 mg, 0.20 mmol) was added. To the resulting solution, 
isopropenyl methyl ether (3.1 mL, 32 mmol) was added dropwise at 10 oC. The reaction 
mixture was warmed to rt and stirred at rt over 24 h. The reaction was treated with 
Na2CO3.10H2O (4.4 g) and stirred for 2 h. The reaction mixture was filtered. The filtrate 
was concentrated to give 5,6-O-isopropylidene-L-gulono-1,4-lactone which was used 
directly for the next step without further purification. 
To a solution of sodium periodate (7.13 g, 33.3 mmol) and water (70 mL) at 0 oC 
was added NaOH (11 mL of a 3.0 M solution in H2O, 33 mmol) dropwise at a rate such 
that the internal temperature was below 7 oC. 5,6-O-isopropylidene-L-gulono-1,4-lactone 
from above was added. After 0.5 h, the ice bath was removed. The reaction mixture was 
stirred at rt for 2 h at which time NaCl (8.5 g) was added. The reaction mixture was 
filtered and the white solide was washed with brine (2 x 10 mL). The filtrate was adjusted 
to pH = 7 with 15% Na2CO3 solution before extraction with CH2Cl2 (6 x 50 mL). The 
organic extracts were combined, dried with MgSO4 and distillated to give 1,2-O-
isopropylidene-(S)-glyceraldehyde1.129 (1.0 g, 33% for two steps) as a colorless liquid. 
To a solution of 1.129 (1.0 g, 7.7 mmol) in THF (10 mL) at -78 oC was added 
ZnCl2 (32. mL of a 0.50 M solution in THF, 16. mmol).After stirring at -78 oC for 10 min, 
the reaction was cooled to -90 oC. Then a solution of homoallyl magnesium bromide 
(from 4-bromo-1-butene (1.62 mL, 16.0 mmol), Mg (0.77 g, 32. mmol) and THF (10 mL) 
was added. After stirring at -90 oC for 1 h, the reaction mixture was warmed to 0 oC and 
the reaction was quenched with sat. NH4Cl (aq., 10 mL). The phases were separated. The 
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aqueous phase was extracted with CH2Cl2 (5 x 100 mL) and dried with Na2SO4. 
Concentration and chromatography (hexanes:ethyl acetate, 10:1 to 3:1) provided 1.130 
(0.99 g, 70%) as a colorless oil. Rf  0.26 (hexanes:ethyl acetate, 2:1); [α]D20 = -6.8 (c = 
0.16, THF); 1H NMR (300 MHz, CDCl3) δ 5.80 (m, 1 H), 5.01 (m, 2 H), 4.03-3.85 (m, 3 
H), 3.75 (m, 1 H), 2.34-2.08 (m, 2 H), 1.56-1.34 (m, 2 H), 1.40 (s, 3 H), 1.34 (s, 3 H); 13C 
NMR (125 MHz, CDCl3) δ 138.9, 115.3, 109.3, 79.4, 71.0, 65.7, 32.8, 30.5, 27.0, 25.8; 
IR (neat) 3438, 2935, 1216, 917 cm-1; LRMS (APCI) calcd for C10H22NO3 204.2 







(4R,5S)-4-(but-3-enyl)-2-phenyl-1,3-dioxan-5-ol (1.132). To a solution of 1.130 
(0.50 g, 2.7 mmol) in methanol (100 mL) at rt was added PPTS (0.74 g, 3.0 mmol). After 
refluxing overnight, the reaction was cooled to rt and quenched with sat. NaHCO3 (aq., 
10 mL). The phases were separated. The aqueous phase was extracted with CH2Cl2 (5 x 
100 mL) and then dried with Na2SO4. Concentration and chromatography 
(MeOH:CH2Cl2, 1:6) provided triol 1.131 (353 mg, 90 %) as a colorless oil.  
To a solution of triol 1.131 (0.26 g, 1.8 mmol) in CH2Cl2 (10 mL) at rt was added 
benzaldehyde dimethyl acetal (0.30 mL, 2.0 mmol) followed by 10-camphorsulfonic acid 
(41mg, 0.18 mmol). After stirring at reflux overnight, the reaction was quenched with sat. 
NaHCO3 (aq., 10 mL), extracted with CH2Cl2 (5 x 100 mL) and dried with Na2SO4. 
Concentration and chromatography (hexanes:ethyl acetate, 5:1 to 3:1) provided 1.132 
(360 mg, 87%) as a colorless oil. Rf  0.33 (hexanes:ethyl acetate, 3:1); [α]D20 = +3.03 (c = 
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0.13, THF);  1H NMR (500 MHz, C6D6) δ 7.59 (dd, J = 6.8, 1.4 Hz, 2 H), 7.15-7.06 (m, 3 
H), 5.80 (dddd, J = 17.1, 9.7, 6.8, 6.8 Hz, 1 H), 5.27 (s, 1H), 5.04 (dd, J = 17.1, 1.47 HZ, 
1 H), 4.97 (dd, J = 10.25, 0.98 Hz, 2 H),  4.0 (dd, J = 9.3, 4.4 Hz, 1 H), 3.34-3.82 (m, 3 
H), 2.33 (m, 1 H), 2.32-2.15 (m, 3 H), 1.92 (m,  1 H); 13C NMR (125 MHz, C6D6) δ 
139.2, 138.9, 129.0, 128.7, 128.5, 126.0, 115,1, 101.3, 81,6, 71.7, 66.2, 31.5, 29.7; IR 
(neat) 3627, 1387, 1605, 1004 cm-1; LRMS (APCI) calcd for C14H22NO3 252.2 





4-(4-methoxybenzyloxy)butanoic acid (1.133).  To a solution of NaH (1.42 g, 
59.1 mmol) in THF (175 mL) at 0 oC was added 1,4-butanediol (5.0 mL, 56 mmol) 
dropwise. Then p-(methoxy) benzyl chloride (8.0 mL, 56 mmol) was added dropwise 
followed by tBu4NI (2.29 g, 6.20 mmol). After heating at reflux overnight, the reaction 
was quenched with sat. NaHCO3 (aq., 20 mL), extracted with ethyl acetate (5 x 100 mL) 
and dried with Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 3:1) 
provided 4-(p-methoxybenzyloxy)butan-1-ol 1.136 (7.70 g, 65%) as a colorless oil. 
To a solution of 4-(p-methoxybenzyloxy)butan-1-ol 1.136 (2.0 g, 9.5 mmol) in 
acetone (120 mL) at -10 oC was added Jones reagent (10.0 mL of a 2.78 M solution in 
acetone, 27.8 mmol) slowly. After stirring for 1.5 h, the reaction was quenched with i-
PrOH and extracted with EtOAc. The extract was washed with brine and dried with 
Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 1:1) provided 4-(p-
methoxybenzyloxy)butyric acid 1.133 (1.5 g, 70%) as a colorless oil whose spectrum 














anete (1.134). To a solution of 1.132 (0.10 g, 0.43 mmol) in CH2Cl2 (2.0 mL) at rt was 
added the acid 1.133 (0.24 g, 1.1 mmol) followed by 1,3-dicyclohexylcarbodiimide (0.26 
g, 1.3 mmol) and DMAP (0.13 g, 1.1 mmol). After stirring at rt for 12 h, the reaction 
mixture was filtered. The filtrate was washed with sat. NaHCO3 (aq., 2.0 mL) and the 
aqueous phase was extracted with CH2Cl2 (5 x 20 mL). The organic extracts were dried 
with Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 10:1 to 5:1) 
provided 1.134 (0.154 g, 82%) as a colorless oil. Rf  0.50 (hexanes:ethyl acetate, 3:1); 
[α]D20 = +22.4 (c = 1.12, THF); 1H NMR (500 MHz, C6D6) δ 7.54 (d, J = 7.8 Hz, 2 H), 
7.19-7.12 (m, 5 H), 6.78 (d, J = 8.3 Hz, 2 H), 5.72 (dddd, J = 17.1, 10.3, 6.8Hz, 1 H), 
5.28 (s, 1 H), 4.99 (dd, J = 17.09, 0.98 Hz, 1 H), 4.94-4.89 (m, 2 H), 4.31 (dd, J = 10.7, 
5.4 Hz, 1 H), 4.24 (s, 2 H), 3.58 (dt, J = 9.3, 2.4 Hz, 1 H), 3.35-3.31 (m, 4 H), 3.22 (t, J = 
5.9 Hz, 2 H), 2.24-2.21 (m, 3 H), 2.10 (m, 1H), 1.78-1.72 (m, 3 H), 1.50 (m, 1 H); 13C 
NMR (125 MHz, C6D6) δ 172.0, 159.7, 138.6, 138.3, 131.8, 131.0, 129.4, 128.9, 127.7, 
126.7, 115.1, 114.4, 114.1, 101.4, 78.6, 72.7, 68.7, 68.2, 67.0, 54.8, 31.3, 31.2, 29.2, 25.5; 
IR (neat) 2930, 1738, 1607, 1453, 1256, 1169, 1099, 1029 cm-1; LRMS (APCI) calcd for 














o-4H-[1,3]dioxino[5,4-b]oxepine (1.138). To a solution of TiCl4 (0.80 mL, 7.3 mmol) in 
CH2Cl2 (53.2 mL) at 0 oC was added THF (3.83 mL, 43.6 mmol) dropwise. The solution 
was stirred at 0 oC for 0.2 h and then TMEDA (6.55 mL, 43.6 mmol) was added dropwise 
to the light-yellow solution. The ice bath was removed and after 0.3 h Zn dust (1.07 g, 
16.4 mmol) was added followed by PbCl2 (0.24 g, 0.86 mmol). Over 5 min, the reaction 
slurry turned from green to blue to blue-green at which time a solution of 1.134 (0.10 g, 
0.23 mmol), CH3CHBr2 (0.50 ml, 7.3 mmol), and CH2Cl2 (10 mL) was added via a 
cannula. The resulting mixture was stirred rapidly and heated at reflux for 1.5 h. Then the 
reaction mixture was cooled to 0 oC and stirred with sat. K2CO3 (aq., 1.8 mL) for 0.5 h. 
The mixture was filtered and the residue was washed with 1:1 hexanes:ethyl acetate (3 x 
40 mL).  The filtrate was combined and concentrated. Flash chromatography 
(hexanes:ethyl acetate, 10:1 w/ 1% Et3N) provided cyclic enol ether 1.138 (63 mg, 68%) 
as a colorless oil. Rf  0.60 (hexanes:ethyl acetate, 3:1); [α]D20 = -25.0 (c = 0.12, THF); 1H 
NMR (500 MHz, C6D6) δ 7.65 (d, J = 7.8 Hz, 2 H), 7.32-7.13 (m, 5 H), 6.8 (d, J =  8.8 
Hz, 2 H), 5.34 (s, 1 H), 4.71 (dd, J = 7.8, 3.9 Hz, 1 H), 4.32 (s, 2 H), 4.27 (dd, J = 10.7, 
5.4 Hz, 1 H), 3.6 (t, J = 10.5 Hz, 1 H), 3.52 (dt, J = 9.8, 3.9 Hz, 1 H), 3.42 (m, 1 H), 
3.31-3.29 (m, 5 H), 2.11 (m, 2 H), 1.95 (m, 2 H), 1.75-1.72 (m, 3 H), 1.50 (m, 1 H); 13C 
NMR (125 MHz, C6D6) δ 159.4, 139.0, 131.5, 129.6, 129.0, 128.5, 128.4, 127.0, 114.2, 
108.3, 101.3, 83.1, 75.6, 72.9, 69.5, 69.4, 54.9, 32.9, 32.7, 27.7, 21.4; IR (neat) 2921, 
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dioxino[5,4-b]oxepin-7(8H)-one (1.141). To 1.138 (50. mg, 0.12 mmol) in CH2Cl2 (20 
mL) at –78 oC was added dimethyl dioxirane (2.4 mL of a 0.10 M solution in CH2Cl2, 
0.24 mmol) dropwise. The reaction was warmed to 0 oC and concentrated. The colorless 
oil was taken up in CH2Cl2 (20 mL), cooled to -78 oC. iBu2AlH (0.24 mL of a 1.0 M 
solution in hexanes, 0.24 mmol) was added at once. After stirring at -78 oC for 10 min, 
the reaction was warmed up to 0 oC over 1 h. The reaction was quenched with sat. NH4Cl 
(aq., 2.5 mL). The phases were separated. The aqueous phase was extracted with CH2Cl2 
(5 x 50 mL) and dried with Na2SO4. Concentration and chromatography (hexanes:ethyl 
acetate, 5:1 to 3:1) provided the secondary alcohol 1.140 (40.7 mg, 78%) as a colorless 
oil.  
To the alcohol (30 mg, 0.070 mmol) from above in CH2Cl2 (5.0 mL) at rt was 
added 4Å MS (30 mg), NMO (14. mg, 0.14 mmol), then TPAP (ca. 2mg). After stirring 
at rt for 2 h, the reaction mixture was filtered through neutralized silica. Concentration 
and chromatography (hexanes:ethyl acetate, 10:1 to 4:1) provided ketone 1.141 (24 mg, 
80%) as a colorless oil. Rf  0.32 (hexanes:ethyl acetate, 3:1); [α]D20 = +48.0 (c = 0.17, 
THF); 1H NMR (500 MHz, C6D6) δ 7.61 (d, J = 6.8 Hz, 2 H), 7.22-7.11 (m, 5 H), 6.8 (d, 
J = 8.8 Hz, 2 H), 5.27 (s, 1 H), 4.29 (s, 2 H), 4.02 (dd, J = 10.8, 5.4), 3.56 (m, 1 H), 3.45 
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(t, J = 10.3 Hz, 1 H), 3.29 (s, 3 H), 3.26 (m, 3 H), 2.85 (dt, J = 9.8, 5.4 Hz, 1 H), 2.42 (m, 
1 H), 2.11 (m, 1 H), 1.81 (m, 1 H), 1.68 (m, 4 H), 1.49 (m, 1 H); 13C NMR (125 MHz, 
C6D6) δ 213.3, 159.7, 138.6, 131.2, 129.4, 129.0, 126.7, 114.1, 101.2, 87.2, 81.1, 76.1, 
72.4, 69.4, 69.3, 54.8, 36.2, 30.0, 29.5, 26.0; IR (neat) 2839, 1651, 1452, 1022 cm-1; 

















Summary of COSY spectrum for 1.141: 
 
Proton at 4.02 ppm (H-2) shows crosspeaks with protons at 3.45 ppm (H-2) and 2.85 ppm 
(H-3) 
Proton at 3.56 ppm (H-8) shows crosspeak with proton at 1.68 ppm (H-9) 
 
Proton at 3.44 ppm (H-2) shows crosspeak with proton at 4.02 ppm (H-2)  
 
Proton at 3.26 ppm (H-10) shows crosspeak with proton at 1.68 ppm (H-9) 
 
Proton at 2.85 ppm (H-3) shows crosspeaks with protons at 4.02 ppm (H-2), 3.45 ppm 
(H-2) and 3.26 ppm (H-4)  
Summary of 1D nOe difference experiments for 1.141: 
 













hydro-4H-[1,3]dioxino[5,4-b]oxepin-7-ol (1.142). To a solution of 1.141 (20 mg, 0.047 
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mmol) in toluene (2.5 mL) at -78 oC was added MeMgBr (0.063 mL of a 3.0 M solution 
in ether, 0.18 mmol). After stirring at -78 oC for 10 min, the reaction was warmed up to 0 
oC and kept at this temperature for 1 h. The reaction was quenched with sat. NH4Cl (aq., 
2.5 mL). The phases were separated. The aqueous phase was extracted with CH2Cl2 (5 x 
10 mL) and dried with Na2SO4. Concentration and chromatography (hexanes:ethyl 
acetate, 5:1 to 3:1) provided 1.142 (15.7 mg, 86%) and 1.143 (2.0 mg, 11%) as colorless 
oils.  
Data for 1.142: Rf  0.18 (hexanes:ethyl acetate, 3:1); [α]D20 = +0.8 (c = 0.25, 
THF); 1H NMR (500 MHz, C6D6) δ 7.66 (d, J = 7.3 Hz, 2 H), 7.26-7.15 (m, 5 H), 6.82 (d, 
J = 8.8 Hz, 2 H), 5.31 (s, 1 H), 4.35 (s, 2 H), 4.23 (dd, J = 10.0, 4.6 Hz, 1 H), 3.45 (t, J = 
10.3 Hz, 1 H), 3.40-3.36 (m, 3 H), 3.30 (m, 4 H), 3.14 (dd, J = 10.8, 1.5 Hz, 1 H), 1.88-
1.82 (m, 3 H), 1.70 (m, 1 H), 1.63-1.56 (m, 2 H), 1.50-1.41 (m, 2 H), 0.93 (s, 3 H); 13C 
NMR (125 MHz, C6D6) δ 159.8, 139.1, 131.5, 129.6, 129.0, 128.5, 128.4, 127.0,  114.3, 
101.6, 89.0, 83.4, 77.4, 74.5, 73.0, 70.3, 70.2, 54.9, 39.6, 28.1, 28.0, 27.7, 24.1; IR (neat) 
3475, 1768, 1248, 1055 cm-1; LRMS (APCI) calcd for C26H38NO6 460.3 (M+NH4+), 


















Summary of COSY spectrum for 1.142: 
Proton at 4.23 ppm (H-2) shows crosspeak with proton at 3.45 ppm (H-2)  




Proton at 3.30 ppm (H-3) shows crosspeaks with protons at 3.36 ppm (H-4) and 3.45 ppm 
(H-2) 
Proton at 3.14 ppm (H-8) shows crosspeak with proton at 1.41 ppm (H-9) 
Summary of 1D nOe difference experiments for 1.142: 
Irradiation at 0.92 ppm (CH3-12) resulted in enhancement at 1.60 ppm (H-6) and 1.83 
ppm (H-5) 
Data for 1.143: Rf  0.16 (hexanes:ethyl acetate 3:1); [α]D20 = -3.6 (c = 0.03, THF); 
1H NMR (500 MHz, C6D6) δ 7.68 (d, J = 7.8 Hz, 2 H), 7.26-7.13 (m, 5 H), 6.82 (d, J = 
8.3 Hz, 2 H), 5.30 (s, 1 H), 4.34 (d, J =  6.4 Hz, 2 H), 4.21 (dd, J = 10.8, 4.9 Hz, 1 H), 
3.46 (t, J = 10.3 Hz, 1 H), 3.40-3.34 (m, 2 H), 3.30 (s, 3 H), 3.27-3.24 (m, 1 H),  3.12 (dt, 
J = 9.7, 4.9 Hz, 1 H), 2.90 (dd, J = 10.3, 2.0 Hz, 1 H), 1.94 (m, 1 H), 1.83 (m, 1 H), 1.69-
1.46 (m, 6 H), 0.89 (s, 3 H); 13C NMR (125 MHz, C6D6) δ 159.9, 139.2, 131.5, 129.7, 
129.0,  128.5, 128.4, 127.8, 127.6, 127.0,  114.3, 101.6, 89.3, 83.0,  78.3, 74.5, 73.0, 70.2, 
70.1, 54.9, 39.6, 28.7, 27.4, 27.2, 26.8; IR (neat) 3475, 1768, 1247, 1055 cm-1; LRMS 



















Summary of COSY spectrum for 1.143: 
Proton at 4.21 ppm (H-2) shows crosspeak with proton at 3.46 ppm (H-2)  




Proton at 3.12 ppm (H-3) shows crosspeaks with protons at 3.25 ppm (H-4), 3.46 ppm 
(H-2) and 4.21 ppm (H-2) 
Proton at 2.90 ppm (H-8) shows crosspeak with proton at 1.6 ppm (H-9) 
Summary of 1D nOe difference experiments for 1.143: 




Irradiation at 2.90 ppm (H-8) resulted in enhancement at 0.89 ppm (H-12) and 3.12  
 














dimethylsilyloxy)-6-methyloxepan-3-ol (1.148). To a solution of 1.142 (5.0 mg, 11 
μmol) in CH2Cl2 (2.0 mL) at 0 oC was added NEt3 (0.028 mL, 0.20 mmol) followed by 
TBSOTf (0.026 mL, 0.11 mmol) and DMAP (ca. 0.5mg). The reaction mixture was 
warmed to rt over 1 h at which time the reaction was quenched with sat. NaHCO3 (aq., 3 
mL). The phases were separated and the aqueous phase was extracted with CH2Cl2 (5 x 
10 mL).The extracts were dried with Na2SO4. Concentration and chromatography 
(hexanes:ethyl acetate, 50:1 to 10:1) provided protected alcohol 1.144 (5.6 mg, 90%) as a 
colorless oil.  
To a solution of 1.144 (5.0 mg, 9.0 μmol) in MeOH (1 mL) at rt was added PPTS 
(2.5 mg, 10 μmol). After refluxing for 3 h, the reaction mixture was cooled to rt and the 
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reaction was quenched with sat. NaHCO3 (aq., 0.5 mL). The phases were separated and 
the aqueous phase was extracted with CH2Cl2 (5 x 10 mL). The organic extracts were 
dried with Na2SO4. Concentration and chromatography (MeOH:CH2Cl2, 1:6) provided 
diol 1.145 (3.7 mg, 90 %) as a colorless oil. 
To a solution of the diol 1.145 (2.0 mg, 4.3 μmol) from above in CH2Cl2 (1 mL) 
at -78 oC was added 2,6-lutidine (1.0 μl, 8.5 μmol) followed by Tf2O (0.8 μl, 4.5 μmol). 
After 15 min, TESOTf (19 μl, 85 μmol) and 2,6-lutidine (20 μl, 0.17 mmol) were added 
and the reaction mixture was warmed to rt. After 0.5 h, the reaction mixture was cooled 
to -78 oC and the reaction was quenched with sat. NaHCO3 (aq., 3 mL). The phases were 
separated were separated and the aqueous phase was extracted with CH2Cl2 (5 x 10 mL). 
The organic extracts were dried with Na2SO4 and concentrated. The yellow oil was 
passed through a short plug of silica (hexanes:ethyl acetate, 5:1) and immediately taken 
on to the next step. 
A solution of the triflate from above in THF (0.5 mL) at -40 oC was added via 
cannula to a solution of allyl cuprate [Prepared from allyl magnesium chloride (0.66 mL 
of a 2.0 M solution in THF, 1.3 mmol) and CuI (0.14 g, 0.73 mmol) at -78 oC. The 
mixture was slowly warmed to 0 oC and stirred for 1 h]. The reaction mixture was stirred 
at -40 oC for 2 h, warmed to rt and quenched with sat. NH4Cl (aq., 10 mL). The mixture 
was extracted with CH2Cl2 (5 x 10 mL) and dried with Na2SO4. Concentration and 
chromatography (hexanes:ethyl acetate, 5:1 to 3:1) provided protected alcohol 1.147 (2.0 
mg, 75%) as acolorless oil.  
To a solution of 1.147 from above in MeOH (0.5 mL) at 0 oC was added 10-
camphorsulfonic acid (ca. 0.2 mg).The reaction mixture was warmed to rt over 1 h.The 
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reaction was quenched with sat. NaHCO3 (aq., 1 mL). The phases were separated and the 
aqueous phase was extracted with CH2Cl2 (5 x 10 mL).The organic extracts were dried 
with Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 10:1 to 3:1) 
provided alcohol 1.148 (1.5 mg, 90%) as a colorless oil. Rf   0.51 (hexanes:ethyl acetate, 
3:1);  [α]D20 = -13.8 (c = 0.014, THF); 1H NMR (500 MHz, C6D6) δ 7.26 (d, J = 8.8 Hz, 2 
H), 6.82 (d, J = 8.8 Hz, 2 H), 5.88 (dddd, J = 16.6, 10.3, 6.4 Hz, 1 H), 5.10 ( dd, J = 17.1, 
1.9 Hz, 1 H), 5.00 (ddd, J = 10.3, 1.0, 1.0 Hz,1 H),  4.35 (s, 2 H), 3.42  (m, 2 H), 3.34 (dd, 
J = 10.7,1.5 Hz, 1 H), 3.30 (s, 3 H), 3.12 (m, 1 H),  2.48 (m, 1 H), 2.24 (m, 1 H), 2.01 (m, 
1 H), 1.86 (m, 2 H), 1.80-1.50 (m, 7 H), 1.12 (s, 3 H), 0.97 (s, 9 H), 0.09 (d, J = 1.46 Hz, 
6 H); 13C NMR (125 MHz, C6D6) δ 159.6, 139.2, 131.5, 128.3, 114.7, 87.3, 77.7, 76.2, 
72.7, 72.6, 67.1, 54.7, 37.6, 34.8, 30.7, 30.0, 28.0, 27.8, 26.0, 23.8, 18.3, -1.9, -2.0; IR 











dro-2H-pyran-3-yloxy)(tert-butyl)dimethylsilane (1.199). The general procedure for 
the DMDO epoxidation/ZnR2 addition of tri-O-benzyl-D-glucal is given below. To a 
solution of 1.198 (20 mg, 0.048 mmol) and CH2Cl2 (1.0 mL) at 0 °C was added a solution 
of dimethyl dioxirane (0.72 mL of a 0.10 M solution in acetone, 0.072 mmol) dropwise. 
After 10 min, the reaction mixture was concentrated to give epoxide 1.191. 
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     To a solution of epoxide 1.191 and CH2Cl2 (1.0 mL) at 0 °C was added dimethyl zinc 
(0.48 mL of a 1.0 M solution in heptane, 0.48 mmol) followed by a solution of TBSOTf 
(0.025 mL, 0.11 mmol) in CH2Cl2 (0.50 mL). After stirring at 0 °C for 2 h, the reaction 
was quenched with sat. NaHCO3 (aq., 1.0 mL). The phases were separated, and the 
aqueous phase was extracted with CH2Cl2 (3 x 15 mL). The extracts were combined, 
dried with Na2SO4, and concentrated. Flash chromatography (hexanes:ethyl acetate, 10:1) 
provided 24 mg (89%) of 1.199 as a colorless oil. Rf  0.78 (hexanes:ethyl acetate, 3:1); 
[α]D20 = +21.9 (c = 0.40, CH2Cl2); 1H NMR (500 MHz, C6D6) δ 7.40 (d, J = 6.8 Hz, 2 H), 
7.32 (d, J = 7.8 Hz, 2 H), 7.23-7.06 (m, 11 H), 4.92-4.86 (m, 3 H), 4.65 (d, J = 11.2 Hz, 
1 H), 4.49 (d, J = 12.2 Hz, 1 H), 4.42 (d, J = 12.2 Hz, 1 H), 4.19-4.14 (dq, J = 6.8 Hz, 1 
H), 3.93-3.90 (dd, J = 9.3,6.4 Hz, 1 H), 3.83-3.75 (m, 3 H), 3.72-3.67 (m, 2 H), 1.26 (d, J 
= 6.8 Hz, 3 H), 0.89 (s, 9 H), 0.02 (s, 3 H), -0.08 (s, 3 H); 13C NMR (125 MHz, C6D6) δ 
139.7, 139.4, 139.1, 128.8, 128.5, 128.4, 127.8, 127.6, 127.4, 127.3, 83.3, 79.3, 75.4, 75.0, 
73.8, 73.6, 72.7, 72.2, 70.0, 26.0, 18.1, 12.0, -4.6, -4.8; IR (neat) 3031, 2929, 2857, 1454, 









dro-2H-pyran-3-ol (1.200). The general procedure for the deprotection of TBS group is 
given here. To a solution of 1.199 (24 mg, 0.043 mmol) and THF (1.0 mL) at 0 °C was 
added TBAF (0.22 mL of a 1.0 M solution in THF, 0.22 mmol). The reaction mixture 
was warmed up to rt over 1 h. After stirring at rt for 3 h, the reaction was quenched with 
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aq. NH4Cl (sat., 1.0 mL) at 0 °C. The phases were separated, and the aqueous phase was 
extracted with CH2Cl2 (3 x 10 mL). The extracts were combined, dried with Na2SO4, and 
concentrated. Flash chromatography (hexanes:ethyl acetate, 3:1) gave 15.5 mg (81%) of 








1. 201  
     ((2R,3S,4S,5R,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-ethyl-tetrahydro-2H 
-pyran-3-yloxy)(tert-butyl)dimethylsilane (1.201). According to the general procedure 
as described for the preparation of compound 1.199, epoxide 1.191 was generated from 
1.198 (27 mg, 0.065 mmol), CH2Cl2 (1.4 mL) and a solution of dimethyl dioxirane (0.97 
mL of a 0.10 M solution in acetone, 0.10 mmol). Then epoxide 1.191 was treated with 
diethyl zinc (0.65 mL of a 1.0 M solution in hexane, 0.65 mmol), CH2Cl2 (1.4 mL) and a 
solution of TBSOTf (0.034 mL, 0.14 mmol) in CH2Cl2 (0.68 mL) to give 32 mg (86%) of 
1.201 as a colorless oil after flash chromatography (hexanes:ethyl acetate, 10:1). Rf  0.78 
(hexanes:ethyl acetate, 3:1); [α]D20 = +20.6 (c = 0.34, CH2Cl2,); 1H NMR (500 MHz, 
C6D6) δ 7.41 (d, J = 7.3 Hz, 2 H), 7.32 (d, J = 7.8 Hz, 2 H), 7.23-7.04 (m, 11 H), 4.94-
4.87 (m, 3 H), 4.62 (d, J = 11.2 Hz, 1 H), 4.50 (d, J = 12.2 Hz, 1 H), 4.41 (d, J = 12.2 Hz,  
1 H), 3.98 (dd, J = 8.8, 5.9 Hz,  1 H), 3.91-3.87 (m, 1 H), 3.80-3.74 (m, 1 H), 3.73-3.66 
(m, 3 H), 3.64-3.61 (m, 1 H), 1.83-1.77 (m, 1 H), 1.73-1.65 (m, 1 H),  1.03 (t, J = 7.3 Hz, 
3 H), 0.90 (s, 9 H), 0.04 (s, 3 H), -0.06 (s, 3 H); 13C NMR (125 MHz, C6D6) δ 139.7, 
139.4, 139.1, 128.5, 128.4, 127.8, 127.6, 127.4, 127.3, 83.7, 79.3, 78.3, 75.3, 75.0, 74.0, 
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73.6, 71.8, 70.1, 26.0, 18.1, 17.6, 10.3, -4.6, -4.7; IR (neat) 3030, 2929, 2856, 1454, 1359, 









-2H-pyran-3-yl acetate (1.202). According to the general procedure as described for the 
preparation of compound 1.200, TBAF (0.28 mL of a 1.0 M solution in THF, 0.28 mmol), 
THF (1.3 mL) and 1.201 (32 mg, 0.055 mmol) afforded the corresponding alcohol. The 
crude product was used directly without purification. 
To a solution of the alcohol from above in CH2Cl2 (0.50 mL) at rt wasadded 
acetic anhydride (0.042 mL, 0.44 mmol), (i-Pr)2NEt (0.077 mL, 0.44 mmol), and DMAP 
(ca. 5 mg). After stirring 1 h, the reaction was quenched with sat. NH4Cl (aq., 1.0 mL). 
The phases were separated, and the aqueous phase was extracted with CH2Cl2 (3 x 15 
mL). The extracts were combined, dried with Na2SO4, and concentrated. Flash 
chromatography (hexanes:ethyl acetate, 5:1) provided 21 mg (75% for two steps) of 









hydro-2H-pyran-3-yloxy)(tert-butyl)dimethylsilane (1.204). According to the general 
107 
 
procedure as described for the preparation of compound 1.199, tri-O-benzyl-D-glucal 
1.198 (23 mg, 0.055 mmol), CH2Cl2 (1.2 mL) and a solution of dimethyl dioxirane (0.83 
mL of a 0.10 M solution in acetone, 0.083 mmol) afforded epoxide 1.191 which reacted 
with diisopropyl zinc (0.55 mL of a 1.0 M solution in toluene, 0.55 mmol), CH2Cl2 (1.2 
mL) and  a solution of TBSOTf (0.029 mL, 0.12 mmol) in CH2Cl2 (0.58 mL) to give 26 
mg (80%) of 1.204 as a colorless oil after flash chromatography (hexanes:ethyl acetate, 
10:1). Rf  0.76 (hexanes:ethyl acetate, 3:1); [α]D20 = +15.9 (c = 0.11, CH2Cl2); 1H NMR 
(500 MHz, C6D6) δ 7.36 (d, J = 7.8 Hz, 2 H), 7.32-7.31 (m, 2 H), 7.24-7.05 (m, 11 H), 
4.80-4.74 (m, 3 H), 4.57 (d, J = 11.7 Hz, 1 H), 4.49 (d, J = 12.2 Hz, 1 H), 4.42 (d, J = 
12.2 Hz,  1 H), 4.08 (dd, J = 7.3, 4.4 Hz, 1 H), 3.92- 3.89 (m, 1 H), 3.84-3.77 (m, 2 H), 
3.71-3.70 (m, 2 H), 3.54 (dd, J = 9.8, 3.9 Hz, 1 H), 2.12-2.14 (m, 1 H),  1.13 (d, J = 6.4 
Hz, 3 H), 1.08 (d, J = 6.8 Hz, 3 H), 0.92 (s, 9 H), 0.06 (s, 3 H), 0.007 (s, 3 H); 13C NMR 
(125 MHz, C6D6) δ139.4, 139.3, 139.2, 128.5, 128.4, 128.3, 127.9, 127.8, 127.7,  127.6, 
127.5, 82.8, 80.2, 78.9, 74.2, 73.6, 73.0, 70.3, 27.1, 26.2, 20.6, 20.3, 18.3, -4.3, -4.6; IR 
(neat) 3053, 2927, 2857, 1361, 1265, 1075, 837 cm-1; LRMS (ESI) calcd for 








hydro-2H-pyran-3-yl acetate (1.205). According to the general procedure for the 
preparation of alcohol 1.200, TBAF (0.22 mL of a 1.0 M solution in THF, 0.22 mmol), 
1.204 (26 mg, 0.044 mmol) and THF (1.0 mL) afforded the corresponding alcohol.  
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To a solution of the alcohol from above in CH2Cl2 (0.50 mL) at rt wasadded 
acetic anhydride (0.034 mL, 0.36 mmol), (i-Pr)2NEt (0.063 mL, 0.36 mmol), and DMAP 
(ca. 5.0 mg). After stirring 1 h, the reaction was quenched with sat. NH4Cl (aq., 1.0 mL). 
The phases were separated, and the aqueous phase was extracted with CH2Cl2 (3 x 15 
mL). The extracts were combined, dried with Na2SO4, and concentrated. Flash 
chromatography (hexanes:ethyl acetate, 5:1) provided 18 mg (79% for two steps) of 
acetate 1.205 as a colorless oil. Rf 0.53 (hexanes:ethyl acetate, 3:1); [α]D20 = -9.2 (c = 
0.12, CH2Cl2); 1H NMR (500 MHz, C6D6) δ 7.31-7.29 (m, 5 H), 7.23-7.07 (m, 10 H), 
5.32 (t, J = 3.42 Hz, 1 H), 4.69 (d, J = 11.7 Hz, 1 H), 4.60 (d, J = 12.2, Hz, 1 H), 4.53 (d, 
J = 11.7 Hz, 1 H), 4.46-4.38 (m, 3 H), 4.17 (ddd, J = 11.2, 4.9 Hz, 1 H),  3.97 (t, J = 4.4 
Hz, 1 H), 3.78 (t, J =5.4 Hz, 1 H), 3.74 (d, J = 4.4 Hz, 2 H), 3.62 (dd, J = 9.3, 2.5 Hz, 1 
H), 2.06-1.99 (m, 1 H), 1.65 (s, 3H), 1.11 (d, J = 6.4 Hz, 3 H), 0.77 (d, J = 6.4 Hz, 3 H); 
13C NMR (125 MHz, C6D6) δ 170.0, 139.2, 139.0, 138.7, 128.6, 128.5, 128.4, 128.3, 
128.2,  127.8, 127.7, 127.6, 127.5, 78.6, 75.8, 75.5,  73.9, 73.5, 72.9,72.8, 70.6, 69.8, 28.6, 
20.6, 20.0, 18.6; IR (neat) 2958, 2918, 2856, 1738, 1714, 1454, 1368, 1237, 1096, 1073 









butyldimethylsilyloxy)-tetrahydro-2H-pyran-2-yl)acetate (1.208). According to the 
general procedure as described for the preparation of compound 1.199, tri-O-benzyl-D-
glucal 1.198 (36 mg, 0.086 mmol), CH2Cl2 (1.8 mL) and a solution of dimethyl dioxirane 
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(1.3 mL of a 0.10 M solution in acetone, 0.13 mmol) afforded epoxide 1.191. The 
epoxide was treated with CH2Cl2 (2.0 mL), tert-butyl(1-methoxyvinyloxy)dimethylsilane 
(0.32 g, 1.7 mmol) and  a solution of TBSOTf (0.045 mL, 0.19 mmol) in CH2Cl2 (0.90 
mL) at -78 °C. The reaction mixture was kept at -78 °C for 48 h, warmed up to -40 °C 
slowly and kept at -40 °C for another 24 h. The reaction mixture was warmed up to 0 oC 
and quenched with sat. NaHCO3 (aq., 1.0 mL). The phases were separated. The aqueous 
phase was extracted with CH2Cl2 (3 x 15 mL). The extracts were combined, dried with 
Na2SO4, and concentrated. Flash chromatography (hexanes:ethyl acetate, 10:1) provided 
42 mg (79%) of 1.208 as a colorless oil after flash chromatography (hexanes:ethyl acetate, 
10:1). Rf  0.70 (hexanes:ethyl acetate, 3:1); [α]D20 = -14.5 (c = 0.20, CH2Cl2); 1H NMR 
(500 MHz, C6D6) δ 7.35-7.30 (m, 4 H), 7.21-7.03 (m, 11 H), 5.02 (d, J = 12.1 Hz, 1 H), 
4.73 (t, J = 11.9 Hz, 2 H), 4.61 (d, J = 11.0 Hz, 1 H), 4.44 (d, J = 12.1 Hz, 1 H), 4.35 (d, 
J = 12.1 Hz, 1 H), 3.89 (dt, J = 9.3, 2.6 Hz, 1 H), 3.81 (t, J = 9.2 Hz, 1 H), 3.66 (d, J = 2.8 
Hz, 2 H), 3.51 (t, J = 8.8 Hz, 1 H), 3.45- 3.41 (m, 2 H), 3.38 (s, 3 H), 2.95 (dd, J = 15.4, 
2.8 Hz, 1 H), 2.57 (dd, J = 15.4, 9.5 Hz, 1 H), 0.90 (s, 9 H), 0.04 (s, 3 H), -0.04 (s, 3 H);  
13C NMR (125 MHz, C6D6) δ 173.2, 139.6, 139.0, 128.5, 128.4, 128.3, 127.8, 127.6, 
127.2, 126.7, 87.0, 79.8, 79.3, 78.0, 75.0, 74.8, 74.3, 73.4, 69.1, 51.3, 38.0, 26.1, 18.2, -
3.5, -4.3; IR (neat) 3063, 3030, 2951, 2928, 2857, 1743, 1256, 1089, 859, 837 cm-1; 







1. 208'  
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 Preparation of acetate 1.208’. To a solution of 1.208 (32 mg, 0.052 mmol) and 
MeOH (1.0 mL) at rt was added p-toluenesulfonic acid monohydrate (32 mg, 0.17 mmol). 
After stirring at rt for 24 h, the reaction mixture was cooled to 0 °C and the reaction was 
quenched by the slow addition of sat. NaHCO3 (aq., 2.0 mL). The resulting mixture was 
extracted with CH2Cl2 (3 x 10 mL), dried (Na2SO4), and concentrated. The crude product 
was used directly without further purification. 
To a solution of the alcohol from above and CH2Cl2 (0.50 mL) at rt was added 
acetic anhydride (0.038 mL, 0.41 mmol), (i-Pr)2NEt (0.071 mL, 0.41 mmol), and DMAP 
(ca. 5.0 mg). After stirring 1 h, the reaction was quenched with aq. NH4Cl (sat., 1.0 mL). 
The phases were separated, and the aqueous phase was extracted with CH2Cl2 (3 x 15 
mL). The extracts were combined, dried with Na2SO4, and concentrated. Flash 
chromatography (hexanes:ethyl acetate, 10:1) gave 23 mg (80% for two steps) of acetate 
1.208’ as a colorless  oil. Rf  0.47 (hexanes:ethyl acetate, 3:1); [α]D20 = +11.6 (c = 0.11, 
CH2Cl2); 1H NMR (500 MHz, C6D6) δ 7.31-7.25 (m, 3 H), 7.20 (d, J = 7.3 Hz, 2 H), 
7.15-7.05 (m, 10 H), 5.33 (dd, J = 7.8, 4.9 Hz, 1 H), 4.89 (ddd, J = 8.8, 5.4 Hz, 1 H), 
4.66-4.59 (m, 3 H), 4.47 (d, J = 11.7 Hz, 1 H), 4.43 (d, J = 11.7 Hz, 1 H), 4.35(d, J = 11.7 
Hz, 1 H), 3.88 (ddd, J = 8.3, 3.9 Hz, 1 H), 3.76 (t, J = 7.8 Hz, 1 H), 3.70-3.66 (m, 3 H), 
3.31 (s, 3 H), 2.63 (dd, J = 15.1, 8.8 Hz, 1 H), 2.43 (dd, J = 15.1, 5.9 Hz, 1 H), 1.53 (s, 3 
H); 13C NMR (125 MHz, C6D6) δ 170.6, 169.3, 139.0, 128.6, 128.5, 128.3, 127.9, 127.8, 
127.7, 127.6, 127.4, 79.8, 77.5, 74.3, 73.8, 73.6, 72.1, 69.6, 69.5, 51.3, 34.0, 20.3; IR 
(neat) 3061, 3031, 2952, 2918, 2857, 1744, 1713, 1453, 1363, 1226, 1087 cm-1; LRMS 










1. 209  
(2R,3R,4S,4aS,8aS)-3,4-bis(benzyloxy)-2-(benzyloxymethyl)-6-ethyl-2,3,4,4a, 
8,8a-hexahydropyrano[3,2-b]pyran (1.209). An oven dried two-necked flask fitted with 
a condenser was cooled to 0 °C and charged with CH2Cl2 (31. mL) followed by TiCl4 
(0.38 mL, 3.4 mmol). To the resulting solution was added THF (1.8 mL, 20. mmol) 
dropwise at which time the solution turned yellow. The addition of THF was followed by 
the dropwise addition of TMEDA (3.1 mL, 21 mmol) resulting in the formation of a 
brown solution. The ice bath was removed and the mixture was allowed to stir at rt for 20 
min. Activated Zn dust (0.50 g 7.8 mmol) and PbCl2 (0.11 g, 0.40 mmol) were then 
added. The resulting mixture went through a series of color changes from brown to green 
to purple and finally to blue-green over the course of 3-5 min. To the slurry was 
transferred a solution of ester 1.211 (0.10 g, 0.19 mmol) and CH3CHBr2 (0.31 mL, 3.4 
mmol) in CH2Cl2 (2.0 mL + 2.0 mL rinse) via cannula. The reaction mixture was then 
heated to reflux for 4 h. Following this time period the mixture was cooled to 0 °C and 
quenched with sat K2CO3 (aq., 1.2 mL). After stirring for 30 min at 0 °C, the resulting 
mixture was filtered. The residue was washed with 1:1 hexanes:ethyl acetate (3 x 40 mL).  
The filtrate was combined and concentrated. The resulting residue was purified by flash 
chromatography (hexanes:ethyl acetate, 100:1 to 10:1) to give 0.075 g (80%) of cyclic 
enol ether 1.209 as a colorless oil. Rf  0.70 (hexanes:ethyl acetate, 3:1); [α]D20 = +44.2 (c 
= 0.33, CH2Cl2); 1H NMR (500 MHz, C6D6) δ 7.45 (d, J = 7.3 Hz, 2 H), 7.28-7.25 (m, 4 
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H), 7.20-7.04 (m, 9 H), 5.13 (d, J =  11.7 Hz, 1 H), 4.98 (d, J = 11.7 Hz, 1 H), 4.85 (d, J 
= 11.7 Hz, 1 H), 4.60 (d, J = 11.2 Hz, 1 H), 4.44 (d, J = 11.7 Hz, 1 H), 4.35 (d, J = 12.2 
Hz, 1 H),  4.27-4.26  (m, 1 H), 3.80-3.73 (m, 2 H), 3.69-3.66 (m, 3 H), 3.45 (ddd, J = 8.8, 
3.4, 2.0 Hz, 1 H), 3.3 (ddd, J = 9.3, 6.4 Hz, 1 H), 2.26-2.20 (m, 1 H), 2.18-2.12 (m, 1 H), 
1.96 (q, J = 7.3 Hz, 2 H), 0.98 (t, J = 7.3 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 155.2, 
138.8, 138.2, 138.0, 128.3, 128.0, 127.9, 127.6, 127.5, 91.9, 84.3, 79.3, 78.8, 77.4, 75.2, 
74.9, 73.5, 72.3, 69.1, 27.3, 26.5, 11.6; IR (neat) 3063, 3030, 2967, 2916, 2856, 1677, 
1496, 1453, 1361, 1318, 1109, 921 cm-1; LRMS (ESI) calcd for C32H36O5Na 523.3 









1. 211  
 
(2S,3S,4S,5R,6R)-2-allyl-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-tetrahydro-
2H-pyran-3-yl propionate (1.211). To a solution of 1.210 (0.10 g, 0.21 mmol) in 
CH2Cl2 (10 mL) was added propionic acid (20 mg, 0.27 mmol), DCC (0.13 g, 0.63 mmol) 
and DMAP (0.051 g, 0.42 mmol). After stirring at rt for 5 h, the reaction was quenched 
with sat. NaHCO3 (aq., 10 mL). The phases were separated, and the aqueous phase was 
extracted with CH2Cl2 (3 x 15 mL). The extracts were combined, dried with Na2SO4, and 
concentrated. Flash chromatography (hexanes:ethyl acetate, 5:1) provided 0.10 g of  
1.211 (92%) as a colorless oil.  Rf  0.63 (hexanes:ethyl acetate, 3:1); [α]D20 = +12.0 (c = 
0.10, CH2Cl2); 1H NMR (500 MHz, C6D6) δ 7.31-7.29 (m, 3 H), 7.22-7.04 (m, 12 H), 
5.98 (dddd, J = 17.0, 10.3, 7.0, 7.0 Hz, 1 H), 5.25 (t, J = 9.3 Hz, 1 H), 5.13-5.04 (m, 2 H), 
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4.78 (d, J = 11.5 Hz, 1 H), 4.73 (d, J = 11.4 Hz, 1 H), 4.63 (d, J = 11.7 Hz, 1 H), 4.52 (d, 
J = 11.2 Hz, 1 H), 4.47 (d, J = 12.3 Hz, 1 H),  4.41 (d, J = 12.3 Hz, 1 H), 3.69- 3.55 (m, 
4 H), 3.36 (ddd, J = 9.3, 4.4, 2.0  Hz,  1 H), 3.29-3.24 (m, 1 H), 2.37-2.34 (m, 2 H), 2.01-
1.90 (m, 2 H), 0.93 (t, J = 7.5 Hz, 3 H); 13C NMR (125 MHz, C6D6) δ 172.7, 139.3, 
139.1, 134.5, 128.5, 128.5, 127.9, 127.8, 127.7, 127.6, 117.2, 85.2, 79.9, 78.7, 77.8, 75.0, 
74.9, 73.8, 73.5, 69.4, 36.7, 27.7, 9.1; IR (neat) 3030, 2979, 2939, 2864, 1745, 1453, 













thyl-hexahydropyrano [3,2-b]pyran-3(2H)-one (1.214). The general procedure for the 
DMDO epoxidation/ZnR2 addition of 1.209 is given below. To a solution of 1.209 (30 mg, 
0.060 mmol) and CH2Cl2 (1.3 mL) at -78 °C was added a solution of dimethyl dioxirane 
(0.90 mL of a 0.10 M solution in acetone, 0.090 mmol) dropwise. After 5 min, the 
reaction was warmed to 0 °C and concentrated. The epoxide was taken up in THF (1.0 
mL) at -78 °C. Dimethyl zinc (0.60 mL of a 1.0 M solution in heptane, 0.60 mmol) was 
added followed by a solution of TBSOTf (0.031 mL, 0.13 mmol) in THF (0.63 mL). The 
reaction mixture was warmed up to 0 °C over 1 h. The reaction was quenched with sat. 
NaHCO3 (aq., 1.0 mL). The phases were separated, and the aqueous phase was extracted 
with CH2Cl2 (3 x 15 mL). The extracts were combined, dried with Na2SO4, and 
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concentrated. Flash chromatography (hexanes:ethyl acetate, 10:1) provided 32 mg (82%) 
of 1.212 as a mixture. 
For characterization purposes, 1.212 was converted to ketone 1.214 in two steps:     
To a solution of 1.212 (30 mg, 0.046 mmol) and THF (1.0 mL) at 0 °C was added 
HF•pyridine (0.46 mL of a 1.0 M solution in THF, 0.46 mmol). After stirring overnight at 
rt, the reaction was diluted with CH2Cl2 (10 mL) and quenched with sat. NaHCO3 (aq., 3 
mL) at 0 °C. The phases were separated, and the aqueous phase was extracted with 
CH2Cl2 (3 x 10 mL), dried with Na2SO4 and concentrated. The resulting alcohol was used 
directly without further purification. 
To a solution of the alcohol from above inCH2Cl2 (5 mL) was added 4Å MS (20 
mg), NMO (34 mg, 0.29 mmol) and TPAP (ca. 3.0 mg). After stirring at rt for 2 h, the 
reaction mixture was concentrated. Flash chromatography (hexanes:ethyl acetate, 5:1) 
gave 19 mg(76% for two steps) of ketone 1.214  as a colorless oil. Rf  0.55 (hexanes:ethyl 
acetate, 3:1); [α]D20 = +43.9 (c = 0.09, CH2Cl2); 1H NMR (500 MHz, C6D6) δ 7.39 (d, J = 
7.8 Hz, 2 H), 7.31-7.27 (m, 4 H), 7.20-7.0 (m, 9 H), 5.0 (t, J = 10.7 Hz, 2 H), 4.76 (d, J = 
11.2 Hz, 1 H), 4.65 (d,  J = 11.2 Hz, 1 H), 4.42 (d, J = 11.7 Hz, 1 H), 4.34 (d, J = 12.2 Hz, 
1 H), 3.80 (t, J = 9.3 Hz, 1 H), 3.69 (dd, J = 10.7, 3.9 Hz, 1 H), 3.64 (dd, J = 10.7, 2.0 Hz, 
1 H), 3.59 (t, J = 8.8 Hz, 1 H), 3.46 (t, J = 9.3 Hz, 1 H), 3.33 (ddd, J = 9.8, 3.9, 1.5 Hz, 1 
H),  3.04 (ddd, J = 11.2, 9.3, 5.9 Hz, 1 H), 2.70 (dd, J = 16.6, 5.9 Hz, 1 H), 2.33 (dd, J = 
16.6, 11.7 Hz, 1 H), 1.88 (dq, J = 14.6, 7.3 Hz, 1 H), 1.55 (dq, J = 14.6, 7.3 Hz, 1 H), 
0.96 (s, 3 H), 0.86 (t, J = 7.3 Hz, 3 H); 13C NMR (125 MHz, C6D6) δ 207.8, 139.7, 139.4, 
138.9, 128.5, 128.3, 127.9, 127.8, 127.7, 127.5, 127.4, 84.3, 83.4, 79.5, 77.7, 75.8, 75.2, 
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74.9, 73.9, 73.6, 69.6, 43.0,  31.7, 21.1, 8.1; IR (neat) 3030, 2923, 1720, 1454, 1101, 698 























Summary of COSY spectrum for 1.214: 
Proton at 1.55 ppm (H-8) shows crosspeaks with protons at 1.88 ppm (H-8) and 0.86 ppm 
(H-9) 
Proton at 1.88 ppm (H-8) shows crosspeaks with protons at 1.55 ppm (H-8) and 0.86 ppm 
(H-9) 
Proton at 2.33 ppm (H-6’) shows crosspeaks with protons at 2.70 ppm (H-6) and 3.04 
ppm (H-5) 
Proton at 2.70 ppm (H-6) shows crosspeaks with protons at 2.33 ppm (H-6’) and 3.04 
ppm (H-5) 
Proton at 3.04 ppm (H-5) shows crosspeaks with protons at 2.33 ppm (H-6’), 2.70 ppm 
(H-6) and 3.46 ppm (H-4) 
Proton at 3.46 ppm (H-4) shows crosspeaks with protons at 3.59 ppm (H-3), 3.04 ppm 
(H-5)  
Summary of 1D nOe difference experiments for 1.214: 












1. 217  
(2R,4aS,6R,7R,8S,8aS)-7,8-bis(benzyloxy)-6-(benzyloxymethyl)-2-ethyl-2-me- 
thyl-hexahydropyrano[3,2-b]pyran-3(2H)-one (1.217). According to the general proce- 
dures for the preparation of 1.212, enol ether 1.215 (25 mg, 0.051 mmol), CH2Cl2 (1.0 
mL) and a solution of dimethyl dioxirane (0.77 mL of a 0.10 M solution in acetone, 0.077 
mmol) afforded the epoxide which reacted with diethyl zinc (0.51 mL of a 1.0 M solution 
in hexane, 0.51 mmol), THF(1.0 mL) and  a solution of TBSOTf (0.027 mL, 0.11 mmol) 
in THF(0.53 mL) to give 27 mg (81%) 1.216 as a mixture after flash chromatography 
(hexanes:ethyl acetate, 10:1). 
For characterization purposes, 1.216 was converted to ketone 1.217 in two steps. 
According to the general procedures for the preparation of 1.214, 1.216 (27 mg, 0.042 
mmol) reacted with HF•pyridine (0.42 mL of a 1.0 M solution in THF, 0.42 mmol) to 
give the crude alcohol. The crude alcohol was reacted with 4Å MS (20 mg), NMO (31 
mg, 0.26 mmol) and TPAP (ca. 3.0 mg) to give 17 mg (75% for two steps) of 1.217 as a 
colorless oil.  Rf  0.56 (hexanes:ethyl acetate, 3:1); [α]D20 = +67.7 (c = 0.13, CH2Cl2); 1H 
NMR (500 MHz, C6D6) δ 7.41 (d, J = 7.3 Hz, 2 H), 7.28-7.25 (m, 4 H), 7.20-7.05 (m, 9 
H), 5.06 (d, J = 11.2 Hz, 1 H), 5.0 (d, J = 11.2 Hz, 1 H), 4.79 (d, J = 11.2 Hz, 1 H), 4.65 
(d,  J = 11.2 Hz, 1 H), 4.41 (d, J = 11.7 Hz, 1 H), 4.32 (d, J = 12.2 Hz, 1 H), 3.83 (t, J = 
8.8 Hz, 1 H), 3.69 (dd, J = 10.7, 3.9 Hz, 1 H), 3.62 (dd, J = 10.8, 2.0 Hz, 1 H), 3.57 (t, J = 
8.8 Hz, 1 H), 3.43 (t, J = 9.3 Hz, 1 H), 3.31 (ddd, J = 9.8, 3.9, 2.0 Hz, 1 H),  3.02-2.97 (m, 
1 H), 2.72 (dd, J = 15.6, 5.9 Hz, 1 H), 2.40 (dd, J = 15.6, 11.7 Hz, 1 H), 1.45 (dq, J = 
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14.6, 7.3 Hz, 1 H), 1.27 (s, 3 H), 1.12 (dddd, J =  19.5, 12.7, 7.3 Hz, 1 H), 0.74 (t, J = 7.3 
Hz, 3 H); 13C NMR (125 MHz, C6D6) δ 207.0, 139.5, 139.3, 138.8, 128.5, 128.3, 127.9, 
127.8, 127.7, 127.5, 84.4, 83.0, 79.6, 77.8, 75.3, 75.2, 74.5, 73.6, 69.5, 42.5,  26.3, 21.0, 
6.6; IR (neat) 3032, 2923, 1721, 1454, 1363, 1101,739 cm-1; LRMS (ESI) calcd for 
























Summary of COSY spectrum for 1.217: 
Proton at 1.12 ppm (H-8) shows crosspeaks with protons at 1.45 ppm (H-8’) and 0.74 
ppm (H-9) 
Proton at 1.45 ppm (H-8’) shows crosspeaks with protons at 1.12 ppm (H-8) and 0.74 
ppm (H-9) 
Proton at 0.74 ppm (H-9) shows crosspeaks with protons at 1.12 ppm (H-8) and 1.45 ppm 
(H-8’) 
Proton at 2.40 ppm (H-6’) shows crosspeaks with protons at 2.72 ppm (H-6) and 2.99 
ppm (H-5) 
Proton at 2.72 ppm (H-6) shows crosspeaks with protons at 2.40 ppm (H-6’) and 2.99 
ppm (H-5) 
Proton at 2.99 ppm (H-5) shows crosspeaks with protons at 2.40 ppm (H-6), 2.72 ppm 
(H-6) and 3.43 ppm (C-4) 
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Proton at 3.43 ppm (H-4) shows crosspeaks with protons at 3.57 ppm (H-3) and 2.99 ppm 
(H-5) 
Proton at 3.57 ppm (H-3) shows crosspeaks with protons at 3.43 ppm (H-4) and 3.83 ppm 
(H-2) 
Proton at 3.83 ppm (H-2) shows crosspeaks with protons at 3.31 ppm (H-1) and 3.57 ppm 
(H-3) 
Summary of 1D nOe difference experiments for 1.217: 
Irradiation at 1.12 ppm (H-8) resulted in enhancement at 1.45 ppm (H-8’) and 3.43 ppm 
(H-4) 
Irradiation at 1.45 ppm (H-8’) resulted in enhancement at 1.12 ppm (H-8), 2.40 ppm (H-










vinyl-hexahydr -opyrano[3,2-b]pyran-3(2H)-one (1.219). According to the general 
procedures for the preparation of 1.212, enol ether 1.215 (28 mg, 0.058 mmol), CH2Cl2 
(1.0 mL) and a solution of dimethyl dioxirane (0.86 mL of a 0.10 M solution in acetone, 
0.086 mmol) afforded the epoxide which was taken up in THF (1.0 mL) and reacted with 
divinyl zinc (2.3 mL of a 0.25 M solution in THF, 0.58 mmol) to give 23 mg (75%) of 
1.218 as colorless oils after flash chromatography (hexanes:ethyl acetate, 5:1). 
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Divinyl zinc (0.25 M solution in THF) was prepared according to the following 
procedure: vinly magnesium bromide (5.2 mL of a 1.0 M solution in THF, 5.2 mmol) 
was added to a solution of ZnCl2 (2.6 mL of a 1.0 M solution in THF, 2.6 mmol) and 
THF (1.0 mL) at -30 oC.  The reaction was warmed up to 0 oC and stirred at 0 oC for 0.5 h. 
For characterization purposes, 1.218 was oxidized to give ketone 1.219. To a 
solution of 1.218 (23 mg, 0.043 mmol) and CH2Cl2 (3.5 mL) was added 4Å MS (20 mg), 
NMO (25 mg, 0.22 mmol) and TPAP (ca. 3.0 mg). After stirring at rt for 2 h, the reaction 
was concentrated to give 20 mg (90%) of 1.219 as a colorless oil after flash 
chromatography (hexanes:ethyl acetate, 5:1). Rf 0.68 (hexanes:ethyl acetate, 3:1); [α]D20 
= +24 (c = 0.05, CH2Cl2); 1H NMR (500 MHz, C6D6) δ 7.42-7.41 (m, 2 H), 7.26-7.25 (m, 
4 H), 7.20-7.04 (m, 9 H), 5.56 (dd, J = 17.6, 10.7 Hz, 1 H), 5.12 (d, J = 18.1 Hz, 1 H), 
5.05 (d,  J = 11.2 Hz, 1 H), 4.97 (d, J = 11.2 Hz, 1 H), 4.89 (d, J = 10.8 Hz, 1 H), 4.83 (d, 
J = 11.7 Hz, 1 H), 4.62 (d, J = 11.2 Hz, 1 H), 4.39 (d, J = 12.2 Hz, 1 H), 4.31 (d, J = 12.2 
Hz, 1 H),  3.76 (t, J = 8.8 Hz, 1 H), 3.71-3.59 (m, 4 H), 3.32 (ddd, J = 9.8, 3.9, 2.0 Hz, 1 
H),  3.03 (ddd, J = 11.7, 9.8, 5.9 Hz, 1 H), 2.76 (dd, J = 15.6, 5.4 Hz, 1 H), 2.40 (dd, J = 
16.1, 11.7 Hz, 1 H), 1.42 (s, 3 H); 13C NMR (125 MHz, C6D6) δ 204.7, 139.5, 139.2, 
138.8, 138.7, 128.5, 128.3, 128.2, 127.9, 127.8, 127.7, 127.6, 127.4, 116.8, 84.4, 79.6, 
78.0, 76.7,  75.3, 74.5,  73.6, 69.5, 43.7, 25.1; IR (neat) 2918, 2850, 1722, 1453, 1363, 






















Summary of COSY spectrum for 1.219: 
Proton at 2.40 ppm (H-6’) shows crosspeaks with protons at 2.76 ppm (H-6) and 3.03 
ppm (H-5) 
Proton at 2.76 ppm (H-6) shows crosspeaks with protons at 2.40 ppm (H-6’) and 3.03 
ppm (H-5) 
Proton at 3.03 ppm (H-5) shows crosspeaks with protons at 2.76 ppm (H-6), 2.40 ppm 
(H-6’) and 3.76 ppm (H-4) 
Proton at 5.56 ppm (H-8) shows crosspeaks with protons at 5.12 ppm (H-9) and 4.89 ppm 
(H-9’) 
Summary of 1D nOe difference experiments for 1.219: 
Irradiation at 5.56 ppm (H-8) resulted in enhancement at 3.76 ppm (H-4), 5.12 ppm (H-9) 










-hexahydropyrano[3,2-b]pyran-3(2H)-one (1.222). According to the general procedure 
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for the preparation of 1.212, enol ether 1.215 (34 mg, 0.070 mmol), CH2Cl2 (1.4 mL) and 
a solution of dimethyl dioxirane (1.0 mL of a 0.10 M solution in acetone, 0.10 mmol) 
generated the epoxide which reacted with diphenyl zinc (2.8 mL of a 0.25 M solution in 
THF, 0.70 mmol) to give 27 mg (68%) of 1.220 as colorless oils after flash 
chromatography (hexanes:ethyl acetate, 5:1). 
Diphenyl zinc (0.25 M solution in THF) was prepared according to the following 
procedures: PhMgBr (2.0 mL of a 1.0 M solution in THF, 2.0 mmol) was added to a 
solution of ZnCl2 (1.0 mL of a 1.0 M solution in THF, 1.0 mmol) and THF (1.0 mL) at 0 
oC.  The reaction was stirred at 0 oC for 0.5 h and then warmed up to rt over 1 h. 
For characterization purposes, 1.220 was converted to ketone 1.222 in three steps. 
To a solution of 1.220 (19 mg, 0.033 mmol) and CH2Cl2 (2.7 mL) was added 4Å MS (15 
mg), NMO (19 mg, 0.17 mmol) and TPAP (ca. 2.0 mg). After stirring at rt for 2 h, the 
reaction was concentrated to give 16 mg (86%) of 1.221  as a colorless oil after flash 
chromatography (hexanes:ethyl acetate, 5:1).  
To a solution of 1.221 (10 mg, 0.017 mmol) in dry ethanol (0.2 mL) was added 
Pd/C (5 wt%, 2 mg). The reaction mixture was stirred at rt under hydrogen atmosphere 
for 3 h. The reaction mixture was diluted with ethanol, passed through a bed of Celite and 
concentrated. The crude triol was used directly without further purification. 
To a solution of the triol from above and CH2Cl2 (1.0 mL) at rt was added acetic 
anhydride (0.016 mL, 0.17 mmol), (i-Pr)2NEt (0.030 mL, 0.17 mmol), and DMAP (ca. 
1.0 mg). After stirring 5 h, the reaction was quenched with aq. NH4Cl (sat., 1.0 mL). The 
phases were separated, and the aqueous phase was extracted with CH2Cl2 (3 x 10 mL). 
The extracts were combined, dried with Na2SO4, and concentrated. Flash 
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chromatography (hexanes:ethyl acetate, 3:1) gave 5.0 mg (67% for two steps) of acetate 
1.222 as a colorless  oil. Rf  0.23 (hexanes:ethyl acetate, 3:1); [α]D20 = +22.0 (c = 0.20, 
CH2Cl2); 1H NMR (500 MHz, C6D6) δ 7.29 (d, J = 7.8 Hz, 2 H), 7.10 (d, J = 7.3 Hz, 1 H), 
7.05-7.0 (m, 2 H), 5.43 (t, J = 9.5 Hz, 1 H), 5.06 (t, J = 9.8 Hz, 1 H), 4.20 (dd, J = 4.9, 
12.7 Hz, 1 H), 3.95 (d, J = 12.2 Hz, 1 H), 3.56 (t, J = 9.8 Hz, 1 H), 3.25 (dd, J = 9.3, 3.9 
Hz, 1 H), 2.92 (ddd, J = 16.6, 11.2, 5.4 Hz, 1 H), 2.70 (dd, J = 15.1, 5.4 Hz, 1 H), 2.20 
(dd, J = 14.7, 12.7 Hz,  1 H), 1.85 (s, 3 H), 1.72 (3 H), 1.61 (3 H),  1.58 (s, 3 H); 13C 
NMR (125 MHz, C6D6) δ 203.5, 169.9, 169.9, 169.7, 139.9, 129.4, 125.1, 85.7, 76.2, 
74.8, 74.3, 73.1, 69.3, 62.2, 43.9, 32.3, 29.8, 28.1, 20.4; IR (neat) 2921, 2851, 1746, 1715, 
















Summary of COSY spectrum for 1.222: 
Proton at 2.20 ppm (H-6’) shows crosspeaks with protons at 2.70 ppm (H-6) and 2.92 
ppm (H-5) 
Proton at 2.70 ppm (H-6) shows crosspeaks with protons at 2.20 ppm (H-6’) and 2.92 
ppm (H-5) 
Proton at 2.92 ppm (H-5) shows crosspeaks with protons at 2.70 ppm (H-6’), 2.20 ppm 
(H-6) and 3.56 ppm (H-4) 
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Proton at 3.56 ppm (H-4) shows crosspeaks with protons at 5.43 ppm (H-3) and 2.92 ppm 
(H-5) 
Proton at 5.43 ppm (H-3) shows crosspeaks with protons at 3.56 ppm (H-4) and 5.06 ppm 
(H-2) 
Proton at 5.06 ppm (H-2) shows crosspeaks with protons at 5.43 ppm (H-3) and 3.25 ppm 
(H-1) 
Proton at 4.20 ppm (H-7) shows crosspeaks with protons at 3.95 ppm (H-7’) and 3.25 
ppm (H-1) 
Summary of 1D nOe difference experiments for 1.222: 













methyl-3-oxo-octahydropyrano[3,2-b]pyran-2-yl)acetate (1.224). According to the 
general procedures for the preparation of 1.212, enol ether 1.215 (41 mg, 0.084 mmol), 
CH2Cl2 (1.7 mL) and a solution of dimethyl dioxirane (1.3 mL of a 0.10 M solution in 
acetone, 0.13 mmol) afforded the epoxide which reacted with tert-butyl(1-
methoxyvinyloxy)dimethylsilane (0.33 g, 1.8 mmol), THF (1.7 mL) and  a solution of 
TBSOTf (0.046 mL, 0.19 mmol) in THF (0.9 mL) to give 45 mg (77%) of 1.223 as 
colorless oils after flash chromatography (hexanes:ethyl acetate, 10:1). 
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     For characterization purposes, 1.223 was converted to ketone 1.224 in two steps. To a 
solution of 1.223 (45 mg, 0.059 mmol) and MeOH (1.2 mL) at rt was added p-
toluenesulfonic acid monohydrate (0.056 g, 0.30 mmol). After stirring at rt for 24 h, the 
reaction mixture was cooled to 0 °C and the reaction was quenched by the slow addition 
of sat. NaHCO3 (aq., 2.0 mL). The resulting mixture was extracted with CH2Cl2 (3 x 10 
mL), dried (Na2SO4), and concentrated. The crude product was used directly without 
further purification. 
     The crude alcohol was taken up in CH2Cl2 (3.0 mL) and reacted with 4Å MS (20 mg), 
NMO (29 mg, 0.25 mmol) and TPAP (ca. 3.0 mg). After stirring at rt for 2 h, the reaction 
was concentrated to give 22 mg (65% for two steps) of 1.224 as a colorless oil. Rf 0.60 
(hexanes:ethyl acetate, 3:1); [α]D20 = +6.0 (c = 0.10, CH2Cl2); 1H NMR (500 MHz, C6D6) 
δ 7.43 (d, J = 7.3 Hz, 2 H), 7.28-7.24 (m, 4 H), 7.20-7.05 (m, 9 H), 5.02 (d,  J = 11.7,  Hz, 
1 H), 4.98 (d, J = 11.2 Hz, 1 H), 4.75 (d, J = 11.7 Hz, 1 H), 4.59 (d, J = 11.2 Hz, 1 H), 
4.41 (d, J = 12.2 Hz, 1 H), 4.34 (d, J = 12.2 Hz, 1 H), 3.80-3.72 (m, 2 H), 3.65-3.64 (m, 2 
H), 3.54 (t, J = 9.3 Hz, 1 H), 3.34 (ddd, J = 5.9, 3.4 Hz, 1 H),  3.22 (s, 3 H), 3.02 (ddd, J 
= 11.2, 9.8, 5.9 Hz, 1 H), 2.76 (dd, J = 16.6, 5.9 Hz, 1 H), 2.64 (d, J = 14.7 Hz, 1 H), 2.57 
(dd, J = 17.1, 11.7 Hz, 1 H), 2.29 (d, J = 14.6 Hz, 1 H), 1.39 (s, 3 H); 13C NMR (125 
MHz, C6D6) δ 205.7, 169.6, 139.7, 139.3, 138.8,  128.6, 128.5, 128.4, 128.3,  127.9, 
127.8, 127.7, 127.6, 84.7, 81.1, 79.6, 77.8, 77.0,  75.0, 73.6, 73.4, 69.5, 51.4, 42.5, 41.3, 
24.6; IR (neat) 3030, 2917,2869, 1738, 1497, 1356, 1212, 1103, 1065, 752 cm-1; LRMS 



















Summary of COSY spectrum for 1.224: 
Proton at 2.29 ppm (H-8) shows crosspeak with proton at 2.64 ppm (H-8’)  
Proton at 2.57 ppm (H-6’) shows crosspeaks with protons at 2.76 ppm (H-6) and 3.02 
ppm (H-5) 
Proton at 2.76 ppm (H-6) shows crosspeaks with protons at 2.57 ppm (H-6’) and 3.02 
ppm (H-5) 
Proton at 3.02 ppm (H-5) shows crosspeaks with protons at 2.76 ppm (H-6),2.57 ppm (H-
6’) and 3.78 (H-4) 
Proton at 3.78 ppm (H-4) shows crosspeaks with protons at 3.02 ppm (H-5) and 3.54 ppm 
(H-3) 
Proton at 3.54 ppm (H-3) shows crosspeaks with protons at 3.78 ppm (H-4) and 3.74 ppm 
(H-2) 
Proton at 3.34 ppm (H-1) shows crosspeaks with protons at 3.65 ppm (H-7) and 3.72 ppm 
(H-2) 
Summary of 1D nOe difference experiments for 1.224: 
Irradiation at 2.29 ppm (H-8) resulted in enhancement at 3.78 ppm (H-4), 2.64 ppm (H-8’) 
and 3.22 ppm (OMe) 
Irradiation at 2.64 ppm (H-8’) resulted in enhancement at 3.78 ppm (H-4), 2.29 ppm (H-8) 
and 3.22 ppm (OMe) 
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Irradiation at 3.54 ppm (H-1) resulted in enhancement at 3.54 ppm (H-3), 3.02 ppm (H-5) 







1. 237  
 
(4R,5S)-4-(but-3-enyl)-2-phenyl-1,3-dioxan-5-yl-4-(benzyloxy)butanoat (1.237) 
To a solution of 1.132 (1.01 g, 4.27 mmol) in CH2Cl2 (20.0 mL) at rt was added acid 
1.236 (1.24 g, 6.39 mmol) followed by 1,3-dicyclohexylcarbodiimide (1.58 g, 7.67 mmol) 
and DMAP (0.78 g, 6.4 mmol). After stirring at rt for 12 h, the reaction mixture was 
filtered. The filtrate was washed with sat. NaHCO3 (aq., 10 mL). The phases were 
separated. The aqueous phase was extracted with CH2Cl2 (5 x 50 mL) and dried with 
Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 10:1 to 5:1) provided 
1.237 (1.51 g, 86%) as a colorless oil. Rf  0.55 (hexanes:ethyl acetate, 3:1); [α]D20 = 
+16.3 (c = 0.258, THF); 1H NMR (500 MHz, C6D6) δ 7.60 (d, J = 7.3 Hz, 2 H), 7.24 (d, J 
= 7.3 Hz, 2 H), 7.20-7.07 (m, 6 H), 5.73 (dddd, J = 17.1, 10.3, 6.8, 6.8 Hz, 1 H), 5.29 (s, 
1 H), 5.04-4.94  (m, 3 H), 4.36 (dd, J = 10.3, 4.89 Hz, 1 H), 4.24 (s, 2 H), 3.58 (dt, J = 
9.3, 2.4 Hz, 1 H), 3.33 (t, J = 10.3 Hz,1 H), 3.19 (t, J = 5.9 Hz, 2 H), 2.34-2.26 (m, 1 H), 
2.11 (t, J = 6.83 Hz,2 H), 2.18-2.10 (m, 1 H), 1.79-1.72 (m, 3 H), 1.66-1.59 (m, 1 H); 13C 
NMR (125 MHz, C6D6) δ 171.7, 138.7, 138.3, 138.0, 128.7, 128.3, 127.7, 127.5, 127.4, 
126.4, 114.8, 101.1, 78.3, 72.7, 68.7, 68.0, 66.8, 31.1, 30.8, 28.9, 25.1; IR (neat) 2929, 
2857, 1741, 1453, 1365, 1166, 1093, 1027 cm-1; LRMS (ESI) calcd for C25H30O5Na 










1. 238  
(4aS,9aR,Z)-6-(3-(benzyloxy)propyl)-2-phenyl-4a,8,9,9a-tetrahydro-4H-[1,3]- 
dioxino[5,4-b]oxepine (1.238). To a solution of TiCl4 (8.0 mL, 73 mmol) in CH2Cl2 (650 
mL) at 0 oC was added THF (38.3 mL, 436 mmol) dropwise. The solution was stirred at 0 
oC for 0.2 h and then TMEDA (65.5 mL, 436 mmol) was added dropwise to the light-
yellow solution. The ice bath was removed and after 45 min Zn dust (10.7 g, 164 mmol) 
was added followed by PbCl2 (2.4 g, 8.6 mmol). Over 20 min, the color of the reaction 
slurry turned from green to blue to blue-green at which time a solution of 1.237 (1.40 g, 
3.41 mmol), CH3CHBr2 (6.60 ml, 96.0 mmol), and CH2Cl2 (50 mL) was added via a 
cannula. The resulting mixture was stirred rapidly and heated at reflux for 3 h. Then the 
reaction mixture was cooled to 0 oC and stirred with sat. K2CO3 (aq., 20 mL) for 1 h. The 
mixture was filtered and the residue was washed with 1:1 hexanes:ethyl acetate (3 x 100 
mL).  The filtrate was combined and concentrated. Flash chromatography (hexanes:ethyl 
acetate, 10:1 w/ 1% Et3N) provided cyclic enol ether 1.238 (856 mg, 66%) as a colorless 
oil. Rf 0.63 (hexanes:ethyl acetate, 3:1); [α]D20 = -9.5 (c = 0.42, THF); 1H NMR (500 
MHz, C6D6) δ 7.59 (d, J = 7.8 Hz, 2 H), 7.22 (d, J = 7.8 Hz, 2 H), 7.15-7.02 (m, 6 H), 
5.29 (s, 1 H), 4.65 (dd, J = 8.3, 4.2 Hz, 1 H), 4.25 (s, 2 H), 4.20 (dd, J = 10.8, 5.1 Hz, 1 
H), 3.5 (t, J = 10.6 Hz, 1 H), 3.46-3.32 (m, 2 H), 3.22 (t, J = 6.2 Hz, 2 H), 2.10-1.97 (m, 
2 H), 1.92-1.84 (m, 2 H), 1.77-1.58 (m, 3 H), 1.49-1.38 (m, 1 H); 13C NMR (125 MHz, 
C6D6) δ 159.3, 139.4, 138.8, 128.9, 128.5, 127.6, 126.8, 108.1, 101.1, 82.9, 75.4, 73.0, 
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69.6, 69.3, 32.7, 32.6, 27.5, 21.2; IR (neat) 2933, 2854, 1453, 1094 cm-1; LRMS (ESI) 












[5,4-b]oxepin-7(8H)-one (1.239). To 1.238(100 mg, 0.263 mmol) in CH2Cl2 (20 mL) at 
–78oC was added dimethyl dioxirane (2.0 mL of a 0.2 M solution in CH2Cl2, 0.4 mmol) 
dropwise. The reaction was warmed to 0 oC and concentrated. The colorless oil was taken 
up in CH2Cl2 (20 mL), cooled to -78 oC and iBu2AlH (0.53 mL of a 1.0 M solution in 
CH2Cl2, 0.53 mmol) was added at once. After stirring at -78 oC for 10 min, the reaction 
mixture was warmed up to 0 oC over 1 h. The reaction was quenched with sat. NH4Cl (aq., 
5 mL). The phases were separated. The aqueous phase was extracted with CH2Cl2 (5 x 
100 mL) and dried with Na2SO4. Concentration and chromatography (hexanes:ethyl 
acetate, 5:1 to 3:1) provided the secondary alcohol (79 mg, 75%) as a colorless oil.  
To the secondary alcohol from above (105 mg, 0.263 mmol) in CH2Cl2 (10.0 mL) 
at rt was added 4Å MS (100 mg), NMO (53 mg, 0.52 mmol), then TPAP (ca. 2.0 mg). 
After stirring at rt for 2 h, the reaction mixture was filtered through neutralized silica. 
Concentration and chromatography (hexanes:ethyl acetate, 10:1 to 4:1) provided ketone 
1.239 (87.0 mg, 83%) as a colorless oil. Rf  0.40 (hexane:ethyl acetate, 3:1); [α]D20 = 
+32.7 (c = 0.15, THF); 1H NMR (500 MHz, C6D6) δ 7.61 (d, J = 7.8 Hz, 2 H), 7.28 (d, J 
= 7.8 Hz, 2 H), 7.22-7.09 (m, 6 H), 5.27 (s, 1 H), 4.28 (s, 2 H), 4.02 (dd, J = 10.8, 5.5, 1 
H), 3.54 (dd, J = 7.7, 4.9 Hz, 1 H), 3.39 (t, J = 10.0 Hz, 1 H), 3.29-3.20 (m, 3 H), 2.85 
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(ddd, J = 9.5, 5.3 Hz, 1 H), 2.42 (ddd, J = 14.1, 12.2,2.6 Hz, 1 H), 2.10 (dddd, J = 6.8, 
1.8 Hz, 1 H), 1.85-1.78 (m, 1 H), 1.73-1.57 (m, 4 H), 1.54-1.44 (m, 1 H); 13C NMR (125 
MHz, C6D6) δ 213.3, 139.2, 138.6 129.0, 128.6, 128.3, 127.7,127.7, 126.7, 101.2, 87.1, 
81.0, 76.0, 73.0, 69.8, 69.2, 36.2, 30.0, 29.5, 26.0; IR (neat) 2925, 2856, 1713, 1453, 


















Summary of COSY spectrum for 1.239: 
 
Proton at 4.02 ppm (H-2) shows crosspeaks with protons at 3.39 ppm (H-2) and 2.85 ppm 
(H-3) 
Proton at 3.54 ppm (H-8) shows crosspeak with proton at 1.68 ppm (H-9) 
 
Proton at 3.39 ppm (H-2) shows crosspeak with proton at 4.02 ppm (H-2)  
 
Proton at 3.26 ppm (H-10) shows crosspeak with proton at 1.68 ppm (H-9) 
 
Proton at 2.85 ppm (H-3) shows crosspeaks with protons at 4.02 ppm (H-2), 3.39 ppm 
(H-2) and 3.26 ppm (C-4)  
Summary of 1D NOE difference experiments for 1.239: 
 
Irradiation at 2.85 ppm (H-3) resulted in enhancement at 3.54 ppm (H-8) 
 















1. 240  
 
(4aS,6R,7S,9aR)-6-(3-(benzyloxy)propyl)-7-methyl-2-phenyl-hexahydro-4H-
[1,3] dioxino[5,4-b]oxepin-7-ol (1.240). To a solution of 1.239 (40.0 mg, 0.101 mmol) in 
toluene (4.0 mL) at -78 oC was added MeMgBr (0.13 mL of a 3.0 M solution in ether, 
0.39 mmol). After stirring at -78 oC for 10 min, the reaction mixture was warmed up to 0 
oC and kept at this temperature for 0.5 h. The reaction was quenched with sat. NH4Cl (aq., 
5 mL). The aqueous phase was extracted with CH2Cl2 (5 x 20 mL) and dried with 
Na2SO4. Concentration and chromatography (hexanes:ethyl acetate, 5:1 to 3:1) provided 
1.240 (35 mg, 84%) and epi-1.240 (5.0 mg, 12%) as colorless oils.  
Data for 1.240: Rf 0.18 (hexanes:ethyl acetate, 3:1); [α]D20 = +13.0 (c = 0.115, 
THF); 1H NMR (500 MHz, C6D6) δ 7.67 (dd, J = 8.3, 1.5 Hz, 2 H), 7.32 (d, J = 6.8 Hz, 2 
H), 7.26-7.09 (m, 6 H), 5.31 (s, 1 H), 4.34 (s, 2 H), 4.23 (dd, J = 10.3, 4.4 Hz, 1 H), 3.41 
(t, J = 9.9 Hz, 1 H), 3.37-3.19 (m, 3 H), 3.13 (dd, J = 10.3, 1.5 Hz, 1 H), 1.88-1.74 (m, 3 
H), 1.69-1.62 (m, 1 H), 1.59-1.51 (m, 2 H), 1.48-1.29 (m, 2 H), 0.93 (s, 3 H); 13C NMR 
(125 MHz, C6D6) δ139.4, 138.9, 128.8, 128.5, 127.6, 126.8, 101.5, 88.8, 83.2, 77.2, 74.3, 
73.0, 70.5, 70.0, 39.4, 27.9, 27.7, 27.5, 23.9; IR (neat)  3454, 2932, 2858, 1453, 1366, 


















1. 240  
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Summary of COSY spectrum for 1.240: 
Proton at 4.23 ppm (H-2) shows crosspeak with proton at 3.41 ppm (H-2)  
Proton at 3.41 ppm (H-2) shows crosspeaks with protons at 3.30 ppm (H-3) and 4.23 ppm 
(H-2) 
Proton at 3.13 ppm (H-8) shows crosspeak with proton at 1.40 ppm (H-9) 
Summary of 1D NOE difference experiments for 1.240: 












1. 241  
 
((4aS,6R,7S,9aR)-6-(3-(benzyloxy)propyl)-7-methyl-2-phenyl-hexahydro-4H-
[1,3] dioxino[5,4-b]oxepin-7-yloxy)(tert-butyl)dimethylsilane (1.241). To the solution 
of 1.240 (100 mg, 0.242mmol) in CH2Cl2 (10.0 mL) at 0 oC was added NEt3 (0.610 mL, 
4.36 mmol) followed by TBSOTf (0.560 mL, 2.44 mmol) and DMAP (6.0 mg, 0.050 
mmol). The reaction mixture was warmed to rt over 1 h at kept at this temperature for 1 h. 
The reaction was quenched with sat. NaHCO3 (aq., 5 mL). The aqueous phase was 
extracted with CH2Cl2 (5 x 50 mL) and dried with Na2SO4. Concentration and 
chromatography (hexane/EtOAc, 50:1 to 10:1) provided the protected alcohol 1.241 (117 
mg, 92%) as a colorless oil. Rf 0.83 (hexanes:ethyl acetate, 3:1); [α]D20 = +8.0 (c = 0.2, 
THF ); 1H NMR (500 MHz, C6D6) δ 7.68 (dd, J = 7.3, 1.5 Hz, 2 H), 7.32 (d, J = 7.3 Hz, 
2 H), 7.23-7.09 (m, 6 H), 5.33 (s, 1 H), 4.34 (d, J = 3.42 Hz, 2 H), 4.26 (dd, J = 10.3, 4.4 
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Hz, 1 H), 3.49 (t, J = 9.8 Hz, 1 H), 3.43-3.33 (m, 3 H), 3.31-3.25 (m, 2 H), 2.03-1.96 (m, 
1 H),  1.92-1.79 (m, 4 H), 1.68-1.55 (m, 2 H), 1.46-1.40 (m, 1 H), 1.06 (s, 3 H), 0.94 (s, 9 
H), 0.051 (d, J =1.5 Hz, 6 H); 13C NMR (125 MHz, C6D6) δ 139.4, 139.0, 128.8, 
128.5,128.3, 127.7, 127.7, 127.5, 126.8, 101.5, 89.7, 83.4, 77.9, 77.8, 72.9, 70.5, 70.0, 
39.4, 27.9, 27.7, 27.6,26.0, 25.9, 24.0, 18.3,  -2.0, -2.1; IR (neat) 2953, 2856, 1462, 1361, 









1. 243  
(2R,3S,6R,7S)-2-(3-(benzylox)propyl)-7-(but-3-enyl)-3-(tert-butyldimethylsil- 
yloxy)-3-methyl-6-(triethylsilyloxy)oxepane (1.243). To a solution of 1.241 (65 mg, 
0.12 mmol) in MeOH (10.0 mL) at rt was added PPTS (34 mg, 0.14mmol). After heating 
to reflux for 3 h, the reaction mixture was cooled to rt and the reaction was quenched 
with sat. NaHCO3 (aq., 5 mL). The aqueous phase was extracted with CH2Cl2 (5 x 50 mL) 
and dried with Na2SO4. Concentration and chromatography (MeOH:CH2Cl2, 1:6) 
provided diol 1.242 (50.0 mg, 93 %) as a colorless oil. 
 To a solution of the diol 1.242 (50.0 mg, 0.114 mmol) from above in CH2Cl2 (5.0 
mL) at -78 oC was added 2,6-lutidine (27 μL, 0.23 mmol) followed by Tf2O (20 μL, 0.12 
mmol). After 15 min, TESOTf (0.270 mL, 2.32 mmol) and 2,6-lutidine (0.260 mL, 1.15 
mmol) was added and the reaction mixture was warmed to rt. After 0.5 h, the reaction 
mixture was cooled to -78 oC and the reaction was quenched with sat. NaHCO3 (aq., 6.0 
mL). The aqueous phase was extracted with CH2Cl2 (5 x 50 mL), dried with Na2SO4 and 
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concentrated. The yellow oil was passed through a short plug of silica (hexanes:ethyl 
acetate, 5:1) and immediately taken on to the next step. 
To a solution of the triflate from above in THF (5.0 mL) at -40 oC was added via 
cannula to a solution of allyl cuprate [Prepared from allyl magnesium chloride (1.3 mL of 
a 2.0 M solution in THF, 2.6 mmol) and CuI (280 mg, 1.47 mmol) at -78 oC. The reaction 
mixture was slowly warmed to 0 oC and stirred for 1 h]. The reaction mixture was stirred 
at -40 oC for 2 h, warmed to rt and quenched with sat. NH4Cl (aq., 10 mL). The aqueous 
phase was extracted with CH2Cl2 (5 x 50 mL) and dried with Na2SO4. Concentration and 
chromatography (hexanes:ethyl acetate, 5:1 to 3:1) provided protected alcohol 1.243 
(49.0 mg, 74% for two steps) as a colorless oil. Rf 0.90 (hexanes:ethyl acetate, 5:1); 1H 
NMR (500 MHz, C6D6) δ 7.34-7.31 (m, 2 H), 7.22-7.07(m, 3 H), 5.90 (dddd, J = 16.9, 
10.2, 6.5 Hz, 1 H), 5.14 ( dd, J = 17.2, 1.7 Hz, 1 H), 5.01 (dd, J = 10.4, 1.5 Hz,1 H),  
4.34 (s, 2 H), 3.52-3.39  (m, 5 H), 2.55-2.43 (m, 1 H), 2.35-2.16 (m, 1 H), 2.07-1.50 (m, 
10 H), 1.20 (s, 3 H), 1.02-0.97 (s, 18 H), 0.58 (q, J = 7.82 Hz, 6 H), 0.18 (d, J = 2.34 Hz, 
6 H); 13C NMR (125 MHz, C6D6) δ 139.1, 128.4, 128.3, 127.7, 127.6, 127.5, 127.4, 114.7, 
87.3, 86.9, 77.7, 77.2, 72.8, 70.7, 37.5, 34.8, 30.7, 29.7, 28.0, 27.7, 26.1, 23.5, 18.3, 7.2, 
5.5, -1.9, -2.0; IR (neat) 2954, 2933, 1461, 1254, 1100 cm-1; LRMS (ESI) calcd for 









1. 244  
((2R,3S,6R,7S)-6-(4-methoxybenzyloxy)-2-(3-(benzyloxy)propyl)-7-(but-3-en-
yl)-3-methyloxepan-3-yloxy)(tert-butyl)dimethylsilane (1.244). To a solution of 1.243 
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(20. mg, 0.035 mmol) in MeOH (4.0 mL) at 0 oC was added 10-camphorsulfonic acid 
(8.0 mg, 0.035 mmol).The reaction mixture was warmed to rt over 1 h. The reaction was 
quenched with sat. NaHCO3 (aq., 2.5 mL). The aqueous phase was extracted with CH2Cl2 
(5 x 50 mL) and dried with Na2SO4. Concentration and chromatography (hexanes:ethyl 
acetate, 10:1 to 3:1) provided the free alcohol (16 mg, 100%) as a colorless oil.  
To the free alcohol (10. mg, 0.022 mmol) from above in THF (4.0 mL) was added 
KH (5.0 mg of a 30 wt% solution in mineral oil, 0.038 mmol ) at 0 oC. The reaction 
mixture was warmed up to rt and stirred at rt for 1 h. The reaction mixture was cooled to 
0 oC and PMBBr (4.0 µL, 0.031 mmol) was added. The reaction mixture was warmed up 
to rt and stirred at rt for 5 h. The reaction was quenched with sat. NH4Cl (aq., 1.0 mL). 
The aqueous phase was extracted with CH2Cl2 (5 x 50 mL) and dried with Na2SO4. 
Concentration and chromatography (hexanes:ethyl acetate, 10:1) provided protected 
alcohol 1.244 (11 mg, 87%) as a colorless oil. Rf  0.80 (hexanes:ethyl acetate, 3:1);  
[α]D20 =  +8.0 (c = 0.014, THF); 1H NMR (500 MHz, C6D6) δ 7.33-7.31 (m, 2 H), 7.23-
7.09 (m, 5 H), 6.81 (d, J = 8.8 Hz, 2 H), 5.85 (dddd, J = 16.7, 10.1, 6.4 Hz, 1 H), 5.09 
( dd, J = 17.2, 2.0 Hz, 1 H), 5.0-4.98 (m, 1 H),  4.40 (d, J = 11.4 Hz, 1 H), 4.34 (s, 2 H), 
4.17 (d,  J = 11.4 Hz, 1 H),  3.58-3.54  (m, 1 H), 3.49-3.39 (m, 3 H), 3.29 (s, 3 H), 3.22-
3.18 (m, 1 H),  2.44-2.37 (m, 1 H), 2.26-2.14 (m, 1 H), 2.07-1.93 (m, 3 H), 1.89-1.57 (m, 
7 H), 1.22 (s, 3 H), 0.97 (s, 9 H), 0.13 (d, J = 1.8 Hz, 6 H); 13C NMR (125 MHz, C6D6) δ 
158.5, 139.0, 134.0, 130.2, 130.1, 129.7, 129.4, 128.4, 128.3, 127.6, 127.4, 114.7, 114.1, 
114.0, 87.3, 85.1, 83.2, 77.6, 72.8, 71.6, 70.7, 54.7, 37.6, 37.5, 35.0, 30.7, 30.2, 27.9, 27.6, 
26.1, 24.4, 23.0, 18.3, -1.8, -1.9; IR (neat) 2928, 1612, 1512, 1247 cm-1; LRMS (ESI) 
















tyldimethylsilyloxy)-6-methyloxepan-2-yl)propanoic acid (1.245). To a solution of 
1.244 (10. mg, 0.017 mmol), THF: tBuOH: H2O (5:5:1, 1 mL), N-methylmorpholine N-
oxide (2.1 mg, 0.021 mmol) was added OsO4 (10.3 µL of a 0.16 M solution in H2O, 
0.0016 mmol) at rt. The reaction mixture was stirred at rt for 16 h. Sodium bisulfite (0.2 g) 
was added to the reaction mixture.  After stirring at rt for 2 h, the reaction was diluted 
with H2O and the aqueous phase was extracted with CH2Cl2 (5 x 20 mL). The organic 
extracts were dried with Na2SO4  and concentrated. The resulting oil was passed through 
a plug of silica gel and used in the next step without further purification.  
To a solution of the diol from above in benzene (2.0 mL) was added Pb(OAc)4 
(9.4 mg, 0.021 mmol) at rt. After 1 h at rt, the reaction mixture was passed through a plug 
of silica gel, concentrated and used in the next step. 
To a solution of the aldehyde from above in tBuOH (0.5 mL) at rt was added 2-
methyl-2-butene (0.30 mL, 2.8 mmol). A solution of NaClO2 (9.0 mg, 0.10 mmol) with 
NaH2PO4 (16 mg, 0.13 mmol) in H2O (0.5 mL) was added dropwise. After stirring 
rapidly at rt for 3 h, the reaction was quenched with sat. NH4Cl (aq., 1.0 mL). The 
aqueous phase was extracted with CH2Cl2 (5 x 50 mL) and dried with Na2SO4. 
Concentration and chromatography (hexanes:ethyl actate, 10:1 to 2:1) provided acid 
1.245 (5.6 mg, 54% for three steps) as a colorless oil. Rf  0.15 (hexanes:ethyl actate, 1:1);  
[α]D20 = -0.13 ( c = 0.12, benzene); 1H NMR (500 MHz, C6D6) δ 7.34 (d, J = 7.5 Hz, 2 
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H), 7.24-7.08 (m, 5 H), 6.82 (d, J = 8.5 Hz, 2 H), 4.37-4.32 (m, 3 H), 4.14 (d, J = 11.2 
Hz, 1 H), 3.451-3.47 (m, 1 H), 3.43-3.36 (m, 3 H), 3.31 (s, 3 H), 3.12-3.08 (m, 1 H),  
2.53-2.47 (m, 1 H), 2.39-2.33 (m, 1 H), 2.0-1.90 (m, 4 H), 1.81-1.74 (m, 2 H), 1.68-1.59 
(m, 2 H), 1.55-1.46 (m, 2 H), 1.18 (s, 3 H), 0.97 (s, 9 H), 0.11 (s, 6 H); 13C NMR (125 
MHz, C6D6) δ 179.1, 159.7, 139.5, 131.0, 129.5, 128.5, 128.3,127.7, 127.4, 114.1, 87.1, 
84.5, 82.7, 77.5, 72.8, 70.6, 54.7, 37.4, 30.4, 30.2, 27.8, 27.5, 26.1, 24.3, 23.0, 18.3, -1.8, 
-1.9; IR (neat) 3500, 2854, 1709, 1513, 1250, 1105 cm-1; LRMS (ESI) calcd for 






















hylsilyloxy)oxepan-2-yl)propanoate (1.246). To a solution of 1.245 (9.0 mg, 0.015 
mmol) in THF (1.0 mL) was added NEt3 (16. µL, 0.12 mmol), and 2,4,6-trichlorobenzoyl 
chloride (14 µL, 0.090 mmol). After stirring at 40 oC for 2 h, the mixture was 
concentrated under reduce pressure. A solution of 1.171 (8.6 mg, 0.014 mmol), DMAP 
(20. mg, 0.18 mmol) and toluene (1.0 mL) was added at room temperature. A white solid 
precipitated out of solution immediately. The reaction mixture was stirred at 40 oC 
overnight. The reaction was quenched with sat. NaHCO3 (aq., 3 mL). The aqueous phase 
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was extracted with CH2Cl2 (5 x 10 mL). The organic extracts were dried with Na2SO4. 
Concentration and chromatography (hexanes:ethyl actate 20:1 to 10:1) provided ester 
1.246 (12.6 mg, 77%) as a colorless oil. Rf  0.78 (hexanes:ethyl actate, 3:1); [α]D20 = -
16.5 (c = 0. 2, CH2Cl2); 1H NMR (500 MHz, C6D6) δ 7.79 (d, J = 3.4 Hz, 4 H), 7.36-7.06 
(m, 18 H), 6.85 (d, J = 8.3 Hz, 2 H), 5.98-5.90 (m, 1 H),  5.64 (s, 1 H), 5.09-5.01 (m, 2 
H), 4.50 (d, J = 12.2 Hz, 1 H) 4.41-4.37 (m, 3 H), 4.20 (d, J = 11.2 Hz, 1 H),  3.84-3.69  
(m, 5 H), 3.52-3.43 (m, 6 H), 3.31 (s, 3 H), 3.16 (br, 1 H),  2.68-2.59 (m, 2 H), 2.52-2.45 
(m, 1 H), 2.35 (t, J = 6.3 Hz,  2 H), 2.09-1.89 (m, 6 H), 1.81-1.77 (m, 2 H), 1.68-1.59 (m, 
4 H), 1.56-1.51 (m, 6 H), 1.37-1.31 (m, 3 H),1.18 (s, 12 H), 1.15 (s, 3 H), 0.97 (s, 9 H), 
0.11 (s, 6 H); 13C NMR (125 MHz, C6D6) δ172.6, 159.7, 139.7, 138.9, 136.0, 134.4, 
131.1, 129.9, 129.6, 129.5,  128.6, 128.4, 128.3,128.2, 127.7, 127.6, 127.4, 117.7, 114.1 ,  
87.1, 84.6, 84.4, 82.8, 81.3, 77.5, 77.4, 74.2, 74.1, 73.9, 72.8, 70.8, 70.7, 70.6, 64.3, 54.8, 
43.1, 39.6, 37.5, 34.5, 33.0, 31.4, 30.8, 29.8, 29.4, 27.9, 27.6, 27.2, 26.1, 24.4, 23.0, 19.5, 
18.4, 16.4, 12.6, -1.79, -1.84; IR (neat) 2951, 2857, 1737, 1612, 1455, 1249, 1107 cm-1; 




















Enol ether ring 1.247. A flame-dried three-necked flask fitted with a condenser 
was cooled to 0 °C and charged with CH2Cl2 (9.3 mL) followed by TiCl4 (0.113 mL, 1.03 
mmol). To the resulting solution was added THF (0.550 mL, 6.27 mmol) dropwise at 
which time the solution turned yellow. The addition of THF was followed by the 
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dropwise addition of TMEDA (0.930 mL, 6.17 mmol), resulting in the formation of a 
brown solution. The ice bath was removed and the mixture was allowed to stir for 20 min. 
Activated Zn dust (151 mg, 2.32 mmol) and PbCl2 (34.0 mg, 0.122 mmol) were then 
added. The resulting mixture went through a series of color changes from brown to green 
to purple and finally to blue-green over the course of 5 min. To the slurry was transferred 
a solution of ester 1.246 (10.0 mg, 8.16 µmol) and CH3CHBr2 (0.093 mL, 1.0 mmol) in 
CH2Cl2 (0.5 mL + 0.5 mL rinse) via cannula. The reaction mixture was then heated at 
reflux for 4 h. Following this time period the mixture was cooled to 0 °C and quenched 
with sat. K2CO3 (aq., 0.1 mL). After stirring for 30 min at 0 °C, the resulting mixture was 
filtered. The mixture was filtered and the residue was washed with 1:1 hexanes:ethyl 
acetate (3 x 10 mL).  The filtrate was combined and concentrated. Chromatography 
(hexanes:ethyl acetate, 20:1 to 10:1) provided cyclic enol ether 1.247 (7.0 mg, 72%) as a 
colorless oil. Rf  0.85 (hexanes:ethyl acetate, 3:1); [α]D20 = -18.3 (c = 0. 18, CH2Cl2); 1H 
NMR (500 MHz, C6D6) δ 7.80-7.78 (m, 4 H), 7.46 (d, J =7.3 Hz, 1 H), 7.31 (d, J = 6.8 
Hz, 2 H), 7.24-7.06 (m, 15 H), 6.81-6.79 (m, 2 H), 4.73-4.61 (m, 3 H), 4.46-4.45 (m, 1 
H),4.41 (d, J =11.2 Hz, 1 H), 4.33 (s, 2 H), 4.25-4.18 (m, 2 H), 3.92 (m, 1 H), 3.74-3.61  
(m, 3 H), 3.51-3.39 (m, 4 H), 3.35-3.30 (m, 2 H), 3.28 (s, 3 H), 2.58-2.54 (m, 1 H), 2.48-
2.28 (m, 2 H), 2.24-2.19 (m, 1 H), 2.11-1.97 (m, 5 H), 1.94-1.82 (m, 2 H), 1.79-1.71 (m, 
3 H), 1.69-1.47 (m, 8 H), 1.45-1.35 (m, 4 H), 1.22 (s, 3 H), 1.18 (s, 9H), 0.97 (s, 9 H), 
0.91 (d, J = 6.8 Hz, 3 H), 0.12 (d, J =2.9 Hz, 6 H); 13C NMR (125 MHz, C6D6) δ 159.7, 
154.2, 139.7, 139.5, 136.0, 134.5, 131.2, 129.9, 129.4, 128.8, 128.4,128.3, 127.6, 127.5, 
127.4, 127.2, 126.6, 125.4, 114.0, 93.2, 87.4, 85.4, 83.3, 81.5, 79.2, 77.7, 77.6, 72.8, 72.8, 
72.2, 71.7, 71.4, 70.8, 70.7, 64.4, 54.7, 44.4, 37.6, 35.0, 33.5, 33.2, 30.8, 30.5, 30.2, 29.9, 
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29.5, 27.7, 27.2, 27.1, 26.1, 24.6, 23.1, 20.4, 19.5, 18.4, 12.8, 12.7, -1.7, -1.8; IR (neat) 
2927, 2856, 1612, 1587, 1462, 1378, 1249, 1110, 834 cm-1; LRMS (ESI) calcd for 
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OLEFINIC AMIDE AND OLEFINIC LACTAM CYCLIZATIONS 
BY USING A REDUCED TITANIUM ALKYLIDENE 
 
 Introduction 
Because enamides show a good balance between reactivity and stability, they are 
important in organic synthesis.1Thenucleophilic reactivity by the virtue of the enamine 
character is tempered by the electron withdrawing functionality upon the nitrogen center, 
leading to significant chemical stability. These two characteristics make enamides key 
intermediates in the synthesis of a variety of heterocyclic compunds.1 The importance and 
relevance of enamides both as building blocks and target units has been reflected in the 
number of different approaches reported for their synthesis.2 However, addition work is 
still needed. In particular, methods that utilize simple methods to accomplish their 
synthesis are needed. 
 
Titanium reagents for the alkylidenation of  
carboxylic acid derivatives 
Alkylidenation of esters as illustrated for 2.1 are very useful transformations. 
Ring closing metathesis of alkylidenated product 2.2 afford cyclic enol ether 2.3 which is 
a powerful intermediate in organic synthesis (Scheme 2.1).3 
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Scheme 2.1. A general way to synthesize cyclic enol ethers 
 
Titanium-based reagents have been used widely to alkylidenate carbonyl 
groups.3,4 The methylenation of aldehyde and ketones by these non-basic, highlyreactive 
reagents provides advantages over other methylenation methods (such as the Wittig 
reaction), particularly when base-sensitive substrates are used or when the carbonyl group 
is sterically hindered.3(a) In addition,the alkylidenation of esters makes these titanium-
based reagents distinct.3(a) 
The Tebbe reagent 2.5 is a titanium-aluminum metallacycle which contains two 
tetrahedral centers linked by a pair of bridging ligands.5,6 Titanium features two 
cyclopentadienyl ([C5H5]−, or Cp) ligands and aluminum features two methyl ligands. 
The titanium and aluminum atoms in the Tebbe reagent are bridged by both CH2 and 
chloride ligands. It is synthesized from titanocene dichloride and trimethylaluminum in 
toluene solution6 (Scheme 2.2). Treatment of Tebbe reagent with a mild Lewis base such 
as pyridine affords a highly reactive titanocene methylidene 2.6 which is able to react 
with a wide range of carbonyl derivatives.5, 7 
In 1994, Grubbs and co-workers reported the synthesis of furan and pyran rings 
by a two-step sequence involving Tebbe methylenation followed by ring closing 
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Scheme 2.3. Synthesis of the cyclic enol ether by a two-step’s protocol 
 
Dimethyltitanocene 2.10, also commonly called the Petasis reagent,  is readily 
prepared by the reaction of methyl magnesium chloride9 or methyllithium10 with 
titanocene dichloride. Studies by Hughes11 showed the methylenation of carbonyl groups 
by the Petasis reagent proceeds by rate-determining generation of titanocene methylidene 
2.6 via α-elimination, followed by a rapid reaction with a carbonyl group (Scheme 2.4). 
The advantages of the Petasis reagent include its stability to air and moisture and its non- 
























The Takeda reagent,Cp2Ti[P(OEt)3]2 2.13, is generated by reduction of titanocene 
dichloride with magnesium in the presence of triethylphosphite in dry THF (Scheme 2.5). 
In 1997, Takeda and co-workers reported the reduction of thioacetals by low valent 
titanium complex 2.13 to give titanium reagents 2.15 which would alkylidenate esters.12 
The key advantage of the Takeda reagent is the range of alkylidenating reagents than can 
be produced and the ease of synthesis of thioacetal substrates.3(a)   
In 1987, Takai and co-workers reported the stereoselective alkylidenation of 
esters to give Z-enolethers3(d) (Scheme 2.6). A titanium alkylidene reagent prepared from 
TiCl4, TMEDA, THF,1,1-dibromoalkane, Zn and PbCl2 was used in these reactions. 
Rainier and co-workers developed a general synthetic strategy to polycyclic ethersthat 
involves a sequential esterification, a Takai methylenation, ring closing metathesis and C-
glycoside formation.In the formal total synthesis of (±)-hemibrevetoxin B, alcohol 2.19 
was esterified and subjected to methylenation followed by ring closing metathesis to give 
cyclic enol ether 2.21. Epoxidation followed by trimethylaluminum addition gave 2.23 
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then AlMe3, hexane, 
-65 oC to 0 oC (75%)
Scheme 2.7. Rainier’s strategy towards polycyclic enol ethers 
 
Clark and co-workers reported a similar approach to construct cyclic enol ethers 
involving a Takai methylenation and ring closing metathesis (Scheme 2.8). They first 
converted olefinic-ester 2.24 to acyclic enol ether 2.25. Then they used ring closing 
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Related work on one-step olefinic-ester cyclization 
There are relatively few reports of transforming 2.1 into 2.3 bypassing acyclic 
enol ether 2.2 although it is more efficient than the two-step protocol. Here is a brief 
summary of the one-step olefinic-ester cyclization. 
In the total synthesis of capnellene15, Grubbs and co-workers found that ester-
substituted norbornene 2.27 reacted with the Tebbe reagent to give stable metallacycle 
2.28. On heating, metallacycle 2.28 rearranged to a carbene-olefin complex 2.29. An 
intramolecular trapping of the intermediate titanium alkylidene by tert-butyl ester 
afforded 2.30 which underwent hydrolysis and protection to give ketal 2.31 in 81% yield 




















(81% for 2 steps)
2. 27
2. 28 2. 29






Scheme 2.9. Synthesis of capnellene using titanium reagents 
150 
 
Later, Nicolaou and coworkers reported a one-pot methylenation-RCM procedure 
using the Tebbe and the Petasis reagents.16  Tebbe methylenation of ester 2.32 was carried 
out at rt to give acyclic enol ether 2.33. Heating 2.33 with the same reagent afforded 
cyclic enol ether 2.34. A combination of the two steps in a single pot proved convenient 
and efficient (Scheme 2.10). This process could effect the formation of seven-membered 
enol ether ring 2.36 in moderate yield. Complex substrate 2.37 also cyclized under these 
conditions to give 2.38 in 61% yield.16 
There are limitations to the use of the Tebbe reagent. Yamamoto and co-workers 
found Nicolaou’s process to be ineffective in their approach to the gambierol G-ring.17 
All attempts to effect cyclization of 2.39 resulted in failure and none of 2.40 was obtained 
(Scheme 2.11).  
Another impressive approach was reported by Takeda and co-workers in 2001. 
They reported the intramolecular carbonyl olefination using a thioacetal-Cp2Ti[P(OEt)3]2 
system.18 The reaction was able to deliver a series of five-, six- and seven-membered 
cyclic enol ethers in good yield (Scheme 2.12). Five-membered cyclic enol ether 2.42 
was formed in 71% yield from 2.41. Six-membered cyclic enol ether 2.44 was formed in 
56% yield from 2.43. Seven-membered enol ether 2.46 was formed in 68% yield. 
Hirama and co-workers found that the tandem methylenation-RCM was difficult 
when the ester was sterically hindered. During the synthesis of HIJKLM ring segment of 
ciguatoxin CTX3C, they found that the transformation of 2.47 to 2.48 was not 
reproducible using the Tebbe reagent.19 However, the intramolecular Takeda 
alkylidenation of thioacetal 2.49 gave the same enol ether 2.48 reproducibly in 52-67% 























Tebbe reagent (4 eq.) 















Tebbe reagent (4 eq.), THF, 







































Tebbe reagent (4 eq.), THF, 





THF, 25 oC, 20 min (77%)
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THF, rt, 3 h
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Discovery of a titanium ethylidenereagent 
Over the past several years, our group has reported the cyclizations of olefinic-
esters and olefinic-lactones using an in situ generated titanium ethylidene reagent.20 
These reactions represent a significant milestone because when compared to a two-step 
metathesis sequence, the methodology is more efficient. A reduced titanium reagent was 
chosen here because of its increased reactivity relative to dimethyltitanocene and its 
diminished Lewis acidity relative to the Tebbe reagent.21 In addition, the in situ 
preparation of the reduced titanium and its tolerance of a wide variety of functionality 
makes it among the more useful titanium reagents.22 
The special reactivity of the reduced titanium ethylidene reagent can be traced 
back to the mid-2000s. During the total synthesis of gambierol,23 Henry Johnson from our 
group found that a related titanium methylidene reagent that comes from the use of 
dibromomethane as the alkylidene source decomposed the cyclization precursor. 
However, the use of a titanium ethylidene (utilizing dibromoethane instead of 
dibromomethane) gave a 2:1 mixture favoring cyclic enol ether 2.51 over acyclic enol 
ether 2.52 as shown in Scheme 2.14. These results showed, for the first time, the different 
reactivity profile between the titanium methylidene and the titanium ethylidene.   
Later, in the synthesis of a model of gambieric acid A,24 Scott Roberts also found 
that the cyclic to acyclic product distribution was dependent on the titanium alkylidene 
reagent used as shown in Scheme 2.15. If dibromomethane was used, olefinic ester 2.53 
was converted to acyclic enol ether 2.55. However, if dibromoethane was used, only 







































































































TiCl4, CH2Cl2, THF, 
TMEDA, Zn, PbCl2
CH2Br2, 65 oC
2. 53 (R= H)



















In terms of scope, we found that the titanium ethylidene can be used in olefinic- 
ester and olefinic-lactone cyclizations (Scheme 2.16). Linear olefinic ester 2.57 was 
converted to seven-membered enol ether ring 2.58 with 82% yield.20(a) Similarly, lactone 
2.59 was converted to 2.60 in one step in  87% yield.20(b) 
 
Related work on olefinic-amide cyclization 
Although a substantial amount of work has been published on olefinic-ester 
cyclizations, there are few reports on the corresponding olefinic-amide reactions.  
Takeda and co-workers reported a Ti(II)-promoted cyclization of dithianes with 
pendant amides as shown in Scheme 2.17. They believe the highly substituted enamine 
2.62 is produced by the isomerization of the enamine 2.64. Enamine 2.64 was formed 
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2. 63 2. 64  
Scheme 2.17. Ti(II)-promoted reductive alkylation of anilides with thioacetals 
 
from an intramolecular carbonyl olefination of the intermediary titanium carbene 
complex 2.63.25 
In work more closely related to that described here, Bennasar reported a 
methylenation/ring-closing metathesis sequence to synthesize enamide-containing benzo-
fused heterocycles26 (Scheme 2.18). They first converted amide 2.65 to the acyclic 
enamide using dimethyltitanocene. In the next step, Grubbs’ second generation catalyst 
was used to convert the acyclic enamide to the corresponding cyclic enamide 2.66 in 44% 
overall yield for the two steps. They used this chemistry to synthesize indoles, 
dihydroquinolines and dihydroisoquinolines in yields that ranged from 40% to 55%.  
Considering our group’s work on olefinic-lactone and olefinic-ester cyclizations, 




1) Cp2TiMe2, reflux, 4 h





2) Grubbs' 2nd Gen












Grubbs' 2nd generation catalyst
 
Scheme 2.18. Sequential methylenation-enamide ring-closing metathesis 
 
Results and Discussion 
We first studied the olefinic-lactam cyclizations as show in Scheme 2.19. Due to 
the potential reaction of the carbonyl protecting groups with the titanium reagent, we 
used Ts protected amides in these studies. When ε-caprolactam derivative 2.67 was 
subjected to the titanium ethylidene reagent, 6-membered enamide ring 2.68 was formed 
in 82% yield. The cyclization of δ-valerolactam derivative 2.69 and 2-pyrrolidinone 
derivative 2.72 also gave cyclic enamides 2.70 and 2.73 in 70% and 65% yields, 
respectively.27 
Further studies demonstrated that not only six-membered enamide ring could be 
formed in this way, but that five-membered and seven-membered rings could also be 
formed (Scheme 2.20). Cyclization of 2.75 generated five-membered enamide ring 2.76 
as the exclusive product in 80% yield. Cyclization of 2.77 afforded the seven-membered 
ring substrate 2.78 in 60% yield, along with 10% of acyclic enamide 2.79 and 5% of 




















TiCl4, CH2Cl2, THF, 
TMEDA, Zn, PbCl2
CH3CHBr2
TiCl4, CH2Cl2, THF, 
TMEDA, Zn, PbCl2
CH3CHBr2
2. 67 2. 68
2. 69 2. 70 (70%) 2. 71 (8%)




Scheme 2.19. Olefinic-lactam cyclizations 
 
Interestingly, when ε-caprolactam derivative 2.81 was subjected to the reaction 
conditions, four-membered ring 2.82 was formed. Due to its instability, 2.82 was 
hydrolyzed to cyclobutanone 2.83 for characterization. What is more, 2.82 could be 
converted into useful intermediates in organic synthesis such as bromoaminal 2.84 which 
came from the treatment of 2.82 with NBS in methanol. 
The formation of the four-membered ring substrate 2.82 provided support for our 
mechanistic hypothesis where olefin metathesis to give 2.92 is followed by carbonyl 
olefination (Scheme 2.21). It is unlikely to form the cyclobutene through metathesis of 















TiCl4, CH2Cl2, THF, 
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CH3CHBr2
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M = Ti, Zn, Pb






















































Scheme 2.21. Proposed mechanism for the generation of cyclic lactam 2.82 
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Having demonstrated olefinic-lactam cyclizations, we next explored the 
cyclization of aromatic substrates as shown in Scheme 2.22. The cyclization of 2.93 
afforded indole 2.94 with 70% yield. Bennasar’s two-step protocol on a related substrate 
2.100 resulted in a 40% overall yield26 (Scheme 2.23). The cyclization of 2.95 resulted in 
a 78% yield of dihydroquinoline 2.96. The more challenging cyclization of olefinic-
amide 2.97 resulted in a 58% of seven-membered ring 2.98 and a 18% yield of the 
corresponding acyclic enamide 2.99. When Bennasar used their two-step protocol to 
construct the seven-membered ring from 2.103, they were able to isolate 50% of 2.105 
and 7% of 1.106 which came from olefin isomerization and cyclization26 (Scheme 2.23). 
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Scheme 2.23. Bennasar’smethylenation/ring-closing metathesis 
 
Finally, we examined the cyclization of linear amides such as 2.107 and 2.108 
which lack cyclic templates (Scheme 2.24). The cyclization of 2.107 resulted in a 60% 
yield of cyclic enamide 2.109 and a 20% yield of acyclic enamide 2.110. In support of 
the olefin metathesis, carbonyl olefination proposed in Scheme 2.21, we resubjected 
acyclic enamide 2.110 to the reaction conditions and did not observe the formation of 
cyclic enamide 2.109. The cyclization of 2.108 also gave a similar result with a 60% of 
cyclic enamide 2.111 and 20% of acyclic enamide 2.112. 
All the lactams and amides discussed above were protected with a tosyl group. 
The deprotection of tosyl group generally takes place under harsh conditions. In order to 
make this chemistry more user friendly, we tested some other protecting groups (Table 
2.1). When benzyl protected substrate 2.113 was subjected to the reaction conditions, no 
cyclic product was observed. The reaction gave an inseparable and unidentified mixture. 

























2.107 2.109 (60%) 2.110 (20%)




Scheme 2.24. Olefinic-amide cyclizations 
 
But in the reaction of substrate 2.114, the nosyl group was reduced, which made the 
reaction very messy. Boc protected olefinic-amide 2.115 gave 30% of the cyclic product, 
along with a number other products that made the purification very difficult.  
 








Entry Substrate Protecting Group Result 
1 2.113 Bn Inseparable mixture 
2 2.114 Ns Ns was reduced 
3 2.115 Boc 30% of cyclic product 
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In summary, the distinct activity of titanium ethylidene reagent makes it useful 
not only in olefinic-ester cyclizations, but also in olefinic-amide cyclizations. This 
chapter has described the olefinic-amide and olefinic-lactam cyclizations using an in situ 
generated reduced titanium ethylidene reagent in good to excellent yields. The 
advantages of this reagent are obvious. It’s relatively inexpensive, generated in situ and 
tolerant of a variety of function groups. However, the excess amount of reagents used in 
the reaction limits its use in large scale reactions. We will further optimize the reaction 
conditions and explore the scope of olefinic-carbonyl cyclization. 
 
Experimental Section 
NMR spectra were recorded on either a Varian Inova-500 MHz or a Varian VXR-
500 MHz spectrometer. Chemical shifts were reported in δ, parts per million (ppm), 
relative to benzene (7.15) or chloroform (7.25) as internal standards. Coupling constants, 
J, were reported in Hertz (Hz) and refer to apparent peak multiplicities and not true 
coupling constants. Mass spectra were recorded at the Mass Spectrometry Facility at the 
Department of Chemistry of the University of Utah at Salt Lake City on a Finnigan MAT 
95 mass spectrometer. IR spectra were recorded on a Bruker Tensor 27 FT-IR 
spectrometer. Solvents were purified according to the guidelines in Purification of 
Common Laboratory Chemicals (Perrin, Armarego, and Perrin: Oxford, 1966). (i-Pr)2NEt, 
2,6-lutidine, TMEDA and pyridine were distilled from CaH2. Spectroscopic grade DMF 
was stored over activated 4Å molecular sieves and used without purification. Zn dust 
(<10 μm, Aldrich) was activated by sequentially washing with HCl, H2O, ether, and 
acetone and then drying under vacuum overnight. All other reagents were used without 
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purification. Unless otherwise stated, all reactions were run under an atmosphere of dried 
nitrogen in flame-dried glassware. Concentration refers to removal of solvent under 
reduced pressure (house vacuum at ca. 20 mmHg). 
General procedure for the formation of N-tosyl protected amides: 
            To a cold (0 °C) solution of NaH (60% dispersion in mineral oil, 1.3 equiv.) in 
dry THF (4.0 mL/mmol substrate) was added a solution of amide (1.0 equiv.) in THF (1.0 
mL/mmol substrate). The reaction mixture was stirred at 0 °C for 1 h. To this mixture 
was added a solution of tosyl chloride (1.3 equiv.) in dry THF (2.0 mL/mmol substrate) 
via cannula. The reaction mixture was warmed to rt over 1 h and quenched with sat. 
NH4Cl (aq., 10 mL/mmol substrate) once the starting material had been completely 
consumed. The aqueous phase was extracted with CH2Cl2, dried (MgSO4) and 
concentrated. The resulting residue was purified by flash chromatography. 
General procedure for the formation of N-tosyl protected lactams: 
To a solution of lactam (1.0 equiv.) in THF (2 mL/mmol substrate) at 0 °C was 
added a solution of n-BuLi (1.1 equiv.) in THF (2 ml/mmol substrate). After the resulting 
reaction mixture had stirred for 1 h, a solution of tosyl chloride (1.3 equiv.) in THF (2.0 
mL/mmol substrate) was added via cannula. The ice bath was removed after 0.5 h, the 
reaction mixture was warmed to rt, and the reaction was quenched with water. The 
aqueous phase was extracted with CH2Cl2, the extracts were dried (MgSO4) and 
concentrated. The resulting residue was purified by flash chromatography. 
General procedure for olefinic-amide/lactam cyclizations: 
A flame-dried three-necked flask fitted with a condenser was cooled to 0 °C and 
charged with CH2Cl2 (288 mL/mmol substrate) followed by TiCl4 (32 equiv.). To the 
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resulting solution was added THF (192 equiv.) dropwise at which time the solution 
turned yellow. The addition of THF was followed by the dropwise addition of TMEDA 
(192 equiv.) resulting in the formation of a brown solution. The ice bath was removed 
and the mixture was allowed to stir for 20 min. Activated Zn dust (72 equiv.) and PbCl2 
(3.8 equiv.) were then added. The resulting mixture went through a series of color 
changes from brown to green to purple and finally to blue-green over the course of 3-5 
min. To the slurry was transferred a solution of lactam (1.0 equiv.) or amide (1.0 equiv.) 
and CH3CHBr2 (32 equiv.) in CH2Cl2 (20 mL/mmol substrate) via cannula. The reaction 
mixture was then heated at reflux for 2-4 h. Following this time period the mixture was 
cooled to 0 °C and quenched with sat. K2CO3 (aq., 6.5 mL/mmol substrate). After stirring 
for 30 min at 0 °C, the resulting mixture was filtered. The residue was washed with 1:1 
hexanes:ethyl acetate (3 x 200 mL/mmol).  The filtrate was combined and concentrated. 






2. 67  
3-(pent-4-enyl)-1-tosylazepan-2-one (2.67). Prepared according to the general 
procedure described above using hexahydro-3-(4-penten-1-yl)-2H-azepin-2-one29 (91 mg, 
0.50 mmol), n-BuLi (0.34 mL of a 1.6 M solution in THF, 0.55 mmol), and tosyl chloride 
(124 mg, 0.650 mmol) to give 144 mg (86%) of  N-tosyl protected lactam 2.67 as a 
colorless oil after flash chromatography (hexanes:ethyl acetate, 20:1 to 5:1). Rf  0.52 
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(CH2Cl2);  1H NMR (500 MHz, C6D6) δ 8.08 (d, J = 8.3 Hz, 2 H), 6.76 (d, J = 8.3 Hz, 2 
H), 5.68 (dddd, J = 17.1, 10.3, 6.8, 6.8 Hz, 1 H), 4.98-4.92 (m, 2 H), 4.50 (ddd, J = 16.2, 
3.9, 3.9 Hz, 1 H), 2.95-2.90 (m, 1 H), 1.97-1.84 (m, 3 H), 1.82 (s, 3 H), 1.73-1.66 (m, 1 
H), 1.38-0.92 (m, 9H); 13C NMR (125 MHz, C6D6) δ 175.3, 143.8, 138.8, 138.3, 129.2, 
129.1, 114.7, 45.7, 45.1, 34.2, 32.0, 30.0, 28.7, 28.1, 26.8, 21.1; IR (neat) 3062, 2934, 
2860, 1700, 1350, 1168, 1107, 1089 cm-1; LRMS (ESI) calcd for  C18H25NO3SNa  358.1 
(M+Na+), found 358.1. 
NTs
2. 68  
1-tosyl-2,3,4,5,5a,6,7,8-octahydro-1H-benzo[b]azepine (2.68). The general 
cyclization protocol was carried out on lactam 2.67 (25 mg, 0.075 mmol) using 
TiCl4(0.26 mL, 2.4 mmol) in CH2Cl2 (21.5 mL), THF (1.26 mL, 14.4 mmol), TMEDA 
(2.15 mL, 14.4 mmol), activated Zn dust (350 mg, 5.4 mmol), PbCl2 (79 mg, 0.28 mmol), 
and CH3CHBr2 (0.22 mL, 2.4 mmol) in CH2Cl2 (1.4 mL + 1.4 mL rinse) to give 19 mg 
(82 %) of 2.68 as a colorless oil after flash chromatography (hexanes:ethyl acetate, 20:1 
to 10:1 to 5:1). Rf  0.52 (CH2Cl2);1H NMR (500 MHz, C6D6) δ 7.80 (d, J = 7.8 Hz, 2 H), 
6.80 (d, J = 7.8 Hz, 2 H), 5.56-5.55 (m, 1 H), 3.59 (ddd, J = 12.7, 7.8, 4.4 Hz 1 H), 3.14 
(ddd, J = 12.2, 7.3, 3.4 Hz, 1 H), 2.24-2.20 (m, 1 H), 1.89 (s, 3 H), 1.88-1.82 (m, 1 H), 
1.77-1.70 (m, 1 H), 1.64-1.56 (m, 1 H), 1.52-1.46 (m, 1 H), 1.41-1.09 (m, 7 H);  13C 
NMR (125 MHz, C6D6) δ 142.3, 140.9, 139.4, 129.3, 127.6, 127.6, 50.6, 38.8, 33.8,  30.3, 
28.8, 25.44, 25.41,  21.1, 19.6; IR (neat) 2929, 2858, 1450, 1340, 1158, 1112, 1090 cm-1; 






2. 69  
3-(pent-4-enyl)-1-tosylpiperidin-2-one (2.69). Prepared according to the general 
tosylate forming procedure using3-(4-penten-1-yl)- 2-piperidinone30 (91 mg, 0.50 mmol), 
n-BuLi (0.34 mL of a 1.6 M solution in THF,  0.55 mmol), and tosyl chloride (124 mg, 
0.650 mmol) to give 141 mg (88%) of  N-tosyl protected lactam 2.69 as a colorless oil 
following flash chromatography (hexanes:ethyl acetate, 20:1 to 5:1). Rf 0.77 
(CH2Cl2:CH3OH, 10:1);  1H NMR (500 MHz, C6D6) δ 8.08 (d, J = 8.3 Hz, 2 H), 6.80 (d, 
J = 8.3 Hz, 2 H), 5.64 (dddd, J = 16.6, 10.3, 6.4, 6.4 Hz, 1 H), 4.95-4.91 (m, 2 H), 3.66-
3.56 (m, 2H), 1.84 (s, 3 H), 1.81-1.71 (m, 3 H), 1.66-1.60 (m, 1H), 1.29-1.22 (m, 1H), 
1.19-1.02 (m, 5H), 0.79-0.71 (m, 1H); 13C NMR (125 MHz, C6D6) δ 172.5, 144.0, 138.6, 
137.6, 129.2, 114.7, 46.5, 43.3, 33.9, 30.6, 26.3, 25.6, 22.2, 21.1; IR (neat) 3072, 2932, 
2867, 1694, 1352, 1168, 1120, 1090 cm-1; LRMS (ESI) calcd for C17H23NO3SNa  344.1 
(M+Na+), found 344.1. 
NTs
2. 70  
1-tosyl-1,2,3,4,4a,5,6,7-octahydroquinoline (2.70). The general cyclization 
protocol was carried out on lactam 2.69 (26 mg, 0.081 mmol) using TiCl4 (0.28 mL, 2.6 
mmol) in CH2Cl2 (23 mL), THF (1.37 mL, 15.6 mmol), TMEDA (2.32 mL, 15.6 mmol), 
activated Zn dust (378 mg, 5.82 mmol), PbCl2 (86. mg, 0.31 mmol), and CH3CHBr2 (0.24 
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mL, 2.6 mmol) in CH2Cl2 (1.5 mL + 1.5 mL rinse) to give 16.5 mg (70 %) of 2.70 and 
2.2 mg (8%) of the corresponding acyclic enamide 2.71 as colorless oils after flash 
chromatography (hexanes:ethyl acetate, 20:1 to 10:1 to 5:1). Data for 2.70: Rf 0.53 
(hexanes:ethyl acetate, 3:1); 1H NMR (500 MHz, C6D6) δ 7.80 (d, J = 8.3 Hz, 2 H), 6.76 
(d, J = 8.3 Hz, 2 H), 6.11 (dd, J = 5.3, 2.9 Hz, 1 H), 4.36-4.31 (m, 1 H), 2.79-2.73 (m, 1 
H), 1.99-1.92 (m, 1 H), 1.86 (s, 3 H), 1.85-1.79 (m, 1 H), 1.58-1.51 (m, 1 H), 1.40-1.35 
(m, 2 H), 1.28-1.18 (m, 3 H), 1.04-1.00 (m, 1 H), 0.92-0.71 (m, 2 H); 13C NMR (125 
MHz, C6D6) δ 142.4, 140.1, 137.4, 129.4, 128.3, 124.7, 48.1, 35.3, 32.7, 31.3, 25.6, 24.9, 
21.6, 21.1; IR (neat) 3056, 2931, 2857, 1452, 1337, 1265, 1158, 1087 cm-1; LRMS (ESI) 
calcd for C16H21NO2SNa  314.1 (M+Na+), found 314.1. 
Acyclic enamide2.71:  1H NMR (500 MHz, C6D6) δ 7.84-7.78 (m,3 H), 6.78-6.74 
(m, 2 H), 5.75-5.71 (m, 1 H), 5.51-5.32 (m, 3 H), 4.14-4.11 (m, 1 H), 2.76-2.74 (m, 1 H), 
2.40 (m, 1 H), 1.89-1.83 (m, 11 H), 1.74-1.60 (m, 8 H), 1.47-1.32 (m, 27 H); IR (neat) 
2925, 2856, 1711, 1452, 1339, 1267, 1160, 1092, 706 cm-1; LRMS (ESI) calcd for 




2. 72  
3-(pent-4-enyl)-1-tosylpyrrolidin-2-one (2.72). Prepared according to the 
general tosylate forming procedure described above using3-(4-penten-1-yl)-2-
pyrrolidinone29 (77 mg, 0.50 mmol), n-BuLi (0.34 mL of a 1.6 M solution in THF, 0.55 
mmol), and tosyl chloride (124 mg, 0.650 mmol) to give 130 mg (85%) of N-tosyl 
protected lactam 2.72 as a colorless oil following flash chromatography (hexanes:ethyl 
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acetate, 20:1 to 5:1). Rf  0.40 (hexanes:ethylacetate, 3:1);  1H NMR (500 MHz, C6D6) δ 
8.10 (d, J = 8.3 Hz, 2 H), 6.74 (d, J = 8.3 Hz, 2 H), 5.59 (dddd, J = 16.2, 11.2, 6.8, 6.8 Hz, 
1 H), 4.92-4.88 (m, 2 H), 3.54 (ddd, J = 9.8, 8.8, 2.5 Hz, 1 H), 3.16 (ddd, J = 9.3, 9.3, 7.3 
Hz 1H), 1.79 (s, 3 H), 1.74-1.69 (m, 2 H), 1.60-1.45 (m, 2H), 1.17-1.11 (m, 1H), 1.04-
0.71 (m, 4H); 13C NMR (125 MHz, C6D6) δ 172.4, 144.5, 138.3, 136.6, 129.5, 128.6, 
114.8, 45.2, 42.7, 33.6, 29.7, 26.2, 24.6, 21.1; IR (neat) 2930, 2857, 1699, 1347, 1166, 
1088 cm-1; LRMS (ESI) calcd for C16H22NO3S  308.1 (M+H+), found 308.1. 
NTs
2. 73  
1-tosyl-2,3,3a,4,5,6-hexahydro-1H-indole (2.73). The general cyclization 
protocol was carried out on lactam 2.72 (19 mg, 0.062 mmol) using TiCl4 (0.22 mL, 2.0 
mmol) in CH2Cl2 (18 mL), THF (1.04 mL, 11.9 mmol), TMEDA (1.77 mL, 11.9 mmol), 
activated Zn dust (289 mg, 4.45 mmol), PbCl2 (65 mg, 0.23 mmol), and CH3CHBr2 (0.18 
mL, 2.0 mmol) in CH2Cl2 (1.2 mL + 1.2 mL rinse) to give 11 mg (65 %) of 2.73 and 2 
mg (10%) of the corresponding acyclic enamide 2.74 as colorless oils after flash 
chromatography (hexanes:ethyl acetate, 20:1 to 10:1 to 5:1). Data for 2.73: Rf  0.55 
(hexanes:ethyl acetate, 3:1); 1H NMR (500 MHz, C6D6) δ 7.80 (d, J = 7.8 Hz, 2 H), 6.76 
(d, J = 7.8 Hz, 2 H), 6.07 (dd, J  = 6.4, 3.5 Hz, 1 H), 3.61 (dd, J = 8.8, 8.8 Hz, 1 H), 2.96 
(ddd, J = 10.7, 9.7, 5.8, 1 H), 2.03-1.88 (m, 2 H), 1.84 (s, 3 H), 1.49-1.40 (m, 3 H), 1.19 
(ddd, J = 11.7, 6.3, 6.3 Hz, 1 H), 1.08-0.98 (m, 1 H), 0.85-0.69 (m, 2 H); 13C NMR (125 
MHz, C6D6) δ 143.0, 139.9, 136.1, 129.4, 127.7, 105.0, 49.2, 39.5, 29.4, 28.3, 24.1, 22.0, 
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21.0; IR (neat) 3055, 2987, 2926, 2850, 1420, 1362, 1266, 1222, 1164, 1091 cm-1; LRMS 
(ESI) calcd for C15H19NO2SNa  300.1 (M+Na+), found 300.1. 
Acyclic enamide 2.74: 1H NMR (500 MHz, C6D6) δ 7.80 (d, J = 8.3 Hz, 2 H), 
7.76 (d, J = 7.82 Hz, 2 H), 6.75 (m, 4 H), 5.33-5.22 (m, 3 H), 3.52-3.46 (m, 1 H), 3.33-
3.23 (m, 2 H), 2.2 (m, 2 H), 1.89-1.80 (m, 10 H), 1.73-1.68 (m, 4 H), 1.58-1.57 (m, 6 H), 
1.50-1.46 (m, 4 H), 1.35-1.18 (m, 7 H), 1.14-1.06 (m, 3 H), 1.01-0.70 (m, 16 H), 0.57 (t, 
1 H); IR (neat) 2930, 1349, 1165, 1092 cm-1; LRMS (ESI) calcd for C19H27NO2SNa  






3-(but-3-enyl)-1-tosylazepan-2-one (2.75). Prepared according to the general 
procedure described above using hexahydro-3-(3-buten-1-yl)-2H-azepin-2-one30 (84 mg, 
0.50 mmol), n-BuLi (0.34 mL of a 1.6 M solution in THF, 0.55 mmol), and tosyl chloride 
(124 mg, 0.650 mmol) to give 135 mg (84%) of  N-tosyl protected lactam 2.75 as a 
colorless oilafter flash chromatography (hexanes:ethyl acetate, 20:1 to 5:1). Rf  0.39 
(hexanes:ethyl acetate, 3:1); 1H NMR (500 MHz, C6D6) δ 8.07 (d, J = 8.3 Hz, 2 H), 6.79 
(d, J = 8.3 Hz, 2 H), 5.64-5.56 (m, 1 H), 4.92-4.88 (m, 2 H), 4.50 (ddd, J = 16.1, 3.9, 2.9 
Hz, 1 H), 2.96 (ddd, J = 15.6, 9.8, 2.4 Hz, 1H), 2.07-2.02 (m,1 H), 1.89-1.78 (m, 3 H), 
1.83 (s, 3 H), 1.37-1.28 (m, 3H), 1.14-1.07 (m, 2 H), 0.94 (m, 2 H); 13C NMR (125 MHz, 
C6D6) δ 175.3, 143.9, 138.5, 138.1, 129.2, 127.8, 115.0, 45.1, 44.7, 31.5, 31.4, 29.8, 28.7, 
28.0, 21.1; IR (neat) 3060, 2935, 2860, 1699, 1348, 1167, 1088 cm-1; LRMS (ESI) calcd 




2. 76  
1-tosyl-1,2,3,4,5,5a,6,7-octahydrocyclopenta[b]azepine (2.76). The general 
cyclization protocol was carried out on lactam 2.75 (15 mg, 0.047 mmol) using TiCl4 
(0.165 mL, 1.51 mmol) in CH2Cl2 (13.5 mL), THF (0.79 mL, 9.0 mmol), TMEDA (1.35 
mL, 9.07 mmol), activated Zn dust (219 mg, 3.37 mmol), PbCl2 (50 mg, 0.18 mmol), and 
CH3CHBr2 (0.137 mL, 1.50 mmol) in CH2Cl2 (1.0 mL + 1.0 mL rinse) to give 10.9 mg 
(80 %) of 2.76 as a colorless oil following flash chromatography (hexanes:ethyl acetate, 
20:1 to 10:1 to 5:1). Rf 0.56 (hexanes:ethyl acetate, 3:1); 1H NMR (500 MHz, C6D6) δ 
7.78 (d, J = 8.3 Hz, 2 H), 6.75 (d, J = 7.9 Hz, 2 H), 5.85 (dd, J = 4.4, 2.5 Hz, 1 H), 4.24-
4.19 (m, 1 H), 2.73-2.67 (m, 1 H), 2.23-2.07 (m, 2 H), 1.85 (s, 3 H), 1.82-1.75 (m, 1 H), 
1.54-1.09 (m, 6 H), 1.02-0.94 (m, 1 H), 0.87-0.76 (m, 1 H);  13C NMR (125 MHz, C6D6) 
δ 144.2, 142.7, 138.4, 129.3, 127.7 115.8, 49.3, 46.5,  34.8, 32.5, 29.7, 29.6, 28.7, 21.0; 
IR (neat) 2922, 2850, 1450, 1343, 1160, 1090 cm-1; LRMS (ESI) calcd for 




2. 77  
3-(hex-5-enyl)-1-tosylazepan-2-one (2.77). To a solution of ε-caprolactam (95 
mg, 0.80 mmol) in THF (5 mL) at 0 °C was added n-BuLi (0.65 mL of a 2.5 M solution 
in hexane, 1.6 mmol) dropwise. The resulting reaction mixture was stirred for 1 h, after 
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which 6-bromo-1-hexene (0.11 mL, 0.80 mmol) was added. The reaction was quenched 
after 1 h by pouring the mixture into sat. NaCl (aq., 10 mL). The organic phase was 
separated and the aqueous phase was extracted with CH2Cl2 (3 x 20 mL). The combined 
organic extracts were dried (Na2SO4) and concentrated to give a pale brown oil which 
was taken to the next step without further purification.  
The oil from above was subjected to the general tosylation procedure using n-
BuLi (0.344 mL of a 1.6 M solution in THF, 0.55 mmol), and tosyl chloride (124 mg, 
0.650 mmol) to give 142 mg (51% for 2 steps) of N-tosyl protected lactam 2.77 as a 
colorless oil after flash chromatography (hexanes:ethyl acetate, 20:1 to 5:1). Rf  0.43 
(hexanes:ethyl acetate, 3:1);  1H NMR (500 MHz, C6D6) δ 8.09 (d, J = 8.3 Hz, 2 H), 6.75 
(d, J = 8.3 Hz, 2 H), 5.72 (dddd, J = 17.1, 10.3, 6.8, 6.8 Hz, 1 H), 5.01-4.95 (m, 2 H), 
4.50 (ddd, J = 16.1, 3.4, 3.4 Hz, 1 H), 2.89 (ddd, J = 15.6, 6.4, 6.4 Hz, 1 H), 1.95-1.87 (m, 
3 H), 1.80 (s, 3 H), 1.74-1.67 (m, 1 H), 1.37-0.88 (m, 11 H);  13C NMR (125 MHz, C6D6) 
δ 175.4, 143.8, 139.0, 138.2, 129.2, 129.1, 114.5, 45.8, 45.1, 33.9, 32.3, 30.0, 29.3, 28.8, 
28.1, 27.0, 21.1; IR (neat) 2929, 2857, 1700, 1348, 1166 cm-1; LRMS (ESI) calcd for 
C19H27NO3SNa  372.2 (M+Na+), found 372.2. 
NTs
2. 78  
(E)-1-tosyl-1,2,3,4,5,5a,6,7,8,9-decahydrocyclohepta[b]azepine (2.78). The 
general cyclization protocol was carried out on lactam 2.77 (31 mg, 0.089 mmol) using 
TiCl4 (0.31 mL, 2.9 mmol) in CH2Cl2 (26 mL), THF (1.5 mL, 17 mmol), TMEDA (2.50 
mL, 16.8 mmol), activated Zn dust (417 mg, 6.41 mmol), PbCl2 (94 mg, 0.33 mmol), and 
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CH3CHBr2 (0.26 mL, 2.8 mmol) in CH2Cl2 (1.7 mL + 1.7 mL rinse) to give 17  mg 
(60 %) of  2.78 and 2.7 mg (10%) of the corresponding acyclic enamide 2.79 as  colorless 
oils after flash chromatography (hexanes:ethyl acetate, 20:1 to 10:1 to 5:1). Data for 2.78: 
Rf  0.56 (hexanes:ethyl acetate, 3:1); 1H NMR (500 MHz, C6D6) δ 7.82 (d, J = 7.8 Hz, 2 
H), 6.79 (d, J = 7.8 Hz, 2 H), 5.72 (dd, J = 6.8, 6.8 Hz, 1 H), 3.76 (ddd, J = 13.2, 4.4 Hz, 
1 H), 2.95 (ddd, J = 13.2, 10.3, 3.0 Hz, 1 H), 2.33 (dd, J = 9.8, 9.8 Hz, 1 H),  1.89 (s, 3 H), 
1.85-1.55 (m, 7 H), 1.51-1.23 (m, 6 H), 1.11-1.04 (m, 1 H); 13C NMR (125 MHz, C6D6) δ 
142.1, 140.2, 132.6, 129.3, 128.3, 128.2, 52.4, 45.1, 33.5, 32.4, 30.5, 29.3, 27.3, 26.9, 
25.9, 21.1;IR (neat) 3282, 2928, 1599, 1328, 1160, 1093 cm-1; LRMS (ESI) calcd for 
C18H27NO3SNa  342.1 (M+Na+), found 342.1. 
Acyclic enamide 2.79: 1H NMR (500 MHz, C6D6) δ 8.09 (d, J = 7.82 Hz, 2 H), 
6.75 (d, J = 7.81 Hz, 2 H), 5.46-5.34 (m, 2 H), 4.51-4.47 (m, 1 H), 2.9 (m, 1 H), 1.95-
1.89 (m, 2 H), 1.81 (s, 3 H), 1.74 (m, 1 H), 1.59 (m, 2 H), 1.52-1.48 (m, 1 H), 1.35-1.30 
(m, 3 H), 1.26-1.22 (m, 1 H), 1.18-1.16 (m, 2 H), 1.13-1.02 (m, 3 H), 1.0-0.93 (m, 2 H), 
0.83 (m, 1 H); IR (neat) 2928, 2856, 1700, 1597, 1348, 1166, 1087 cm-1; LRMS (ESI) 
calcd for C22H33NO2SNa  386.2 (M+Na+), found 386.2. 
NTs
O
2. 81  
3-allyl-1-tosylazepan-2-one (2.81). Prepared according to the general procedure 
described above using hexahydro-3-(2-propen-1-yl)-2H-azepin-2-one31 (77 mg, 0.50 
mmol), n-BuLi (0.34 mL of a 1.6 M solution in THF,  0.55 mmol), and tosyl chloride 
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(124 mg, 0.650 mmol) to give 131 mg (85%) of  N-tosyl protected lactam 2.81 as a 
colorless oil after flash chromatography (hexanes:ethyl acetate, 20:1 to 5:1). Rf 0.45 
(hexanes:ethyl acetate, 3:1); 1H NMR (500 MHz, C6D6) δ 8.08 (d, J = 8.3 Hz, 2 H), 6.79 
(d, J = 8.3 Hz, 2 H), 5.60 (dddd, J = 17.1, 10.3, 8.3, 5.8 Hz, 1 H), 4.90-4.84 (m, 2 H), 
4.48 (ddd, J = 15.5, 5.0, 3.0 Hz, 1 H), 2.84 (ddd, J = 15.7, 9.8, 2.5 Hz, 1H), 2.39 (dtt, J = 
14.1, 9.3, 1.5 Hz,1 H), 2.01-1.97 (m, 1 H), 1.89-1.83 (partially obscured m,  1 H), 1.83 (s, 
3 H), 1.37-1.26 (m, 4 H), 0.92-0.86 (m, 2 H); 13C NMR (125 MHz, C6D6) δ 175.1, 143.9, 
138.0, 136.4, 129.2, 127.8, 116.9, 45.3, 45.1, 36.4, 28.9, 28.3, 21.1; IR (neat) 3071, 2933, 
2859, 1700, 1348, 1107, 1037 cm-1; LRMS (ESI) calcd for C16H21NO3SNa 330.1 
(M+Na+), found 330.1. 
NHTs
O
2. 83  
4-methyl-N-(4-(2-oxocyclobutyl)butyl)benzenesulfonamide (2.83). The general 
cyclization protocol was carried out on lactam 2.18 (10.0 mg, 0.0325 mmol) using TiCl4 
(0.116 mL, 1.06 mmol) in CH2Cl2 (9.5 mL), THF (0.56 mL, 6.39 mmol), TMEDA (0.95 
mL, 6.39 mmol), activated Zn dust (154 mg, 2.37 mmol), PbCl2 (35 mg, 0.126 mmol), 
and CH3CHBr2 (0.096 mL, 1.05 mmol) in CH2Cl2 (0.6 mL + 0.6 mL rinse) to give 2.82. 
Because of its instability, 2.82 was characterized as the hydrolyzed product 2.83 as 
described below. 
To a solution of the residue from the cyclization of 2.81 in ethyl acetate (3 mL) at 
0 °C was added 1.0 M HCl (2 mL) . After the reaction mixture was allowed to warm to rt 
over 1 and the reaction was quenched with sat. NaHCO3 (aq., 10 mL). The phases were 
separated and the aqueous phase was extracted with CH2Cl2 (3 × 30 mL). The organic 
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extracts were dried with MgSO4 and concentrated. The resulting residue was purified by 
flash chromatography (hexanes:ethyl acetate, 10: to 5:1 to 2:1) to give ketone 2.83 (6.0 
mg, 63% for two steps) as a colorless oil. Rf  0.17 (hexanes:ethyl acetate, 3:1); 1H NMR 
(500 MHz, CDCl3) δ 7.72 (d, J = 8.2 Hz, 2 H), 7.29 (d, J = 7.9 Hz, 2 H), 4.32 (broad s, 1 
H), 3.20 (broad s, 1 H), 3.04-2.96 (m, 1 H), 2.93-2.84 (m, 3 H), 2.41 (s, 3 H), 2.14 (ddd, J 
= 21.0, 10.3, 4.9 Hz, 1 H), 1.63-1.55 (m, 3 H), 1.47-1.23 (m, 5 H); 13C NMR (125 MHz, 
CDCl3) δ 211.8, 143.4, 137.0, 129.7, 127.1, 60.1, 44.5, 42.9, 29.4, 29.0, 24.0, 21.5, 16.8; 
IR (neat) 3425 (broad), 1769, 1643, 1324, 1157, 1091 cm-1; LRMS (ESI) calcd for 




2. 84  
(1S,7R,9S)-9-bromo-1-methoxy-2-tosyl-2-aza-bicyclo[5.2.0]nonane (2.84). To 
a solution containing crude 2.82 (0.072 mmol) in methanol (5 mL) at 0 °C was added 
NBS (20 mg, 0.11 mmol). The reaction mixture was stirred at 0 °C for 2 h at which time 
the reaction was quenched with sat. NaHCO3 (aq., 2 mL). The resulting mixture was 
extracted with CH2Cl2 (3 × 20 mL), dried (MgSO4) and concentrated. The resulting 
residue was purified by flash chromatography (hexanes:ethyl acetate, 10:1 to 5:1) to give 
diasteromers 2.84a (10.9 mg, 39% for two steps) and 2.84b (5.3 mg, 19% for 2 steps) as 
colorless oils. Data for isomer 2.84a: Rf  0.53 (hexanes:ethyl acetate, 3:1); 1H NMR (500 
MHz, C6D6) δ 7.92 (d, J = 8.3 Hz,  2 H), 6.76 (d, J = 7.8 Hz, 2 H), 5.34 (dd, J = 9.6, 9.6 
Hz, 1 H), 3.66-3.62 (m, 1 H), 3.17 (s, 3 H), 2.60 (ddd, J = 15.0, 12.5, 1.0 Hz, 1 H), 2.42-
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2.36 (m, 1 H), 2.12-2.07 (m, 1 H), 1.85 (s, 3 H), 1.64-1.59 (m, 1 H), 1.47-1.11 (m, 4 H), 
1.02-0.99 (m, 1 H), 0.77-0.68 (m, 1 H); 13C NMR (125 MHz, C6D6) δ 142.9, 139.5, 129.4, 
128.3, 128.2, 127.8, 94.7, 52.1, 48.4, 47.4, 47.2, 35.1, 32.0,  29.5, 29.0, 21.1; IR (neat) 
2918, 2852, 1441, 1160, 1087, 1041 cm-1; LRMS (ESI) calcd for C18H22BrNO3SNa  









Summary of COSY spectrum for 2.84a: 
Proton at 5.34 ppm (H-1) shows crosspeaks with protons at 2.39 ppm (H-2) and 1.61 ppm 
(H-2’) 
Proton at 2.09 ppm (H-3) shows crosspeaks with protons at 2.39 ppm (H-2), 1.61 ppm 
(H-2’) and 1.24 (H-4) 
Proton at 3.64 ppm (H-7) shows crosspeaks with protons at 2.60 ppm (H-7’) and 1.14 
ppm (H-6)  
Proton at 2.60 ppm (H-7’) shows crosspeaks with protons at 3.64 ppm (H-7) and 1.42 
ppm (H-6’) 
Data for isomer 2.84b: Rf  0.48 (hexanes:ethyl acetate, 3:1); 1H NMR (500 MHz, C6D6) δ 
8.18 (d, J = 7.8 Hz,  2 H), 6.77 (d, J = 8.3 Hz, 2 H), 4.82 (dd, J = 5.4, 5.4 Hz, 1 H), 3.61 
(d, J = 16.1 Hz, 1 H), 3.23 (s, 3 H), 2.82-2.75 (m, 1 H), 2.68 (ddd, J = 12.7, 8.8 Hz, 1 H), 
2.55 (ddd, J = 13.3 Hz, 1 H), 2.17-2.10 (m, 1 H), 1.86 (s, 3 H), 1.69 (d, J = 12.7 Hz, 1 H), 
1.46-1.35 (m, 2 H), 1.12-1.09 (m, 2 H), 0.76-0.68 (m, 1 H); 13C NMR (125 MHz, C6D6) δ 
143.0, 138.7, 129.3, 129.2, 128.3, 128.2, 127.8, 95.6, 52.0, 49.9, 48.1, 47.4, 36.4, 34.1,  
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29.98, 29.96, 21.1; IR (neat) 3056, 2927, 2854, 1443, 1342, 1264, 1162, 1088, 1045 cm-1; 
LRMS (ESI) calcd for C18H22BrNO3SNa 410.0 (M+Na+), found 410.0, 412.0 (M+Na++2). 
Summary of COSY spectrum for 2.84b: 
Proton at 4.82 ppm (H-1) shows crosspeak with proton at 2.68 ppm (H-2)  
Proton at 2.55 ppm (H-3) shows crosspeaks with protons at 2.68 ppm (H-2), 2.13 ppm 
(H-4), and 1.46 (H-4’) 
Proton at 3.61 ppm (H-7) shows crosspeaks with protons at 2.79 ppm (H-7’) and 1.11 
ppm (H-6)  





2. 93  
N-tosyl-N-(2-vinylphenyl)acetamide (2.93). Prepared according to the general 
procedure described above using N-(2-ethenylphenyl) acetamide32 (80. mg, 0.50 mmol), 
NaH (26 mg of a 60% dispersion in mineral oil, 0.65 mmol), and tosyl chloride (124 mg, 
0.650 mmol) to give 140 mg (89%) of  N-tosyl protected amide 2.93 as a white waxy 
solid after flash chromatography (hexanes:ethyl acetate, 20:1 to 10:1). mp 73-74 °C; Rf 
0.36 (hexanes:ethyl acetate, 3:1);  1H NMR (500 MHz, C6D6) δ 8.16 (d, J = 8.3 Hz, 2 H), 
7.34 (d,  J = 7.8 Hz, 1 H), 7.00-6.91 (m, 4 H), 6.77 (d, J = 8.8 Hz, 2 H), 5.50 (d, J = 17.0 
Hz, 1 H), 5.02 (d, J = 10.7 Hz, 1 H), 1.85 (s, 3 H), 1.38 (s, 3 H); 13C NMR (125 MHz, 
C6D6) δ 169.4, 144.6, 138.2, 137.2, 135.5, 131.9, 130.6, 130.2, 129.9, 129.3, 129.0, 126.5, 
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117.9, 24.4, 21.2; IR (neat) 3066, 2921, 1709, 1423, 1167 cm-1; LRMS (ESI) calcd for 
C17H17NO3SNa  338.1 (M+Na+), found 338.1. 
N
Ts
2. 94  
2-methyl-1-tosyl-1H-indole (2.94). The general cyclization protocol was carried 
out on amide 2.93 (17 mg, 0.054 mmol) using TiCl4 (0.19 mL, 1.7 mmol) in CH2Cl2 
(15.5 mL), THF (0.91 mL, 10. mmol), TMEDA (1.55 mL, 10.4 mmol), activated Zn dust 
(252 mg, 3.88 mmol), PbCl2 (57 mg, 0.20 mmol), and CH3CHBr2 (0.157 mL, 1.72 mmol) 
in CH2Cl2 (1.0 mL + 1.0 mL rinse) to give 10.8 mg (70 %) of 2.94 as a waxy solid after 
flash chromatography (hexanes:ethyl acetate, 20:1 to 10:1 to 5:1). mp 65-67 °C; Rf  0.62 
(hexanes:ethyl acetate, 3:1);  1H NMR (500 MHz, C6D6) δ 8.50 (d, J = 8.3 Hz, 1 H), 7.50 
(d, J = 8.3 Hz, 2 H), 7.19 (d, J = 7.8 Hz, 1 H), 7.11-7.10 (partially obscured m, 1 H), 7.02 
(t, J = 7.6 Hz, 1 H), 6.38 (d, J = 7.8 Hz, 2 H), 5.91 (d, J = 0.98 Hz, 1 H), 2.40 (s, 3 H), 
1.58 (s, 3 H); 13C NMR (125 MHz, C6D6) δ 144.1, 137.2, 130.2, 129.7, 128.2, 127.8, 
126.4, 124.1, 123.8, 120.3, 115.2, 109.9, 20.9, 15.7; IR (neat) 2921, 1596, 1449, 1367, 




2. 95  
N-(2-allylphenyl)-N-tosylacetamide (2.95). Prepared according to the general 
procedure described above using N–[2-(2-propen-1-yl)phenyl]- acetamide33 (88 mg, 0.50 
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mmol), NaH (26 mg of a 60% dispersion in mineral oil,  0.65 mmol), and tosyl chloride 
(124 mg, 0.650 mmol) to give 140 mg (85%) of N-tosyl protected amide 2.95 as a 
colorless oil after flash chromatography (hexanes:ethyl acetate, 20:1 to 10:1). Rf 0.51 
(CH2Cl2); 1H NMR (500 MHz, C6D6) δ 8.14 (d, J = 8.3 Hz, 2 H), 7.10 (d, J = 7.8 Hz, 1 
H), 7.01 (dd, J = 7.7, 7.6 Hz, 1 H), 6.88 (ddd, J = 7.8, 7.8, 1.5 Hz, 1 H), 6.77-6.75 (m, 3 
H), 5.77 (dddd, J = 17.6, 10.3, 7.8 Hz, 1 H), 5.08 (ddt, J = 17.1, 1.8, 1.8 Hz, 1 H), 4.96 
(dd, J = 9.8, 0.9 Hz, 1 H), 3.59-3.46 (m, 2 H), 1.84 (s, 3 H), 1.40 (s, 3 H); 13C NMR (125 
MHz, C6D6) δ 169.4, 144.5, 141.2, 137.3, 136.8, 135.7, 131.0, 130.1, 129.9, 129.8, 129.3, 
128.3, 127.5, 117.4, 36.1, 24.6, 21.1; IR (neat) 2923, 1708, 1360, 1167 cm-1; LRMS (ESI) 
calcd for C18H19NO3SNa  352.1 (M+Na+), found 352.1. 
N
Ts
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     2-methyl-1-tosyl-1,4-dihydroquinoline (2.96). The general cyclization protocol was 
carried out on amide 2.95 (20 mg, 0.061  mmol) using TiCl4 (0.21 mL, 1.9 mmol) in 
CH2Cl2 (17.5 mL), THF (1.03 mL, 11.8 mmol), TMEDA (1.75 mL, 11.8 mmol), 
activated Zn dust (285 mg, 4.38 mmol), PbCl2 (64 mg, 0.23 mmol), and CH3CHBr2 (0.18 
mL, 1.97 mmol) in CH2Cl2 (1.2 mL + 1.2 mL rinse) to give 14 mg (78 %) of  2.96 as a 
colorless oil following flash chromatography (hexanes:ethyl acetate, 20:1 to 10:1 to 5:1). 
Rf  0.55 (CH2Cl2); 1H NMR (500 MHz, C6D6) δ 8.02 (d, J = 8.3 Hz, 1 H), 7.39 (d, J = 7.8 
Hz, 2 H), 7.05 (t, J = 7.8 Hz, 1 H), 6.89 (dt, J = 7.4, 1.0 Hz, 1 H), 6.54 (d, J = 7.3 Hz, 1 
H), 6.50 (d, J = 7.8 Hz, 2 H), 5.12-5.10 (m, 1 H), 2.32-2.31 (m, 3 H), 1.86 (brs , 2 H), 
1.74 (s, 3 H); 13C NMR (125 MHz, C6D6) δ 143.3, 138.7, 138.7, 135.5, 134.9, 129.1, 
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128.3, 127.8, 127.2, 126.7, 126.6, 120.7, 27.4, 22.6, 21.0; IR (neat) 3032, 2921, 2850, 
1487, 1455, 1356, 1169, 1089 cm-1; LRMS (ESI) calcd for C17H17NO2SNa 322.1 




2. 97  
N-(2-(but-3-enyl)phenyl)-N-tosylacetamide (2.97). To a solution of 2-(3-
butenyl)aniline13 (106 mg, 0.720 mmol) in CH2Cl2 (4.0 mL) at 0 °C was added pyridine 
(0.064 mL, 0.79 mmol) followed by a solution of acetyl chloride (0.065 mL, 0.79 mmol) 
in CH2Cl2 (1.5 mL). After 12 h, the mixture was quenched with sat. NH4Cl (aq., 5 mL). 
The aqueous phase was extracted with CH2Cl2 (3 × 20 mL), dried (MgSO4) and 
concentrated. The resulting residue containing the acetamide corresponding to 2-(3-
butenyl)aniline was taken on to the next step without additional purification. 
The tosyl amide 2.97 was prepared according the general procedure using the 
acetamide from above, NaH (26 mg of a 60% dispersion in mineral oil,  0.65 mmol), and 
tosyl chloride (124 mg, 0.650 mol) to give 136 mg (55% over two steps) of  N-tosyl 
protected amide 2.97 as a colorless oil after flash chromatography (hexanes:ethyl acetate, 
20:1 to 10:1). Rf  0.43 (hexanes:ethyl acetate, 3:1);  1H NMR (500 MHz, C6D6) δ 8.14 (d, 
J =  8.3 Hz, 2 H), 7.06-7.01(m, 2 H), 6.90-6.86 (m, 1 H), 6.79 (d, J = 7.8 Hz, 1 H), 6.77 
(d, J = 7.9 Hz, 2 H), 5.74 (ddt, J = 17.1, 10.3, 6.3 Hz, 1 H), 5.04 (ddd, J = 17.1, 1.8, 1.8 
Hz, 1 H), 4.94 (dd, J = 9.8, 1.0 Hz, 1 H), 2.96-2.90 (m, 1 H), 2.78-2.72 (m, 1 H), 2.44-
2.41 (m, 1 H), 2.33-2.25 (m, 1 H), 1.85 (s, 3 H), 1.40 (s, 3 H); 13C NMR (125 MHz, C6D6) 
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δ 169.4, 144.5, 142.6, 137.8, 137.4, 136.8, 130.4, 130.1, 129.8, 129.8, 129.3, 127.2, 115.6, 
33.7, 30.6, 24.4, 21.1; IR (neat) 3072,  2925, 1708, 1362, 1167 cm-1; LRMS (ESI) calcd 
for C19H21NO3SNa  366.1 (M+Na+), found 366.1. 
N
Ts
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(Z)-2-methyl-1-tosyl-4,5-dihydro-1H-benzo[b]azepine (2.98). The general 
cyclization protocol was carried out on amide 2.97 (35 mg, 0.10 mmol) using TiCl4 (0.37 
mL, 3.4 mmol) in CH2Cl2 (31 mL), THF (1.82 mL, 20.8 mmol), TMEDA (3.10 mL, 20.8 
mmol), activated Zn dust (504 mg, 7.75 mmol), PbCl2 (110 mg, 0.41 mmol), and 
CH3CHBr2 (0.31 mL, 3.4 mmol) in CH2Cl2 (2.0 mL + 2.0 mL rinse) to give 18 mg (58 %) 
of 2.98 and 6.8 mg (18%) of acyclic enamine 2.99 as  colorless oils following flash 
chromatography (hexanes:ethyl acetate, 20:1 to 10:1 to 5:1). Data for 2.98: Rf 0.62 
(hexanes:ethyl acetate, 3:1); 1H NMR (500 MHz, C6D6) δ 7.70 (d, J = 8.3 Hz, 2 H), 7.29 
(dd, J = 7.8, 1.5 Hz, 1 H), 6.94 (dt, J = 7.2, 1.4 Hz, 1 H), 6.91 (t, J = 7.6, 2.0 Hz, 1 H), 
6.79 (dd, J = 7.32, 1.5 Hz, 1 H), 6.65 (d, J = 7.8 Hz, 2 H), 4.79 (t, J = 3.5 Hz, 1 H), 2.88 
(dt, J = 14.7, 5.4 Hz, 1 H), 2.30-2.29 (m, 3 H), 1.97-1.90 (m, 2 H), 1.81 (s, 3 H), 1.66-
1.58 (m, 1 H); 13C NMR (125 MHz, C6D6) δ 142.9, 142.4, 141.2, 138.8, 135.8, 129.5, 
129.4, 129.2, 128.6, 127.8, 126.8, 121.8, 29.2, 28.0, 25.5, 21.1; IR (neat) 2922, 1487, 
1453,  1346, 1162, 1091 cm-1; LRMS (ESI) calcd for C18H19NO2SNa  336.1 (M+Na+), 
found 336.1. 
Acyclic enamine 2.99: Rf 0.67 (hexanes:ethyl acetate, 3:1);  1H NMR (500 MHz, 
C6D6) δ 7.80 (d, J = 8.3 Hz, 2 H), 7.11-6.86 (m, 8 H), 6.72 (d, J = 8.3 Hz, 2 H), 5.78-5.74 
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(m, 1 H), 5.52-5.45 (m, 2 H), 3.0-2.77 (m, 3 H), 2.38 (m, 2 H), 2.0 (m, 3 H), 1.87-1.84 (m, 
6 H), 1.69 (m, 6 H), 1.61-1.56 (m, 6 H), 1.37-1.32 (m, 16 H), 0.99-0.90 (m, 5 H); IR (neat) 
3057, 2920, 2851, 1712, 1350, 1265, 1160, 1092 cm-1; LRMS (ESI) calcd for 





N-(1-phenylpent-4-enyl)-N-tosylacetamide (2.107). To a mixture of NaH (32 
mg of a 60% dispersion in mineral oil, 0.79 mmol) in THF (2 ml) at 0 °C was added 4-
methyl-N-(1-phenylpent-4-enyl)benzenesulfonamide (50 mg, 0.16 mmol). After stirring 
for 1 h, acetyl chloride (0.034 mL, 0.47 mmol) was added directly to the reaction mixture. 
The ice bath was removed and the reaction mixture was warmed to rt at which time the 
reaction was quenched with sat. NH4Cl (aq., 5 mL). The aqueous phase was extracted 
with CH2Cl2 (3 × 30 mL), dried (MgSO4) and concentrated. The resulting residue was 
purified by flash chromatography (hexanes:ethyl acetate, 20:1 to 5:1) to give amide 2.107 
(51 mg, 90%) as a colorless oil. Rf  0.50 (hexanes:ethyl acetate, 5:1);  1H NMR (500 MHz, 
C6D6) δ 7.56 (d, J = 7.33 Hz, 2 H), 7.38 (d, J = 8.3 Hz, 2 H), 7.15-7.05 (m, 3 H), 6.59 (d, 
J = 8.3 Hz, 2 H), 5.85 (t, J = 7.81 Hz, 1 H), 5.71 (dddd, J = 17.1, 10.3, 6.8 Hz, 1 H), 4.99-
4.94 (m, 2 H), 2.56-2.49 (m, 1 H), 2.46-2.39 (m, 1 H), 2.13-2.08 (m, 2 H), 2.07 (s, 3 H), 
1.79 (s, 3 H); 13C NMR (125 MHz, C6D6) δ 170.2, 144.1, 139.3, 137.9, 137.7,  129.5, 
129.5, 128.4, 128.2, 127.8, 115.6, 61.2, 31.9, 31.7, 26.0,  21.0; IR (neat) 3066, 2930, 
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1770, 1698, 1356, 1237, 1166, 1089 cm-1; LRMS (ESI) calcd for C20H23NO3SNa  380.1 






N-(1-phenylpent-4-enyl)-N-tosylpropionamide (2.108). Prepared according to 
the procedure described above for the preparation of 2.107 using 4-methyl-N-(1-
phenylpent-4-enyl)benzenesulfonamide (50 mg, 0.16 mmol), NaH (32 mg of a 60% 
dispersion in mineral oil,  0.79 mmol), and propionyl chloride (0.041 mL, 0.47 mmol) to 
give 51.6 mg (88%) of  N-tosyl protected amide 2.108 as a colorless oil after flash 
chromatography (hexanes:ethyl acetate, 20:1 to 5:1). Rf  0.50 (hexanes:ethyl acetate, 5:1); 
1H NMR (500 MHz, C6D6) δ  7.56 (d, J = 7.3 Hz, 2 H), 7.42 (d, J = 8.3 Hz, 2 H), 7.11-
7.08 (m, 2 H), 7.05-7.03 (m, 1 H), 6.55 (d, J = 8.3 Hz, 2 H), 5.84 (dd, J = 7.8, 7.8 Hz, 1 
H), 5.69 (dddd, J = 17.1, 10.2, 6.8, 6.8 Hz, 1 H), 4.97-4.91 (m, 2 H), 2.55-2.37 (m, 4 H), 
2.15-2.04 (m, 2 H), 1.73 (s, 3 H), 0.83 (t, J = 7.08 Hz, 3 H); 13C NMR (125 MHz, C6D6) 
δ 174.1, 144.1, 139.5, 138.2, 137.7, 129.5, 129.4, 129.2, 128.5, 128.5, 128.3, 128.2, 115.6, 
61.2, 32.1, 31.8, 31.2, 21.0, 9.2; IR (neat) 3066, 2981, 2940, 1761, 1700, 1353, 1162, 










6-methyl-2-phenyl-1-tosyl-1,2,3,4-tetrahydropyridine (2.109). The general 
cyclization protocol was carried out on amide 2.107 (30. mg, 0.084 mmol) using TiCl4 
(0.29 mL, 2.65 mmol) in CH2Cl2 (24.0 mL), THF (1.42 mL, 16.2 mmol), TMEDA (2.41 
mL, 16.2 mmol), activated Zn dust (392 mg, 6.03 mmol), PbCl2 (88 mg, 0.32 mmol), and 
CH3CHBr2 (0.24 mL, 2.63 mmol) in CH2Cl2 (1.5 mL + 1.5 mL rinse) to give 16.5 mg 
(60 %) of 2.109 and 6.4 mg (20%) of the corresponding acyclic enamine 2.110 as 
colorless oils after flash chromatography (hexanes:ethyl acetate, 20:1 to 10:1 to 5:1). 
Data for 2.109: Rf  0.56 (hexanes:ethyl acetate, 5:1); 1H NMR (500 MHz, C6D6) δ 7.71 (d, 
J = 8.3 Hz, 2 H), 7.24 (dd, J = 6.8, 1.0 Hz, 2 H), 7.12 (partially obscured t, J = 7.8 Hz, 1 
H), 7.04 (t, J = 7.4 Hz, 1 H), 6.71 (d, J = 8.3 Hz, 2 H), 5.68 (broad s, 1 H), 4.60 (broad s, 
1 H), 2.31 (d, J = 1.0 Hz, 3 H), 1.83 (s, 3 H), 1.71-1.69 (m, 1 H), 1.43-1.35 (m, 4 H); 13C 
NMR (125 MHz, C6D6) δ 142.9, 140.3, 138.7, 133.1, 129.6, 128.6, 128.3, 127.8, 127.5, 
127.0, 126.3, 113.7, 57.6, 24.6, 23.9, 21.1, 19.2; IR (neat) 2921, 1450, 1344, 1164, 1092 
cm-1; LRMS (ESI) calcd for C19H21NO2SNa  350.1 (M+Na+), found 350.1. 
Acyclic enamide 2.110: Rf  0.66 (hexanes:ethyl acetate, 5:1); 1H NMR (500 MHz, 
C6D6) δ 7.85-7.82 (m,2 H), 7.26-7.25 (m, 2 H),  7.0-7.0 (m, 4 H), 6.75 (m, 2 H), 5.48-
5.28 (m, 2 H), 4.94-4.88 (m, 1 H), 1.93 (m, 2 H), 1.86 (s, 3 H), 1.83-1.78 (m, 2 H), 1.64-
1.56 (m, 2 H), 1.53 (s, 3 H), 1.35-1.32 (m, 2 H), 1.26-1.17 (m, 5 H), 0.91 (m, 1 H), 0.81 
(m, 3 H); IR (neat) 2928, 1338, 1160, 1092 cm-1; LRMS (ESI) calcd for C22H29NO2SNa 







6-ethyl-2-phenyl-1-tosyl-1,2,3,4-tetrahydropyridine (2.111). The general 
cyclization protocol was carried out on amide 2.108 (25 mg, 0.067 mmol) using TiCl4 
(0.23 mL, 2.1 mmol) in CH2Cl2 (19 mL), THF (1.13 mL, 12.8 mmol), TMEDA (1.92 mL, 
12.8 mmol), activated Zn dust (310 mg, 4.8 mmol), PbCl2 (70.8 mg, 0.255 mmol), and 
CH3CHBr2 (0.195 mL, 2.14 mmol) in CH2Cl2 (1.2 mL + 1.2 mL rinse) to give 13.8 mg 
(60 %) of 2.111 and 5.3 mg (20%) of the corresponding acyclic enamide 2.112 as 
colorless oils after flash chromatography (hexanes:ethyl acetate, 20:1 to 10:1 to 5:1). 
Data for 2.111: Rf  0.63 (hexanes:ethylacetate, 3:1); 1H NMR (500 MHz, C6D6) δ 7.74 (d, 
J = 8.3 Hz, 2 H), 7.33 (d, J = 8.3 Hz, 2 H), 7.14 (partially obscured t, J = 7.8 Hz, 2 H), 
7.05 (t, J = 7.3 Hz, 1 H), 6.73 (d, J = 8.3 Hz, 2 H), 5.58 (broad d, J = 3.4 Hz, 1 H), 4.77 
(broad s, 1 H), 3.03 (dq, J  14.6, 7.3 Hz, 1 H), 2.57 (dq, J = 14.6, 7.3 Hz, 1 H), 1.83 (s, 3 
H), 1.71-1.67 (m, 1 H), 1.57-1.50 (m, 1 H), 1.40-1.33 (m, 2 H), 1.14 ( t, J = 7.3 Hz, 3 H); 
13CNMR (125 MHz, C6D6) δ 142.9, 140.2, 139.0, 138.3, 129.6, 128.5, 128.3, 127.6, 
127.1, 126.7, 113.4, 57.2, 30.0, 23.7, 21.1, 19.2, 13.3; IR (neat) 2924, 1451, 1345, 1166, 
1092, 1022 cm-1; LRMS (ESI)  calcd for C20H23NO2SNa  364.1 (M+Na+), found 364.1. 
Acyclic enamide 2.112: Rf  0.66 (hexanes:ethyl acetate, 3:1);  1H NMR (500 MHz, 
C6D6) δ 7.87-7.83 (m,2 H), 7.31-7.18 (m, 3 H), 7.06-7.0 (m, 5 H), 6.78 (m, 2 H), 5.40-
5.25 (m, 3 H), 5.01-4.92 (m, 1 H), 2.28-2.15 (m, 1H), 2.09-1.96 (m, 3 H), 1.88 (m, 7 H), 
1.81 (s, 2 H), 1.65 (m, 1 H), 1.56 (d, J = 5.86 Hz, 3 H), 1.36-1.30 (m, 5 H), 1.09 (m, 1 H), 
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1.02-0.98 (m, 3 H), 0.80 (t, J = 7.33 Hz, 1 H); IR (neat) 2934, 1454, 1339, 1160, 1092, 
1005, 703, 667 cm-1; LRMS (ESI) calcd for C24H31NO2SNa 420.2 (M+Na+), found 420.2. 
NHTsPh
2.113  
4-methyl-N-(1-phenylpent-4-enyl)benzenesulfonamide (2.113). 3-butenylmag- 
nesium bromide34 (3.8 mL, 0.80 mol/L) was added dropwise to a solution of N-
benzylidenebenzenesulfonamide35 (259 mg, 1.00 mmol) in THF (1.0 mL) at -78°C. The 
reaction mixture was warmed to rt over 1 h after which time the reaction was quenched 
with sat. NH4Cl (aq., 5 mL). The phases were separated and the aqueous phase was 
extracted with CH2Cl2 (3 × 30 mL). The organic extracts were dried (MgSO4) and 
concentrated. The resulting residue was purified by flash chromatography (hexanes:ethyl 
acetate, 10:1 to 3:1) to give 2.113 (246 mg, 78%) as a colorless solid. mp 66-68 °C; Rf 
0.40 (hexanes:ethyl acetate, 3:1);  1H NMR (500 MHz, C6D6) δ 7.74 (d, J = 8.3, 2 H), 
7.00-6.98 (m, 2 H), 6.94-6.88 (m, 3 H), 6.67 (d, J = 8.3, 2 H), 6.43 (d, J = 8.3 Hz, 1 H), 
5.63-5.55 (m, 1 H), 4.91-4.87 (m, 2 H), 4.45 (ddd,  J = 7.3, 7.3, 7.3 Hz, 1 H), 1.95-1.82 
(m, 3 H), 1.85 (s, 3 H), 1.70-1.61 (m, 1 H); 13C NMR (125 MHz, C6D6) δ 142.5, 141.6, 
139.0, 137.6, 129.4, 128.5, 127.4, 127.2, 127.0, 115.4, 58.1, 37.2, 30.4, 21.0; IR (neat) 
3276 (broad), 3064, 2924, 1641, 1599, 1453, 1323, 1158, 1092 cm-1; LRMS (ESI) calcd 
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13C NMR, 125 MHz, CsDs 
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13C NMR, 125 MHz, C6Ds 
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